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Abstract 
 
This thesis represents a continuation of the work on the isolation and 
structure elucidation of potential drug leads from terrestrial fungal sources 
that the natural products group at the University of Canterbury has been 
engaged in. 
 
Capillary NMR spectroscopy was involved in the research as the main tool 
for dereplication and elucidating the structures of novel bioactive 
compounds as well as for biosynthetic studies.  
 
Eleven new compounds including five cyclic peptides, four related pyrones 
and two diketopiperazines were isolated from the extract of Aspergillus sp. 
of endophyte collected from Malaysia. The five peptides F8268-A-1 to 
F8268-A-5 showed excellent P388 (HCT116 (ATCC CCL-247) and human 
breast cancer, MCF7 (ATCC HTB-22)) activities. Two of the peptides 
F8268-A-3 and F8268-A-5 were 4,000 times more active when compared 
with commercial drugs (fluorouracil, cisplatin and tamoxifen). The partial 
stereochemistries of F8268-A-2 and F8268-A-3 were established by 
Marfey’s method.  
Four related pyrones isolated from the same extract were also shown to have 
good P388 activities. They are related to the known compound NF00659A3. 
The relative stereochemistries were established from NOSEY experiments 
and the energy-minimised (MM2) model created using CHEM 3D software. 
Two new diketopiperazines, F7474-D3 and F7474-D11, also isolated from 
the Aspergillus extract did not show activity in the P388 assay. F7474-D11 
contained the amino acid Me-kynurenine which is the first report of this 
from a natural source. The absolute stereochemistry of F7474-D11 was 
elucidated by Marfey’s method. The other diketopiperazine F7474-D3 was 
  
iv 
similar to the known compound lumpidin, and combined use of ROESY 
NMR and Marfey’s method established that the constituent amino acids had 
the unusual R configuration.  
 
Dereplication has been greatly improved by the application of capillary 
NMR. For example, the HPLC analysis and UV library searching of 
compounds from extracts F8095 and F7855 suggested they contained related 
compounds belonging to the lasiodiplodin family. However, CapNMR 
spectroscopic analysis and AntiMarin database searching revealed that the 
compounds from F8095 were all known polyesters while the compounds 
from F7855 did belong to the lasiodiplodin family. Two new lasiodiplodins 
were found in the F7855 extract, 
(3R,4R)-4-hydroxy-de-O-methyl-lasiodiplodin (F7855-4) and 
(E)-9-etheno-de-O-methyl-lasiodiplodin (F7855-6). The relative 
stereochemistries were elucidated from NMR coupling constant analyses. 
 
Two new dimers (F7090-A and F7090-B) were elucidated from a New 
Zealand fungal endophyte. The differences between these two dimers was 
their stereochemistries. F7090-A had the same stereochemistries for the 
three stereocentres in both parts, while the stereochemistry of F7090-B was 
different in the two parts of the dimer.  
 
Biosynthetic studies were also carried out using CapNMR methodology. A 
known compound tetrahydrofuran A and a new compound tetrahydrofuran B 
from an unidentified New Zealand fungus were used for this study. For the 
first time an INADEQUATE NMR experiment was successfully carried out 
using CapNMR spectroscopy, thus demonstrating the capability for carrying 
out biosynthetic studies on a very small scale (<200 µg of 13C-labelled 
compound). 
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The implementation of efficient dereplication procedures with CapNMR 
methodology is paramount for those working in the field of natural products. 
The recent advances that have been made in the dereplication process in the 
natural products group at the University of Canterbury are given using 
examples from this research and where necessary from other group 
members. 
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Abbreviations 
 
%   percent 
ACN   acetonitrile 
amu  atomic mass unit 
°C  degrees Centigrade 
CapNMR     Capillary Nuclear Magnetic Resonance spectroscopy 
CD3OD       deuterated methanol 
CDCl3        deuterated chloroform 
d            doublet (in connection with NMR data) 
DMSO-d6     deuterated dimethylsulfoxide              
EtOAc  ethyl acetate  
g  gram(s) 
hr  hour 
H2O   water 
HPLC   high pressure liquid chromatography  
Hz           Hertz 
IC50   50% inhibitory Concentration 
min          minute 
mL   millilitre 
NMR         Nuclear Magnetic Resonance 
Pet. Ether     petroleum ether 
q             quartet (in connection with NMR data) 
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sp.           species 
t             triplet (in connection with NMR data) 
TFA   trifluoroacetic acid 
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Introduction 
 
 
 
1.1 Natural Products 
 
Natural products are naturally derived metabolites and/or byproducts 
isolated from microorganisms, plants, or animals.1 A natural product is 
generally referred to as a secondary metabolite. In other words a metabolite 
that is not essential for the normal growth, development or reproduction of 
an organism. Until the late 19th Century the major source of drugs was from 
terrestrial plants. After the discovery of penicillin (1.1) in the early 1900s, 
interests were directed towards bioactive secondary metabolites from 
terrestrial microorganisms. Since the early 1940s over 5,000 antibiotic 
agents have been identified, primarily from actinomycetes. Antibiotic 
production by fungi is second only to the actinomycetes with approximately 
1,600 compounds characterized.2 Of the top ten commercially used 
antibiotics or antibiotic classes isolated from fungi, the penicillins (1.1), the 
cephalosporins (1.2), griseofulvin (1.3) and fusidic acid (1.4) have been the 
most important. 
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The natural product landscape offers entry into the drug discovery process in 
a number of ways.3 In the most direct case, a natural product may itself 
possess all of the potency to be a clinically useful drug agent. More often are 
the instances where the natural products themselves serve as lead agents, 
providing the chemist with a structural platform which can be elaborated 
upon, or simplified, to yield a therapeutically valuable pharmaceutical. 
Analogues that can be accessed through modification of the natural product 
itself are considered to be “natural product-derived”. Alternatively, a 
biologically active natural product may serve as an inspiration for the 
medicinal discovery chemist, by providing insight into types of structural 
features that may prove valuable, this being called “natural 
product-inspired”. 
 
1.2 Natural Products and Traditional Approaches in Medicine 
 
Natural products have been exploited for human use for thousands of years. 
The plant kingdom has served as the main source of compounds used for 
medicine. The very first records were written on clay tablets from 
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Mesopotamia and date from about 2600 BC. The best-known Egyptian 
pharmaceutical record is the Ebers papyrus dating from 1500 BC, a 
document that describes around 700 drugs (mostly from plants). It includes 
formulas for gargles, snuffs, poultices, infusions, pills and ointments.4 The 
Chinese Materia Medica has been extensively documented over the centuries, 
with the first record dating from about 1100 BC (Wu Shi Er Bing Fang, 
containing 52 prescriptions), followed by work such as the Shennong Herbal 
(~100 BC; 365 drugs), and Tang Herbal (659 AD; 850 drugs). Likewise the 
documentation of the Indian Ayurvedic systems have records dating back to 
1000 BC.4 Today the largest users of traditional medicines are the Chinese, 
with over 5000 plants and plant products in their pharmacopeia.5 
These traditional medicines, which derive mostly from plants, after clinical, 
pharmacological, and chemical studies, formed the basis of most of the early 
medicines.6 The world’s best known and most universally used medicinal 
agent is aspirin (1.5), which is related to salicin, having its origins in the 
plant genera Salix spp. and Populus spp. is widely used as an antipyretic to 
reduce fever, and as an anti-inflammatory medication. 
Other famous examples include the antimalarial drug quinine (1.6) from the 
bark of Cinchona species, and morphine (1.7), named after Morpheus, the 
Greek god of sleep and dream,7 which comes from the opium poppy, 
Papaver somniferum. 
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1.3 Onset of the “Golden Era” 
 
The discovery of an antibacterial filtrate “Penicillin” (1.1) by Fleming in 
1928, re-isolation and clinical studies by Chain, Florey and co-workers in 
the early 1940s, and commercialisation of synthetic penicillins 
revolutionised drug discovery reseach.8-11 After the success of penicillin, 
drug companies and research groups assembled large microorganism culture 
collections to look for new antibiotics. Successful examples such as 
streptomycin (1.8), chloramphenicol (1.9), chlortetracycline (1.10), 
erythromycin (1.11), and vancomycin (1.12) are still in use as drugs 
today.10-13 
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Natural products as sources of novel therapeutics peaked in the Western 
pharmaceutical industry in the 1970s and 1980s.14 The next breakthrough in 
drug discovery was the use of mechanism-based screens for bioassay-guided 
fraction. In the early 1970s, the β-lactamase inhibitor clavulanic acid (1.13) 
from Streptomyces clavuligerus15 and the HMG-CoA reductase inhibitor 
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mevastatin (1.14) (then named ML-236B) from Penicillium citrinum16 were 
isolated by using the mechanism-based screen methods. 
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1.4 Decline of Natural Products Research  
 
At present, the utility of natural products as sources of novel structures, but 
not necessarily the final drug entity, is still alive and well. In the area of 
cancer, over a time frame from the 1940s to the present, of the 155 small 
molecules, 73% are other than synthetic, with 47% actually being either 
natural products or directly derived therefrom.17 In other areas, the influence 
of natural product structures is also quite marked. For example, the 
antiinfective area is dependent on natural products and their analogues.17 
After very successful drug discovery and development programs based on 
natural products, the pharmaceutical industry de-emphasized natural product 
discovery research in the 1990s and early 2000s.18 This reduction in interest 
in natural products for use in drug development can be attributed to a 
number of factors.14 Firstly, the introduction of high-throughput screening 
(HTS) against defined molecular targets, which prompted many companies 
to move from natural products extract libraries towards ‘screen friendly’ 
synthetic chemical libraries. Secondly, the development of combinatorial 
chemistry, which offered the prospect of simpler, more drug-like screening 
of libraries of wide chemical diversity. Thirdly, advances in molecular 
biology, cellular biology and genomics, which increased the number of 
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molecular targets and prompted shorter drug discovery timelines. Fourthly, a 
declining emphasis among major pharmaceutical companies on infectious 
disease therapy, which has been a traditional area of strength for natural 
products.19 Finally, possible uncertainties with regard to collection of 
biomaterials as a result of the 1992 Rio Convention on Biological 
Diversity.20 
Today’s drug discovery environment calls for rapid screening, hit 
identification and hit-to-lead development. However, traditional resource- 
intensive natural product programmes that are based on extract-library 
screening, bioassay-guided isolation, structure elucidation and subsequent 
production scale-up face a distinct competitive disadvantage when compared 
with defined synthetic chemical libraries.14 
 
1.5 A Natural Products Revival? 
 
Despite the decline in the use of natural products for discovery purposes, 
marketed drugs derived from natural products still account for significant 
revenues. The number of new active substances (NASs), also known as New 
Chemical Entities (NCEs), which encompass all molecules, including 
biologics and vaccines, hit a 24-year low of 25 in 2004, with a rebound of 54 
in 2005.17 
The problems with natural products (vide infra) that resulted in these initial 
decisions are being addressed with technological advances, such as 
increasing the throughput of methods for compound purification and 
identification.21 The combinatorial chemistry approach also has a problem. It 
is imperative that a molecular screening library covers a significant portion 
of chemical diversity space, but is also favourably biased toward ‘biological 
friendliness’ and ‘drug-likeness’.22 Some of the first large combinatorial 
libraries, in some instances containing in excess of one million compounds, 
Chapter 1                          Introduction 
 
8 
were synthesised only to find disappointingly low hit rates, or even no hits. 
These libraries were designed more on the basis of chemical accessibility 
and maximum achievable size than on biologically relevant chemical 
diversity of properties.23  
The reason for natural products possessing the specificity and potency 
compared to artificially designed molecules lies in evolutionary 
selection—nature’s own high-throughput screening process for the 
optimisation of biologically active compounds.24 Natural products 
encompass a wide space of chemical diversity.25 Natural products contain 
well-defined three-dimensional structures with functional groups that are 
suitable for molecular interactions, while synthetic molecules cover a far 
smaller volume of chemical space in comparison to natural products. The 
large molecular diversity of natural products was an enabling factor in lead 
identification when compared with synthetic compounds. Furthermore, 
natural products have evolved in nature to interact with biomolecules. They 
are ‘biologically validated’ to penetrate the cellular barrier and bind to target 
proteins. Also, natural products are desirable targets for drug discovery 
research because the source of natural products is nearly inexhaustible. 
 
1.6 Fungal Secondary Metabolites 
 
Fungi are the second largest group of organisms in the world after the insects. 
It is estimated that there are one and a half million fungi in existence. 
However, with just 5% of this total having being described,26 a huge, still 
unknown and untapped microbial pool remains, which promises the 
discovery of novel, useful and economically profitable compounds. 
Organisms such as fungi, which generally living in highly competitive 
environments, are considered as major producers of secondary metabolites. 
Fungal secondary metabolites are relatively small molecules characterized, 
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not only by their structural diversity,27 but also by diversity of biological 
activity.28 
Cyclosporin A (1.15), mofetil and lovastatin are other well-known examples 
of fungal derived medicines. Cyclosporin A was first discovered as an 
antifungal agent produced by Tolypocladium inflatum.28 Further work found 
it to possess excellent immunosuppressive activity and it has been used as a 
drug to prevent the rejection of transplanted organs.29 
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Even some fungal metabolites that have been known for a long time are 
finding new uses in medicine today. Mycophenolic acid (1.16), a highly 
toxic fungal metabolite, initially discovered from Penicillium compactum in 
1896 with the structure reported in 1952.30 In 1995, this compound was 
developed as an immunosuppressive agent and used to prevent rejection in 
organ transplantation. A prodrug derivative of this substance mofetil (1.17) 
to improve oral bioavailability is commercially available.31 More recently, 
the salt mycophenolate sodium has also been introduced. 
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1.7 Endophytic Fungi 
 
Endophytic microorganisms are to be found in virturally every plant on 
earth.32 The most widely accepted definition of an endophyte is given by 
Bacon et al; “microbes that colonise living, internal tissues of plants without 
causing any immediate, overt negative effects.”33 The most frequently 
encountered endophytes are representatives of the fungi.34 
Endophytes may contribute to their host plant by producing a plethora of 
substances that provide protection and ultimately survival value to the 
plant.32 Endophytic fungi had previously been overlooked as potential 
sources of bioactive metabolites. This was most likely due to the absence of 
any sign of fungal colonization in the host plant.35 In the past few decades 
however, it has been realised that plants may contain countless, previously 
undetected, numbers of these microorganisms known as endophytes. This 
has prompted a worldwide scientific effort to isolate endophytes and to study 
their natural products. Scientists have since discovered that endophytes may 
represent potential sources of novel natural products for exploitation in 
medicine, agriculture, and industry. Of the approximately 300,000 higher 
plant species that exist on earth, each individual plant is thought to play host 
to one or more endophytes.32 
 
The majority of endophytic species have been identified as belonging to the 
ascomycete and deuteromycete classes of fungi.36 
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1.7.1 The Endophyte-host Interaction 
 
It is thought that endophytism may have evolved from the time that higher 
plants first appeared on the earth millions of years ago.37 This is supported 
by the fact that plant-associated microbes have been discovered in the 
fossilized tissues of stems and leaves.38 It is plausible therefore, that due to 
these long-held associations, some endophytes may have developed genetic 
systems allowing for transfer of information between themselves and the 
higher plants and vice versa. 
In an endophyte-host interaction, the minimum contribution that the plant 
provides is one of nutrition.37 There are other possibilities for these 
interactions. These could include the possibility that the plant provides 
compounds necessary for the completion of the life cycle of the 
microorganism.39 It is also possible that in some cases the endophyte could 
be responsible for the degradation of the dead or dying host plant, beginning 
the process of nutrient re-cycling. However, an even more important 
mechanism could exist. If mechanisms exist for the exchange of nucleic 
acids, as is likely, then it could also be possible that some of the rare 
molecules made by higher plants could also be produced by endophytes, for 
example taxol. Recently, it has been hypothesised that endophytes may 
protect their host plants by scavenging the damaging reactive oxygen species 
(ROS) generated by the plant defence mechanisms in response to 
environmental stress.40,41 
 
1.7.1.1 Taxol-a case study 
 
Taxol (1.18) is a highly functionalized diterpenoid which is found in all the 
world’s species of Yew (Taxus) tree, although it was first isolated from the 
Pacific yew, Taxus brevifolia.42 
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Discovered in the 1960s, the structure elucidation of taxol was not 
completed until 1971 and FDA approval was in 1992. This highly 
functionalised diterpenoid natural product has evolved to become a 
blockbuster drug with commercial sales of well overs US $3 billion in 
2004.43 The yew is a slow growing tree, and the inner bark of the tree yields 
only 0.01% to 0.03% of its dried weight of taxol. However, a full regimen of 
anti-tumour treatment requires 2g of purified taxol.44 For this reason the cost 
of the drug is phenomenal, making it out of reach for many people. 
A search for an endophyte, that was able to produce taxol was conducted on 
the basis that plant-associated microbes had been found to produce “plant” 
compounds such as gibberellins. Testing of hundreds of microbes by Stierle 
and co-workers, resulted in the discovery that one, a fungal endophyte, 
Taxomyces andreanae was capable of producing taxol.44 Although the yields 
of taxol produced by T. andreanae were low (24-50 ng/L) this represented a 
breakthrough in solving the supply problem, which could only lead to a 
decrease in the cost of this important drug to patients. Since this initial study, 
taxol has been found from other endophytic fungi isolated from a number of 
different sources other than Yew trees. These include Pestalotiopsis 
microspora from the bald cypress,45 P. guepini from the Wollemin Pine 
(Wollemia nobilis),46 and a novel fungus, Seimatoantlerium tepuiense, 
isolated from the plant, Maguireothamnus speciosus,47 which belongs to the 
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same family as blackberry and raspberry. 
 
1.7.2 Natural Products from endophytic microbes 
 
Fungi are the most commonly isolated endophytic microbes. The diverse 
chemistry and bioactivity displayed by natural products isolated from 
endophytic fungi most likely stems from the fact that there are so many 
endophytes that occupy literally millions of unique biological niches (higher 
plants) growing in so many unusual environments.32 Functional metabolites 
of endophytic origin have already demonstrated a considerable potential to 
impact the pharmaceutical arena. A few examples are presented in the 
following section, with the focus on their presumed therapeutic significance.  
 
1.7.2.1 Antimicrobial compounds 
 
Cryptosporiopsis cf. quercina was isolated as an endophyte form 
Tripterigeum wilfordii, a medicinal plant native to Eurasia.48 A unique 
peptide antimycotic, termed cryptocandin (1.19), was isolated and 
characterized from C. quercina.48 Cryptocandin and its related compounds 
are currently being considered for use against a number of fungal-causing 
diseases of the skin and nails.36 
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Phomopsichalasin (1.20), a metabolite from an endophytic Phomopsis sp., 
displayed antibacterial activity in disk diffusion assays against Bacillus 
subtilis, Salmonella gallinarum, Staphylococcus aureus and a moderate 
activity against the yeast Candida tropicalis.49 
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1.7.2.2 Antiviral compounds 
 
Two human cytomegalovirus (hCMV) protease inhibitors, cytonic acids A 
and B (1.21 and 1.22), have been isolated from the endophytic fungus 
Cytonaema sp.
50 hCMV is an ubiquitous opportunistic pathogen that causes 
disease in congenitally infected immune-deficient infants and adults. 
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Studies of the microbial flora characteristic of oak trees resulted in the 
isolation of a potentially valuable fungal specimen from the leaves of 
Quercus coccifera. This endophyte was the producer of hinnuliquinone (1.23) 
– a potent inhibitor of the HIV-1 protease.51 
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1.7.2.3 Antitumoural compounds 
 
Sequoiatones A (1.24) and B (1.25) were isolated from the fungus 
Aspergillus parasiticus, an endophyte of the coast redwood, Sequoia 
sempervirens. These compounds showed moderate and selective inhibition 
of human tumour cells, with the greatest activity against breast cancer cell 
lines.52 
O
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1.7.2.4 Immunosuppressive compounds 
 
Immunosuppressive drugs are used today to prevent allograft rejection in 
transplant patients. The endophytic fungus Fusarium subglutinans, isolated 
from T. wilfordii, produces the immunosuppressive, but noncytotxic 
diterpene pyrones subglutinols A and B (1.26 and 1.27). These diterpene 
pyrones showed substantial immunosuppressive activity while causing none 
of the detrimental cytotoxic effects characteristic of cyclosporin A.53 
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1.8 Work Carried Out at Universiry of Canterbury 
 
As part of the continuing effort to identify new bioactive natural products 
with pharmaceutical potential, the Marine Group at the University of 
Canterbury has explored various habitats, mostly from around New Zealand, 
but also from Antarctica and other locations. Since 1998, more than 10,000 
marine invertebrate and fungal specimens have been screened for cytotoxic, 
antifungal, antimicrobial and antiviral activity, where it has been established 
that ~10% of all isolates show activity in the assays. 
Although much of the research carried out by the group has traditionally 
been marine-orientated, first with marine invertebrates, and then with marine 
fungi, the focus has changed in recent years, in that the group now almost 
entirely concentrates on the isolation of biologically active natural products 
from terrestrial fungi. These include such diverse groups as endophytes 
(fungi living inside of higher plants), entomopathogenic (insect pathogens) 
fungi, and from biological niches such as Malaysian tropical rainforests. 
Coupled with the development of the HPLC microtitre (MT) plate method 
with CapNMR and AntiMarin Database in the dereplication (see Chapter 2) 
of extracts, this “path” has quickly proven to be a rewarding one. 
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1.9 Aim of this Research 
 
The primary aim of this study was to characterise the compounds 
responsible for the biological activity of a wide range of terrestrial fungi, 
collected mainly from Malaysia and New Zealand, and to develop the 
methodology required to make these characterisations more efficient. 
Furthermore, CapNMR methodology was used as a key step for elucidating 
the structures as well as for the dereplication process. Fungal extracts were 
selected based on the biological activity displayed in the anticancer, 
antimicrobial, and antiviral in-house assays. The active components of a 
crude extract were established by the MT method and these active 
compounds from the MT plates would then be examined using CapNMR 
spectroscopy and mass spectrometry techniques. When compounds were 
based on a “no hit” criterion that had to be met following dereplication, 
larger extracts would be obtained to enable more comprehensive NMR 
spectroscopy that would allow determination of the structures of the 
bioactive compounds.  
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Chapter 2 
 
 
 
Dereplication 
 
 
 
2.1 General Introduction 
 
Dereplication is a process for the rapid identification of already known 
natural products. This is strategically important for scientists when screening 
crude extracts from natural sources for novel bioactive compounds.54 The 
continued demand to get new drugs to the market more quickly and more 
cheaply, requires that the analytical technologies that support this work keep 
up with, for example, the rate at which new chemical entities (NCEs) are 
synthesized for high-throughput screening programmes.55 There are 
numerous approaches to dereplication based on hyphenated techniques, and 
each has its own advantages, be they sensitivity, resolution, or scale (mg vs 
µg).56 
The most common approaches are LC-UV, LC-MS, LC-MS/MS and 
LC-NMR, or combinations thereof, and the increasing use of capillary and 
cryo-NMR probes.57-65 Of course, any technique involving mass 
spectrometry will always potentially suffer from problems associated with 
ionization (or lack thereof) of the compounds being studied. Despite this, in 
the pharmaceutical industry these hyphenated techniques are very powerful 
for the monitoring, characterization and identification of impurities.66 Take 
LC-NMR as an example. There are three main coupling technologies, 
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onflow, stopped-flow and loop-storage. However, they all have 
disadvantages. Onflow results in poor signal-to-noise (S/N) ratio for the 
NMR spectra unless a reduced flow rate is used. However, reduced flow can 
then reduce the effectiveness of the chromatographic separation which 
makes this method only suitable for the more intense signals arising from the 
major constituents. Stopped-flow has the advantage that a number of 
chromatographic peaks can be studied, but the frequent stops then necessary 
for data acquisition can disturb the quality of separation, and concentrated 
samples from the major components can contaminate the NMR detection 
cell. Therefore, this approach is most suitable for mixtures having only a 
small number of constituents. In the loop-storage mode, the 
chromatographic run is not interrupted, instead each analyte is stored in a 
separate capillary loop in order for NMR acquisition to be carried out at a 
later stage. A prerequisite for this technique however, is that the analyte must 
be stable during the long NMR analysis time.67 Also, it is very reliant on the 
sensitivity of the NMR instrument. 
For assisting with the sensitivity problem, the use of a cryoprobe has been a 
recent advancement in LC-NMR. In NMR cryoprobes, the electronic 
components are cryogenically cooled to ~20K while the sample remains at 
ambient temperature68 which reduces the electronic noise68 thus gaining a 
better S/N. Cryoprobes provide quite significant sensitivity gains. 
 
2.2 Introduction 
 
The natural products chemistry group at the University of Canterbury has 
been focused on natural products of fungal and marine origin. As well as 
searching for new bioactive natural products, the group has also focused on 
the development of new methodologies for dereplication. During the course 
of these PhD studies, much effort has been involved with assisting with the 
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development of the group’s strategies for dereplication. This chapter 
represents an overview of the dereplication strategies undertaken within the 
group, as well as contributions that have been made to the overall effort 
through these studies. 
The group’s approach to dereplication utilises a combination of HPLC-UV 
and the establishment of UV libraries using HPLC software, MS analysis, 
screening for bioactivity using an in-house assay system and the use of a 
capillary NMR probe (CapNMR). These are all used in conjunction with the 
combined Marinlit/Antibase database known as AntiMarin.69 
In this chapter, examples will be given which demonstrate the value of using 
CapNMR and AntiMarin for the dereplication of known compounds; work 
which has been done as a major part of the development of procedures for 
the group’s programme. Later chapters will describe the extension of the 
techniques to the characterization of new compounds that were identified 
during the dereplication/screening efforts. 
 
2.3 Dereplication Using an HPLC-UV Library Database 
 
The UV libraries were generated using the Chromeleon software on the 
Dionex HPLC system. Two libraries were constructed; “all compounds, 
unknown and known”; and “known compounds”. Naturally, at first, all peaks 
were entered into the former. As standards were obtained and compounds 
identified, these spectra were copied over to the “known compounds” library. 
The “known compounds” library continues to grow as new data is found 
from new extracts, thus improving on its usefulness for the depelication of 
compounds previously found. 
However, even if a match to a known compound were found in the in-house 
UV library, the result might still not be correct, as the earlier work relied on 
MS analysis as a means of confirmation, but now, with the introduction of 
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the CapNMR technique, a more definitive confirmation of compound 
identity can be achieved to support initial results from the UV library 
searching. MS analysis is still used as well to complete the characterisation. 
  
2.4 Enhanced Dereplication Utilizing a CapNMR Probe 
 
Many natural products with intense biological activity are only produced in 
minuscule amounts, a reflection perhaps of natural potency.70 The quantity 
of such compounds that is able to be isolated inevitably falls well below that 
needed to carry out complete structural elucidation using an 
inverse-detection NMR probe with regular or even low-volume tubes 
(Shigemi). This led the Marine Chemistry group at the University of 
Canterbury, and others around the world,70 to investigate the use of 
CapNMR probes. This is not only as a method for obtaining data on the new, 
highly potent compounds, but also as a tool for the dereplication of natural 
product extracts. 
 
2.4.1 An Introduction to the capillary Probe NMR (CapNMR) 
Technique 
 
The sensitivity of NMR spectroscopy depends primarily on three 
instrumental parameters: the strength of the magnetic field (the use of 
stronger magnets results in higher-sensitivity), the size and fill factor of the 
receiver coil (mass-sensitivity improves with increasing fill factor and 
decreasing coil diameter), and the amount of electronic noise introduced 
during detection.71 
The costs for the purchase and installation of a 900-MHz spectrometer can 
easily reach 10 million US dollars. A 600-MHz instrument may only cost 
around 10% of the price of a 900-MHz spectrometer. Meanwhile, the 
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sensitivity of a 900-MHz instrument is only roughly twice that of a 
600-MHz instrument.71    
Recent advances have involved the development of new probes for use at 
lower magnetic fields, but which attempt to gain a similar sensitivity as 
regular probes on higher magnetic field spectrometers. The cryoprobe was 
introduced to give improved S/N ratios for spectra from regular-sized 
samples while the capillary probe was designed to acquire NMR spectra on 
mass-limited samples. A capillary probe uses a flow cell that typically allows 
a flow rate through the NMR probe of 1-50 µL/min and an observation 
volume in the range of 5-10µL.72 This is the reason why the capillary probe 
is sometimes known as a capillary microflow probe. 
Capillary NMR probes permit the acquisition of data for the structural 
analysis of mass-limited samples. It makes it possible to obtain high quality 
spectra from sample amounts that previously would never have yielded data 
of sufficient quality. Alternatively, a larger amount of material can be used to 
get the same S/N ratio in a shorter period of time.55 Normal data acquisition 
typically requires at least 0.5 mg of material, depending on the molecular 
weight of the compound, for an adequate S/N ratio to be achieved in a range 
of NMR experiments (1D and 2D).  
Small volume NMR flow probes were first constructed in the laboratories of 
Sweedler and Albert in the 1990s.73-75 These were developed for coupling to 
various chromatographic methods, resulting in so-called “hyphenated” 
techniques.76 They were designed especially for coupling to capillary 
electrophoresis (CE) and capillary HPLC (CapLC) for the detection of the 
small volumes associated with these techniques. 
A diagrammatic view and photograph of the Protasis capillary probe NMR 
(CapNMR) system purchased by the Department of Chemistry is presented 
in Figure 2.1. 
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Figure 2.1: Diagram showing the capillary probe set-up
70
 and photograph 
of the Protasis capillary probe injection module. 
 
The CapNMR probe has a small flow cell (~5 µL) that is connected to two 
Teflon capillaries, called the inlet and outlet capillaries. For loading of the 
cell, the sample is dissolved in 5 µL of deuterated solvent and injected into 
the inlet capillary via a syringe. This is then followed by injection of 11 µL 
of the deuterated “push” solvent to position the sample in the probe (see 
Figure 2.1).  
For the use in the dereplication process, a CapNMR probe only requires 
2-10 µg of pure compound which can be easily obtained from the microtitre 
plate method (see Experimental 8.1.4). This involves the eluant from the 
HPLC being collected into a 96 well polypropylene microtitre (MT) plate 
(250 µL/well). Daughter plates for biological assays are made into a 
duplicate polystrene MT plate. Typically 5 µL or 50 µL aliquots are removed 
from each well (250 µL) in the master plate. The daughter plates are assayed 
for P388 activity, and the master plate is used for CapNMR analysis. The 
sample recovered from CapNMR analysis is then analysed by ES-mass 
spectrometry.  
A photograph of the HPLC system of the Marine Chemistry Group with a 
DAD UV detector and an ELSD as well as a fraction collector and a picture 
of a MT plate are presented in Figure 2.2. 
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Figure 2.2: Dionex HPLC with DAD and ELCD detectors with fraction 
collector and microtitre plate. 
 
2.4.2 Advantages of dereplication with CapNMR 
 
In the past, without CapNMR, the dereplication process was based mainly 
on data from the mass and UV spectra. However, both techniques have 
disadvantages and are not totally reliable. The mass spectrum can contain 
impurities which makes it difficult to assign the correct molecular mass. 
Furthermore, the spectrum may be dominated by the preferential ionization 
of a minor component, again making it difficult to assign a correct molecular 
mass to the major component. The UV spectrum only gives definitive 
structure information for those compounds with strong chromophores. The 
UV library of the Marine Group within the Dionex analytical HPLC system 
only contains the known compounds which the group has worked on, and to 
date this is not yet a comprehensive collection. Furthermore, many entries in 
the AntiMarin database do not have reported UV data for the compound 
listed. However, even typical UV profiles may also give wrong answers 
since similar chromophores may give the same UV spectra (See 2.5). It is for 
these reasons that NMR data is so important because it can deliver definitive 
structural information. The AntiMarin database includes information on, for 
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example, the number and type of methyl groups, that can be recognised from 
1H NMR spectra.  
With the introduction of CapNMR 1H NMR spectra can be obtained from a 
single HPLC-MT plate collection derived from only 200-500 µg of crude 
extract. The 1H NMR spectrum can then provide specific structural 
information for searching the AntiMarin database. The most readily 
interpreted information available is that for methyl groups which can be 
described as singlets, doublets or triplets depending on their environment. 
Other features, such as the type of substituted benzene rings, are also easily 
recognized.  
From the HPLC separation of 200-500 µg of crude extract, a master MT 
plate can be prepared for the CapNMR experiments and daughter plates 
made for P388 bioactivity tests to locate the bioactive components and 
ESMS measurements. The UV profiles are obtained while collecting the MT 
plate. Therefore, it is now possible to determine from ~ 500 µg if a crude 
extract contains bioactive new compounds, or known compounds. This task 
can be easily completed in one or two days. 
 
2.5 Malaysian Endophyte F8095 
 
F8095 has provided a good example with which to demonstrate the new 
dereplication method, including the use of CapNMR and database searching. 
F8095 was an endophytic fungal extract from Malaysia, with the specimen 
originally being collected by Sultan Sadia (UITM). The crude extract that 
was received had a mass of 4.3 mg. An aliquot of F8095 was analysed by 
reverse phase C18 HPLC using a 25-85% linear gradient (see Experimental 
8.2.1). The HPLC analysis (Figure 2.3) revealed that the extract contained 
seven compounds. From the similarity of their UV profiles (Figure 2.4) the 
seven compounds were related. Based on the HPLC-UV profiles the 
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assumption was made that the compounds contained a highly conjugated or 
aromatic system. 
 
Figure 2.3: HPLC chromatogram of the crude extract of F8095. UV 
detection with ELSD comparison 
 
 
Figure 2.4: UV profile of the major peak from F8095-1 to F8095-7 
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A search of the in-house UV database revealed that these compounds could 
be related to the lasiodiplodins (Figure 2.5) (see Chapter 4). Even though 
this conclusion was based on similarity of retention time, under standard 
conditions, as well as comparability of UV profile it was still necessary to 
definitively establish the structures of this series of compounds. 
 
Figure 2.5: Screenshot of UV library search results for F8095-3 within the 
Dionex analytical HPLC system, showing the correspondence of the UV 
profile of F8095-3 with that of desmethyl-lasiodiplodin. 
 
These seven compounds were isolated from the appropriate wells in the MT 
plate and each examined by CapNMR to obtain their 1H spectra. The 1H 
NMR spectra did not match with any of the known lasiodiplodin structures, 
but each compound contained characteristic features that could be used as 
the basis for searching in the AntiMarin database.  
F8095-1 displayed three doublet methyl and 2 aromatic proton signals in the 
1H NMR spectrum (Figure 2.6). Because the compound had the same UV 
profile as the recorded for the lasiodiplodins, it was considered highly likely 
to also contain a 1,2,3,5-tetrasubstituted benzene system. These features 
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were entered into the AntiMarin database, together with the supposed mass 
of 384 Da (Figure 2.7).  
 
Figure 2.6: The 
1
H spectrum of 15 µg of F8095-1 in CD3OD from CapNMR 
 
 
Figure 2.7: AntiMarin search profile for F8095-1 
 
Two matches were found with the same structure (Figure 2.8), a polyester 
named 15G256V.77 The literature NMR data for this compound also matched 
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those obtained for F8095-1. Therefore, F8095-1 was quickly identified as a 
known compound. 
 
Figure 2.8: AntiMarin search result for F8095-1 
 
The next compound examined, F8095-2, had signals for a doublet methyl 
group and for a 1,2,3,5-tetrasubstituted benzene ring in its 1H NMR 
spectrum (Figure 2.9). These features, together with the supposed mass 194 
Da, were used in an AntiMarin search.  
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Figure 2.9: The 
1
H spectrum of 6 µg of F8095-2 in CD3OD from CapNMR 
 
The NMR data for a (+)-6-hydroxymellein77 matched with the data for 
F8095-2 (Figure 2.10). Therefore, F8095-2 was also shown to be a known 
compound. 
 
Figure 2.10: AntiMarin search result for F8095-2 
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The 1H spectrum of F8095-3 was more complex, containing signals for four 
doublet methyl groups and four aromatic protons (Figure 2.11). These four 
aromatic protons were considered to come from two individual aromatic 
rings, and based on the UV profile, the two aromatic rings were both 
1,2,3,5-tetra substituted. These features, together with the supposed mass of 
680 Da, were used to initiate a search in AntiMarin.  
 
Figure 2.11: The 
1
H spectrum of 16 µg of F8095-3 in CD3OD from 
CapNMR 
 
This search found the polyester 15G256α-277 with matching data for 
F8095-3 (Figure 2.12), and have been reported in the same paper which 
published the previous two compounds. Therefore, F8095-3 was identified 
as a known compound. 
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Figure 2.12: AntiMarin search result for F8095-3 
 
F8095-4 had similar features to those for F8095-3 in its 1H NMR spectrum 
(Figure 2.13). It displayed signals for four doublet methyl groups as well as 
for two 1,2,3,5-tetrasubstituted benzene rings. The mass, 578 Da, was 
different from F8095-3, and was put into an AntiMarin search.  
 
Figure 2.13: The 
1
H spectrum of 8 µg of F8095-4 in CD3OD from CapNMR 
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Again the polyester, 15G256п,77 matched the data for F8095-4 (Figure 2.14). 
Therefore, F8095-4 was also identified as a known polyester. 
 
 
Figure 2.14: AntiMarin search result for F8095-4 
 
F8095-5 and F8095-6 had the same mass (662 Da), and both contained 
signals for four doublet methyl groups and four aromatic protons which 
could also be considered as 1,2,3,5-tetrasubstituted benzene rings from their 
1H NMR spectra (Figure 2.15 and 2.16). These features formed part of the 
AntiMarin search. 
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Figure 2.15: The 
1
H spectrum of 22 µg of F8095-5 in CD3OD from 
CapNMR 
 
 
Figure 2.16: The 
1
H spectrum of 22 µg of F8095-6 in CD3OD from 
CapNMR 
 
Two similar macrocyclic polyesters were found from this search 15G256α 
and 15G256α-1, described by Schlingmann et al.77 The literature data 
suggested that F8095-5 was 15G256α and F8095-6 was 15G256α-1 (Figures 
2.17 and 2.18). Both compounds were thus readily identified as known 
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compounds. 
 
Figure 2.17: AntiMarin search result for F8095-5 
 
 
Figure 2.18: AntiMarin search result for F8095-6 
 
Five doublet methyl groups together with two 1,2,3,5-tetrasubstituted 
benzene ring features were noted in the 1H spectrum of F8095-7 (Figure 
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2.19). These structural features, together with the mass 646 Da, were 
included in an AntiMarin database search. 
 
Figure 2.19: The 
1
H spectrum of 23 µg of F8095-7 in CD3OD from 
CapNMR 
 
A macrocyclic polyester called 15G256β77 (Figure 2.20) was found as a 
match, also from the same paper from Schlingmann et al. The literature data 
were consistent with those observed for F8095-7, thus identifying it as a 
known compound. 
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Figure 2.20: AntiMarin search result for F8095-7 
 
2.6 Discussion 
 
This example using the F8095 extract illustrates just how quickly and 
efficiently the use of LC-UV-MS-NMR, through the intermediary of a 
microtitre plate and in combination with appropriate databases, can be used 
to identify the structures of known compounds starting from a very small 
amount of extract. However, it should be pointed out that with the correct 
setup it is not possible to distinguish between enantiomers or perhaps even 
diastereoisomers of the same overall structure. In the example given the 
polyesters77 were in an all R configuration. The compounds from F8095 
could conceivably have been enantiomeric with the literature polyesters. 
Measuring the optical rotation would help to solve the stereochemistries, but 
optical rotation measurements at the µg scale was not possible. Therefore, 
the stereochemistries of the polyesters presented in this thesis should only be 
considered as relative.  
The dereplication method developed by the Marine Group greatly saves the 
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time taken to determine whether the compounds are known or unknown. 
Firstly, the sample collection amounts required are reduced from grams or 
kilograms down to milligrams only, which can provide a reduction in time 
from months to less than a week for working on the extracts. Furthermore, in 
the purification step, only several µg of compounds are required instead of 
the mg of compounds previously required, again reducing the time from 
weeks of effort to only one or two days using the MT plate HPLC method. 
The compounds isolated from HPLC then can be analysed by CapNMR and 
mass spectrometry to provide useful information for subsequent AntiMarin 
database searching to determine the novelty or otherwise of the compounds. 
The Marine Group’s dereplication method is a fast and reliable method for 
obtaining the information on compounds.56,78 An effort that would 
previously have taken possibly months of work, often with the unfortunate 
outcome of finding a known compound.  
More dereplication examples using CapNMR/database searching are 
described in the following chapters, together with examples where the 
identification of new bioactive compounds can also be readily achieved. 
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Chapter 3 
 
 
 
Compounds from a Malaysian 
Fungal Endophyte  
 
 
 
3.1 Introduction 
 
3.1.1 General 
 
The genus Aspergillus now contains more than 200 species,79 has a 
worldwide distribution and is one of the most common of all groups of fungi. 
Species of Aspergillus are among the most economically important fungi, 
being very widely used for synthesis of chemicals, biosynthetic 
transformations and enzyme production. Since ancient times, Aspergillus 
species have been used in the the preparation of soy sauce in China and 
other Asian countries. The ability of these fungi to produce several organic 
acids, especially citric acid, has created major industries worldwide. 
Aspergillus enzymes are used for such diverse applications as starch 
processing, cheese manufacturing, juice clarification, brewing, dough 
conditioning, wine modification, food preservation and instant tea 
production. They are, however, also one of the greatest contaminants of 
natural and man-made organic products, and some Aspergillus species cause 
serious disease in humans and animals, and can be pathogenic. The aspergilli 
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are also one of the most important mycotoxin-producing groups of fungi 
when growing as contaminants on cereals, oil seeds and other foods. 
 
3.1.2 Bioactive Metabolites from an Aspergillus Species 
 
Aspergilli readily produce a variety of secondary metabolites when grown 
on artificial media in the laboratory and some of these occur naturally when 
grown on food or feed products. Literature on secondary metabolites 
isolated from the Aspergillus genus is vast: more than 900 compounds have 
been recorded in Antibase,80 many of which have overt biological activity. A 
number of metabolites are shown below as examples: 
 
Aflatoxins 
 
Aflatoxins, produced mainly by Aspergillus flavus, A. parasiticus and A. 
nominus, are by far the most widely studied mycotoxins. These toxins 
poisoned thousands of poultry, pigs and trout in the early 1960s and are 
highly substituted coumarins containing a double furan ring. The four main 
naturally produced aflatoxins are B1, B2, G1 and G2 (Figure 3.1). 
Aflatoxin B1 is hepatotoxic and one of the most potent animal carcinogens 
known. In human liver cell tissue culture doses of 10 µg/mL are lethal.81 
Since aflatoxins were associated with food contamination the content of 
aflatoxins in foods and feeds was eventually regulated in many countries.82 
The possibility that aflatoxins are responsible for the high incidence of liver 
cancer in parts of Africa where people consume groundnut products was 
suggested as early as 1962.83 Yet today, in populations with relatively high 
exposure, the role for aflatoxins as a risk factor for human primary liver 
cancer is still not clear.84 
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Figure 3.1: Stuctures of the aflatoxins 
 
Fumitremorgins 
 
Fumitremorgins A to N85-87 are a series of diketopiperazines produced by 
certain strains of A. fumigatus.88 
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Figure 3.2: Stuctures of the fumitremorgins A and C 
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Fumitremorgin A and B (Figure 3.2) were first isolated in 197189-91 as 
tremorgenic mycotoxins since they caused severe tremor and convulsions in 
experimental animals due to neurotoxic properties.92,93 In 1998, 
fumitremorgin C (Figure 3.2) was found to be effective in treating 
multi-drug resistance which is a major problem in cancer chemotherapy.94 
Thereafter interest in this class of compounds led to the synthesis of a series 
of analogues.95,96 
 
Scleramide 
 
Scleramide (Figure 3.3), a cyclic hexapeptide was isolated from extracts of 
the sclerotia of Aspergillus sclerotiorum, it showed modest activity against 
the fall armyworm Spodoptera frugiperda.97 
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Figure 3.3: Stucture of scleramide 
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3.2 Preliminary Investigations 
 
The extract of the small-scale Aspergillus sp. culture (F6878) supplied from 
Hamidah Bakar from UiTM (MARA University of Technology) showed 
excellent cytotoxicity in the P388 assay (<97.5 ng/mL). An aliquot of this 
crude extract was analysed (C18 HPLC) (Figure 3.4), using a standard 
elution gradient (see Experimental 8.3.1.1). The chromatogram showed 
major peaks from between 11 min to 20 min. Bioactivity profiling showed 
that the activity was centered from 18-20 min. Proton NMR spectrosopy 
using a CapNMR probe established that a pure compound, which eluted at 
18.5 min (well F6 of MT plate), showed typical peptide features. Two other 
compounds at 11.39 min (well D11 of MT plate) and 13.50 min (well D3 of 
MT plate) were also isolated. The search of the in-house UV database 
revealed that none of the peaks shown in the HPLC trace matched any 
common, known compound. Also, a search of the AntiMarin database (mass 
791 Da) resulted in no hits.  The Aspergillus sp was re-grown twice on a 
larger scale (F8268 and F7474) to allow a full chemical investigation. The 
extract of F8268 was used to study the bioactive peptides as described in 
Part 1, while the extract from F7474 was used to study D3 and D11 as 
described in Part 3. 
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Figure 3.4: HPLC chromatogram of the crude extract of F6878. UV 
detection with ELSD comparison and bioactive region noted 
 
Another bioactive compound was elucidated from the well F9 of the MT 
plate method from the bioactive region from the extract from F6878.56 It was 
found to have seven singlet methyl groups from the 1H spectrum (Figure 
3.5). Searching in the AntiMarin database established that it was a known 
compound called NF00659A3
98,99 (Figure 3.6). Part 2 of this chapter 
describes the study of compounds related to NF00659A3 from the large 
extract from F8268. 
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Figure 3.5: The 
1
H NMR spectrum of F6878-F9 (10 µg) in CD3OD from 
CapNMR 
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Figure 3.6: The structure of NF00659A3 
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Part 1 New peptides from F8268 
 
3.3 HPLC Studies of F8268 Peptides from the Larger Scale 
Extraction 
 
The EtOAc extract of the larger scale culture (200 PDA plates by Hamidah 
Baker, UiTM; F8268) (2.53 g) was first partitioned between Pet. Ether and 
MeOH. The MeOH soluble material was concentrated and fractionated on a 
Sephadex LH-20 column using MeOH as the solvent. Ten fractions were 
collected. HPLC analysis of each fraction (C18 HPLC) column established 
that Fr #2 contained the same peaks from the active region (18.5 min) seen in 
the initial analysis (see Experimental 7.3.1.3). The fractions containing these 
compounds were combined (Fr #A). Fr #A was further purified by applying a 
linear gradient (55-65% ACN/H2O/0.05% formic acid/water; 20 min; 
analytical HPLC, see Experimental 8.3.1.4). From the ELSD trace four 
related minor peaks were present and showed near identical UV 
chromophores to the original peptide (Figure 3.7 and 3.8). By using 
preparative HPLC on the analytical HPLC columns peptides F8268-A-1 to 
F8268-A-5 were obtained in yields of 0.2, 0.9, 4.7, 0.7 and 0.6 mg 
respectively. 
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Figure 3.7: HPLC chromatogram of fraction A  
 
 
Figure 3.8: UV profile of the major peak from Fr 
#
A 
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3.4 Structural Elucidation of the Five Peptides 
 
3.4.1 Structural elucidation of F8268-A-3 
 
The major peptide, F8268-A-3, was isolated as an amorphous pale yellow 
powder and from HRESMS (MH+ 792.5263) the molecular formula, 
C40H69N7O9, was determined. The structural assignment of this initial 
peptide will be covered in detail, but lesser detail will then be used in 
assigning structures to the other four peptides. 
 
From the 1H NMR (Figure 3.9) and HSQC-DEPT (Figure 3.10) spectra, 9 
methine groups were in the region characteristic of the α-protons of α-amino 
acids (δC 45-80, δH 3.5-5). However, in the COSY spectrum (Figure 3.11) 
two pairs of these protons showed H-H couplings. The proton at δ4.78 ppm 
was coupled to the proton at δ3.43 ppm and the other pair were at 3.79 
ppm/3.63 ppm. The 13C data from the HSQC spectrum (Figure 3.10) for the 
two protons at δH 3.43 and 3.63 were δC 75.8 and δC 70.4, which suggested 
that these two methine protons were both adjacent to OH groups and were at 
the β-position of the amino acid units. Therefore, there were just 7 α-protons 
present (Figure 3.10). 
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Figure 3.9: The 
1
H NMR spectrum of F8268-A-3 in DMSO 
 
 
Figure 3.10: The HSQC-DEPT spectrum of F8268-A-3 in DMSO 
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Figure 3.11: The COSY spectrum of F8268-A-3 in DMSO 
 
 
Figure 3.12: The HMBC spectrum of F8268-A-3 in DMSO 
 
Two N-Me alanines were the first amino acids defined. In the first instance 
the methyl group (δH 1.02, δC 15.5) was coupled to the α-proton (δH 5.60, δC 
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50.3) (COSY and HSQC spectra). Therefore, this amino acid could be 
assigned as an alanine. Furthermore, a JCH coupling from an N-Me group (δH 
2.85, δC 30.0) to the α-proton was detected in the HMBC spectrum (Figure 
3.12) allowing assignment as an N-Me-alanine. In similar fashion, a second 
N-Me-alanine could be assigned [methyl group (δH 1.26, δC 14.3) coupled to 
an α-proton (δH 4.99, δC 50.7) and an N-Me group (δH 2.96, δC 31.7) with 
JCH coupling to the α-proton]. The key correlations of those two amino acid 
units are shown below. 
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δH 2.85, δC 30.0
δH 5.60, δC 50.3
δH 1.02, δC 15.5 δH 1.26, δC 14.3
δH 4.99, δC 50.7
δH 2.96, δC 31.7
Key COSY correlation
Key HMBC correlation
Figure 3.13: Key correlations for the two N-Me-alanines in F8268-A-3 
 
An isoleucine residue (Figure 3.14) was the next amino acid defined. An NH 
group (δH 8.58) was coupled to an α-proton (δH 4.47, δC 55.1) which was 
further coupled to a β proton (δH 1.77). However, there were two methine 
groups each with a 1H chemical shift of 1.77 ppm, and an NH group which 
also had a JCH coupling to the β position allowing assignment as δH 1.77 and 
δC 33.9. Two methyl groups (δH 0.86, δC 12.3 and δH 0.87, δC 14.2) also had 
JCH couplings to this β position and additionally to a methylene carbon (δC 
26.4). Finally, the methyl group at δH 0.86 showed H,C-coupling to the 
α-position. Interpretation of this data suggested that this amino acid unit was 
an isoleucine and that the methyl group at 0.86 ppm, a doublet, was attached 
to the β carbon. The key correlations are shown below. 
Chapter 3              Compounds from a Malaysian Fungal Endophyte 
 
53 
HN
Me
Me
O
δH 0.86
δH 0.87
Key COSY correlation
Key HMBC correlation
 
Figure 3.14: Key correlations for isoleucine in F8268-A-3 
 
The residue with an NH group at δH 7.33 was identified as 3-hydroxyleucine 
(Figure 3.15).  The NH proton was coupled to an α-proton (δH 4.78, δC 54.9) 
and further coupled to a β-proton (δH 3.43), on a carbon (δC 75.8) whose 
chemical shifts were characteristic of a carbinol system. Further structural 
clues came from the HMBC correlations. The α-proton also had a 3JCH 
coupling to a methine (δH 1.77, δC 29.0). Two methyl groups (δH 0.88, δC 
15.0 and δH 0.91, δC 21.3) showed correlations to the CH groups (δH 3.43, δC 
75.8 and δH 1.77, δC 29.0) as well as to themselves allowing assignment of 
this amino acid as 3-hydroxyleucine. The key correlations are shown below. 
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Figure 3.15: Key correlations for 3-hydroxyleucine in F8268-A-3 
 
A very similar spin system was next established. This was 
N-Me-3-hydroxyleucine (Figure 3.16). As observed for 3-hydroxyleucine 
the α-proton (δH 3.79, δC 62.7) was coupled to a β-proton (δH 3.63, δC 70.4), 
part of a carbinol system. Two methyl groups (δH 0.76, δC 15.6 and δH 0.81, 
δC 21.5) showed correlations to the β and γ-CH groups (δH 3.63, δC 70.4 and 
δH 1.38, δC 29.5) as well as to each other in the HMBC spectrum. 
Furthermore, there was an N-Me group (δH 2.86, δC 29.7) with a 
3
JCH 
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coupling to the α-position, thus defining an N-Me-3-hydroxyleucine residue 
(see key correlations below). 
HN
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Key HMBC correlation
 
Figure 3.16: Key correlations for N-Me-3-hydroxyleucine in F8268-A-3 
 
Just one NH group (δH 7.82) remained. From the COSY spectrum this NH 
was coupled to an α-proton (δH 4.69, δC 49.0) that was further coupled to a 
methylene group (δH 1.60), which in turn was coupled to a methine (δH 2.02 
δC 36.1) (see correlation diagram below). Further details of the structure 
arose from consideration of the H,C correlations in the HMBC spectrum. 
The vinyl group determined from the COSY and HSQC experiments (CH δH 
5.65, δC 143.0 and CH2 δH 4.86 and 5.00, δC 115.8), had 
2
JCH and 
3
JCH 
couplings to the carbon at 36.1 ppm allowing attachment of the vinyl group 
to the γ-position. Furthermore, the methyl protons (δH 0.93, δC 21.3) had 
3
JCH couplings to the β-position as well as to a vinyl group carbon (δC 143.0) 
fixing the position of this methyl also at the γ-position. Therefore, this amino 
acid unit was determined as the rare amino acid 
2-amino-4-methyl-5-hexenoic acid (Figure 3.17).  
NH
Me
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H Key COSY correlation
Key HMBC correlation
 
 Figure 3.17: Key correlations for 2-amino-4-methyl-5-hexenoic acid in 
F8268-A-3 
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At this point only one α-proton (δH 5.00, δC 52.5) remained unassigned. 
From HSQC data and a consideration of molecular formula data it was 
ascertained there were four methylene groups left unassigned. A 
combination of COSY and TOCSY data, in combination with chemical shift 
data, were used to establish this chain of CH and CH2 groups. The starting 
points were the characteristic α-proton (δH 5.00, δC 52.5) at one end of the 
chain and the similarly distinctive CH2 group attached to N at the other end 
of the chain (δH 2.88 4.02, δC 43.9). COSY data gave the linkages between 
each methylene (see correlation diagram below) and allowed assignment of 
the final amino acid unit as pipecolic acid (Figure 3.18). 
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Figure 3.18: Key COSY correlations for pipecolic acid in F8268-A-3 
 
To establish the sequence of the amino acid units in the peptide 3JCH 
couplings between the amino acid units in the HMBC experiment were 
utilised. But, it was found that three amino acid units had correlations to a 
carbonyl carbon at around 173 ppm, leaving an element of ambiguity. A 
more highly resolved 13C experiment (Figure 3.19) was run and confirmed 
that the 13C chemical shifts at around 173 ppm came from two different 
amino acid carboxyl carbon atoms with a difference of only 0.06ppm which 
could not be resolved in the HMBC experiment. With the 13C and HMBC 
experiment the correlations from these two amino acids could be 
distinguished and assigned. The third amino acid had a carbonyl chemical 
shift value of 174.4 ppm and was readily resolved and also assigned.  The 
completed peptide structure is shown below with the key H, C couplings 
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between the amino acid units (Figure 3.20). The NMR data is shown in 
Table 3.1. 
 
Figure 3.19: The 
13
C NMR spectrum of F8268-A-3 in DMSO 
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Figure 3.20: Structure and key H, C-couplings for F8268-A-3 
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Amino Acids position δ13C, ppm  δ1H, ppm COSY HMBC 
A:  Pipecolic acid 1-CO 168.8     
  2-CH 52.5 5.00 H-3' CO of B 
  3-CH2 25.9 1.24    
  3'-CH2 25.9 2.36 H-2   
  4-CH2 21.4 1.10 H-5, H-5'   
  4'-CH2 21.4 1.60    
  5-CH2 25.9 1.35 H-4, H-6   
  5'-CH2 25.9 1.65 H-4, H-6   
  6-CH2 43.9 2.88 H-5, H-5', H-6'    
  6'-CH2 43.9 4.02 H-6   
B: 3-Hydroxyleucine 1-CO 173.3     
  2-CH 54.9 4.78 H-3, NH C-3, CO of A and B  
  3-CH 75.8 3.43 H-2    
  4-CH 29.0 1.77    
  5-CH3 15.0 0.88  C-3, C-4, C-6 
  6-CH3 21.3 0.91  C-3, C-4, C-5 
  NH  7.33 H-2 CO of A 
C:  Isoleucine 1-CO 172.4       
  2-CH 55.1 4.47 H-3, NH CO of C 
  3-CH 33.9 1.77 H-2, H-6   
  4-CH2 26.4 1.38    
  4'-CH2 26.4 1.48    
  5-CH3 14.2 0.87  C-3, C-4 
  6-CH3 12.3 0.86 H-3 C-2, C-3, C-4 
  NH   8.58 H-2 C-2, C-3, CO B 
D: N-Methylalanine 1-CO 171.3     
  2-CH 50.3 5.60 H-3 CO of C and D 
  3-CH3 15.5 1.02 H-2 C-2, CO of D 
  N-CH3 30.0 2.85   C-2, CO of C 
E: N-Methyl-3-hydroxyleucine 1-CO 167.9       
  2-CH 62.7 3.79 H-3 C-3, N-CH3, CO of D and E 
  3-CH 70.4 3.63 H-2 C-5, C-6 
  4-CH 29.5 1.38    
  5-CH3 15.6 0.76  C-3, C-4, C-6 
  6-CH3 21.5 0.81  C-3, C-4, C-5 
  N-CH3 29.7 2.86    
F:2-Amino-4-methyl-5-hexenoic acid 1-CO 173.3     
  2-CH 49.0 4.69 H-3', NH   
  3-CH2 36.2 1.50    
  3'-CH2 36.2 1.60 H-2, H-4   
  4-CH 36.0 2.02 H-3'   
  5-CH 143.0 5.65  C-4 
  6-CH2 115.8 4.86  C-4 
  6'-CH2 115.8 5.00  C-4 
  7-CH3 21.4 0.93  C-3, C-5 
 NH  7.82 H-2 CO of E 
G: N-Methylalanine 1-CO 174.4     
  2-CH 50.7 4.99 H-3 C-3, CO of G 
  3-CH3 14.3 1.26 H-2 C-2, CO of G 
  N-CH3 31.7 2.96   C-2, CO of F 
Table 3.1: NMR data of F8268-A-3 
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3.4.2 Structural elucidation of F8268-A-4 
 
F8268-A-4 was obtained as a pale yellow powder with a molecular formula 
C40H71N7O9 which was established on the basis of HRESI mass 
spectrometry (MH+ 794.5357). This corresponds to two protons more than 
F8268-A-3. In the 1H (Figure 3.21) and HSQC spectra there were no signals 
corresponding to olefinic protons and carbons.  This suggested that the 
difference between F8268-A-3 and F8268-A-4 was that the vinyl group of 
2-amino-4-methyl-5-hexenoic acid (amino acid F) had been reduced. Careful 
analysis of the COSY and TOCSY spectra revealed that the α-proton (δH 
4.83, δC 48.8) had correlations to a methylene group (δH 1.47, δC 36.1) 
which was further coupled to a methine group (δH 1.78, δC 33.5). And, from 
the HSQC and HMBC spectra, the doublet methyl group (δH 0.76, δC 19.8) 
had H,C-couplings to the same methylene group (δH 1.47, δC 36.1) and 
methine group (δH 1.78, δC 33.5), establishing the relationship this methyl 
group had with the COSY-defined spin system. Another new methyl group, a 
triplet (δH 0.75, δC 11.8) also had a JCH coupling to the methine group at 1.78 
ppm as well as a JCH coupling to an alternative methylene group (δH 0.96, 
1.14, δC 27.5) establishing the structure of the new amino acid as 
2-amino-4-methyl-hexanoic acid (Figure 3.22). A comparison of the NMR 
data compared with F8268-A-3 is shown in Table 3.2.  
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Figure 3.21: The 
1
H NMR spectrum of F8268-A-5 in DMSO 
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Figure 3.22: Key correlations of amino acid F in F8268-A-4 
 
  F8268-A-3   F8268-A-4  
Acid F Position δ
13
C, ppm δ
1
H, ppm Position δ
13
C, ppm δ
1
H, ppm 
 1-CO 173.3  1-CO 173.4  
 2-CH 49.0 4.69 2-CH 48.8 4.83 
 3-CH2 36.2 1.50, 1.60 3-CH2 36.1 1.47 
 4-CH 36.0 2.02 4-CH 33.5 1.78 
 5-CH 143 5.65 5-CH2 27.5 0.96, 1.14 
 6-CH2 115.8 4.86, 5.00 6-CH3 11.8 0.75 
 7-CH3 21.4 0.93 7-CH3 19.8 0.76 
 NH  7.82 NH  7.78 
Table 3.2: 
13
C and 
1
H data comparison of acid F from F8268-A-3 and 
F8268-A-4 
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Signals from other parts of the molecule, including all NH and N-Me groups, 
were the same as for F8268-A-3 including all 2JCH and 
3
JCH HMBC 
correlations allowing the structure of F8268-A-4 (NMR data in Appendix 1, 
Table 1.3) to be assigned as shown in Figure 3.23. 
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Figure 3.23: The structure of F8268-A-4 
 
3.4.3 Structural elucidation of F8268-A-1 
 
F8268-A-1, the first compound to elute in the HPLC separation, was the 
next structure assigned. It too was isolated as a pale yellow powder and had 
a molecular formula of C39H67N7O9, as determined by HREIMS (MH
+ 
778.5051). This corresponded to one less methylene group when compared 
to F8268-A-3. By carefully comparing the 1H (Figure 3.24) and HSQC 
spectra of F8268-A-1 to those of F8268-A-3 it was observed that the 
chemical shift of the α-proton in acid C (isoleucine) had changed from 4.45 
ppm in F8268-A-3 to 4.38 ppm in F8268-A-1. That α-proton showed H-H 
coupling to a methine proton (δH 2.02, δC 28.2), which was also different 
from the proton at this position in F8268-A-3 (δH 1.77, δC 33.9). In the 
HSQC spectrum correlations for an isoleucine methylene group and two 
methyl signals (δH 0.86 and 0.86) were replaced by two other methyl signals 
(δH 0.92 and 1.03). In the HMBC spectra these two new methyl groups 
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showed typical valine H,C-couplings to the α-position (δC 57.6) and to the 
β-position (δC 28.2), as well as to each other, showing that in F8268-A-1 the 
isoleucine at amino acid C had been substituted with a valine.  Key 
correlations are shown in Figure 3.25.  This substitution was in keeping 
with the observed molecular formula for F8268-A-1 as showing in Table 3.3.  
No other major changes in the NMR spectra were discernible. 
 
 
Figure 3.24: The 
1
H NMR spectrum of F8268-A-1 in DMSO 
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Figure 3.25: Key correlations for amino acid C in F8268-A-1 
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  F8268-A-1   F8268-A-3  
Acid C Position δ
13
C, ppm δ
1
H, ppm Position δ
13
C, ppm δ
1
H, ppm 
 1-CO 172.5  1-CO 172.4  
 2-CH 57.6 4.38 2-CH 55.1 4.47 
 3-CH 28.2 2.02 3-CH 33.9 1.77 
    4-CH2 26.4 1.38, 1.48 
 4-CH3 17.5 0.92 5-CH3 14.2 0.86 
 5-CH3 19.9 1.03 6-CH3 12.3 0.86 
 NH  8.65 NH  8.58 
Table 3.3: 
13
C and 
1
H data comparison of acid C from F8268-A-1 and 
F8268-A-3 
 
All other signals and correlations observed for F8268-A-1 remained similar 
to those observed for F8268-A-3, and all the NH and N-Me protons 
remained at the same chemical shifts. Therefore, the structure of F8268-A-1 
(NMR data in Appendix 1, Table 1.1) was assigned as shown in Figure 3.26. 
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Figure 3.26: The structure of F8268-A-1 
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3.4.4 Structural elucidation of F8268-A-2 
 
F8268-A-2 was obtained as a pale yellow powder and had the molecular 
formula C39H69N7O9 by HREIMS (MH
+ 780.5214). F8268-A-2 nominally 
has two more hydrogen atoms than F8268-A-1.  The initial assumption was 
that F8268-A-2 was related to F8268-A-1 simply by hydrogenation of the 
vinyl group (there were no olefinic protons or carbons discernible) as had 
been observed for F8268-A-3/F8268-A-4.  However, from a careful 
assignment of all the 1H NMR data (Figure 3.27) it was apparent that the 
amino acid C was identical to that in F8268-A-3 and F8268-A-4.  That is, 
the mino acid was isoleucine rather than valine and that the major difference 
was centered on amino acid F.  As noted there were no olefinic signals 
present in the spectra associated with F8268-A-2, but the residue at F could 
not be 2-amino-4-methylhexanoic acid based on MF arguments and the 
NMR data.  There were signals for two doublet methyl groups in amino 
acid F (δH 0.84 and δH 0.86) replacing the methyl groups (doublet and triplet 
at δH 0.75 and δH 0.76) found in 2-amino-4-methylhexanoic acid.  Analysis 
of the HMBC spectrum established that these two doublet methyl groups 
were part of a leucine system (H,C couplings to C-3 (δC 38.0) and C-4 (δC 
25.72)) (Figure 3.28). The NMR differences between acid F of F8268-A-2  
and F8268-A-4 are summarised in Table 3.4.         
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Figure 3.27: The 
1
H NMR spectrum of F8268-A-2 in DMSO 
 
O
NH
MeMe
Key COSY correlation
Key HMBC correlation
 
Figure 3.28: Key correlations for amino acid F in F8268-A-2 
 
  F8268-A-2   F8268-A-4  
Acid F Position δ
13
C, ppm δ
1
H, ppm Position δ
13
C, ppm δ
1
H, ppm 
 1-CO 173.2  1-CO 173.4  
 2-CH 49.1 4.84 2-CH 48.8 4.83 
 3-CH2 38.0 1.38, 1.56 3-CH2 36.1 1.47 
 4-CH 25.7 1.54 4-CH 33.5 1.78 
    5-CH2 27.5 0.96, 1.14 
 5-CH3 23.8 0.84 6-CH3 11.8 0.75 
 6-CH3 21.5 0.86 7-CH3 19.8 0.76 
 NH  7.82 NH  7.78 
Table 3.4: 
13
C and 
1
H data comparison of acid F from F8268-A-2 and 
F8268-A-4 
 
 
 
Chapter 3              Compounds from a Malaysian Fungal Endophyte 
 
65 
All other amino acids NMR data and correlations are the same as in 
F8268-A-3, so the structure of F8268-A-2 (NMR data in Appendix 1, Table 
1.2) is as shown in Figure 3.29. 
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Figure 3.29: The structure of F8268-A-2 
 
3.4.5 Structural elucidation of F8268-A-5 
 
F8268-A-5 was isolated as a pale yellow powder and the HREIMS (MH+ 
806.5383) suggested the molecular formula C41H71N7O9. This represents one 
CH2 more than that observed for F8268-A-3. Analysis of all NMR data (
1H 
NMR shown in Figure 3.30) and assignment of structure indicated a close 
comparison with F8268-A-3, except for amino acid E. The amino acid 
residue found in F8268-A-3 at amino acid E was 
N-methyl-3-hydroxyleucine. In F8268-A-5 the two methyl groups of 
N-methyl-3-hydroxyleucine (5-CH3 δH 0.76, δC 15.6 and 6-CH3 δH 0.86, δc 
29.7) have been replaced in the HSQC spectra by two alternative methyl 
groups (δH 0.75, δC 12.4 and δH 0.77, δc 13.5). From the TOCSY spectrum 
the methyl at δH 0.75, δC 12.4 has correlations to methylene (δH 1.11 and 
1.27) and methine (δH 1.10) groups. This evidence suggested that the amino 
acid residue has changed from N-methyl-3-hydroxyleucine to a new amino 
acid N-methyl-2-amino-3-hydroxy-4-methylhexanoic acid. The HMBC data 
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were able to confirm this.  For example, the 4-methyl group has a 3JCH 
coupling to the β carbon (δC 68.0) placing it at the 4-position rather than the 
6-position. The key TOCSY and HMBC correlations observed are shown in 
Figure 3.31. The NMR differences between acid E of F8268-A-3 and 
F8268-A-5 are summarised in Table 3.5. 
 
Figure 3.30: The 
1
H NMR spectrum of F8268-A-5 in DMSO 
 
Key TOCSY correlation
Key HMBC correlation
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Figure 3.31: Key correlations for amino acid E in F8268-A-5 
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  F8268-A-5   F8268-A-3  
Acid E Position δ
13
C, ppm δ
1
H, ppm Position δ
13
C, ppm δ
1
H, ppm 
 1-CO 167.9  1-CO 171.3  
 2-CH 63.1 3.86 2-CH 62.7 3.79 
 3-CH 68.0 3.79 3-CH 70.4 3.63 
 4-CH 35.9 1.10 4-CH 29.5 1.38 
 5-CH2 27.9 1.11, 1.27    
 6-CH3 12.4 0.75 5-CH3 15.6 0.76 
 7-CH3 13.5 0.77 6-CH3 21.5 0.81 
 N-CH3 29.8 2.87 N-CH3 29.7 2.86 
 OH  4.96 OH   
Table 3.5: 
13
C and 
1
H data comparison of acid E from F8268-A-5 and 
F8268-A-3 
 
All other amino acids NMR data and correlations remained the same as in 
the F8268-A-3, therefore, allowing assignment of the structure of 
F8268-A-5 (NMR data in Appendix 1, Table 1.4) as: 
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Figure 3.32: The structure of F8268-A-5 
 
3.4.6 Preparation and analysis of Marfey derivatives 
 
The absolute configurations of some of the amino acid units were 
determined by acid hydrolysis followed by derivatization with Marfey’s 
reagent (Nα-(2,4-dinitro-5-fluorophenyl)-L-alaninamide)100 and subsequent 
HPLC analysis (see Experimental 8.3.2), comparing the chromatograms 
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with those of derivatives of the commercially available amino acids 
N-Me-alanine, isoleucine, pipecolic acid and (2S,3R)-3-hydroxy-leucine. 
Both of the N-Me-alanine units were found to be of (S)-configuration. The 
isoleucine and pipecolic acid units were found to be of (R)-configuration. 
The (2S,3R)-3-hydroxy-leucine unit did not match up with any other amino 
acid units from HPLC analysis which means the 3-hydroxy-leucine is in 
another stereochemistry (2S,3S or 2R,3R or 2R,3S). The partial configuration 
of F8268-A-3 is depicted in Figure 3.33.  
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Figure 3.33: Partial stereochemistry of F8268-A-3 
 
Examples of the HPLC results for Marfey’s derivatives of the commercial 
reference amino acid residues are given in Figure 3.34. 
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Figure 3.34: HPLC chromatograms for Marfey’s derivatives of amino acids 
from the hydrolysis of F8268-A-3 (a) and commercial reference amino acid 
residues mixture (b)  
 
F8268-A-3 is a heptapeptide, however, there were only six amino acid peaks 
from the HPLC analysis (Figure 3.34). Therefore, the two N-Me-alanine 
units were both considered as the (S) or L enantiomer. From the HPLC, Peak 
A had the same retention time as N-Me-D-Alanine, however, this peak was 
considered to be from another amino acid, probably an alternative 3-OH 
leucine diastereoisomer from the 2S, 3R isomer available to us. Several other 
gradient profiles were tried, but no better separation could be achieved. 
From the HPLC analysis and comparion against standard amino acids it was 
possible to identify D-pipecolic acid and D-isoleucine in addition to the two 
N-Me-L-alanines. This left three residues, A, B and C (see Figure 3.34) to be 
assigned. LCMS (Detail, see Experimental 8.1.7) was applied in an attempt 
to identify these three amino acids A, B and C (Figure 3.35). 
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Figure 3.35: LCMS results for F8268-A-3 and commercial amino acids 
 
From the LCMS result, it was very clear that the mass for the N-Me-Alanine 
came from the single peak which proved the side peak A, came from an 
alternative amino acid. These LCMS results also confirmed the D-pipecolic 
acid and the D-isoleucine assignments. It also suggested that peak C was 
3-OH leucine and peak B was N-Me-3-OH leucine. However, the single ion 
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monitoring was not 100% convincing due to low intensity.  
 
In an attempt to resolve this one of the other peptides was hydrolysed and 
analysed. The only difference between F8268-A-3 and F8268-A-2 was a 
change of 2-amino-4-methyl-5-hexenoic acid to a leucine (amino acid F). 
Therefore, Marfey studies on F8268-A-2 would establish the 
stereochemistry of the leucine (acid F), and also help locate which of those 
peaks A, B or C corresponded to 2-amino-4-methyl-5-hexenoic acid in 
Figure 3.34. 
 
Figure 3.36: HPLC chromatograms for Marfey’s derivatives of amino acids 
from the hydrolysis of F8268-A-2 (a) and commercial reference amino acid 
residues mixture (b) 
 
The HPLC analysis of the Marfey derivatives of the amino acids from the 
hydrolysis of F8268-A-2 and the mixture of refence amino acids indicated 
F8268-A-2 also had a D-pipecolic acid, a D-isoleucine and two 
N-Me-L-alanines. Furthermore, peak B in Figure 3.34 had disappeared and a 
L-leucine had appeared (Figure 3.36). Therefore peak B in Figure 3.34 was 
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most likely 2-amino-4-methyl-5-hexenoic acid, and peak A most likely 
corresponded to one of the N-Me-3-hydroxy-leucine diastereoisomers. Peak 
C must therefore be the relevant diasteroisomer of the last remaining amino 
acid, 3-hydroxy-leucine. Unfortunately, at this stage no suitable reference 
samples were readily available for the 3-hydroxy leucines or the vinylogue 
of leucine, 2-amino-4-methyl-5-hexenoic acid. 
 
The partial absolute stereochemistry of F8268-A-2 is shown below.  
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Figure 3.37: Partial stereochemistry of F8268-A-2 
 
3.4.7 Discussion of F8268-A series peptides 
 
Cytotoxicities (IC50) of the five peptides as well as some commercially 
available drugs against P388 (murine leukemia cell line), human colon 
cancer, HCT116 (ATCC CCL-247) and Human breast cancer, MCF7 (ATCC 
HTB-22) are listed below in Table 3.6. 
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  IC50 (ng/mL) IC50 (nM) 
  P388* HCT116# MCF7# P388* HCT116# MCF7# 
F8268-A-1 3 4.7 6.5 3.8 5.9 8.1 
F8268-A-2 45 9.3 6.6 56 11.6 8.3 
F8268-A-3 1 0.2 0.73 1.3 0.3 0.9 
F8268-A-4 19 3.1 5.7 24 3.9 7.1 
F8268-A-5 0.1 0.2 0.8 0.13 0.3 1 
Fluorouracil (5FU)  910 -  7000 - 
Cisplatin  1653 8703  5510 29010 
Tamoxifen   3945 3867   10604 10395 
*
 from UC, New Zealand 
#
 from UiTM.  
Table 3.6: Antitumor activities of F8268-A series compounds and 
commercial drugs 
 
The results represent a very interesting compilation of structure activity 
relationships with a factor of ~450 between the least active (using the P388 
IC50 data for comparison purpose), F8268-A-2, and the most active 
F8268-A-5. There is a high degree of homology across the series with four 
of the seven amino acids in each peptide being invariant.  These are the 
residues at A (pipecolic acid), B (3-hydroxyleucine), D (N-methylalanine) 
and G (N-methylalanine).  Starting from the most abundant peptide, 
F8268-A-3 it is noted that substitution of amino acid C (isoleucine) with a 
valine causes a 3x decrease in activity.  Likewise, a 45x decrease in activity 
occurs if 2-amino-4-methyl-5-hexenoic acid (amino acid F) is replaced by a 
leucine.  Reduction of the vinyl group of 2-amino-4-methyl-5-hexenoic 
acid (amino acid F) also leads to a significant reduction in activity (19x), but 
if N-methyl-3-hydroxyleucine is replaced with 
N-methyl-2-amino-3-hydroxy-4-methylhexanoic acid there is a 10x increase 
in activity. From the structure activity relationships observed across the 
natural series of compounds there is a considerable scope for further 
investigations with the aim of improving the potency of this series of 
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peptides. Also it will be necessary to test this natural series, and any further 
members that are isolated or synthesized, against a range of human cancer 
cell lines to establish if selectivity is observed.  
Furthermore, all five peptides also showed excellent activity in the human 
colon cancer and HCT116 (ATCC CCL-247) and human breast cancer, 
MCF7 (ATCC HTB-22) tests. The most active peptides, F8268-A-3 and 
F8268-A-5, are over 4,000 times more active than the commercial drugs in 
the same test.  
The five heptapeptides in this series are constituted by combinations of five 
regular amino acids – pipecolic acid, valine, isoleucine and N-methylalanine 
– and five irregular amino acids – 3-hydroxyleucine, N-methyl-3-hydroxy- 
leucine, 2-amino-4-methyl-5-hexenoic acid, 2-amino-4-methylhexanoic acid 
and 2-amino-3-hydroxy-4-methyl-hexanoic acid in various combinations.  
The partial absolute stereochemistry of F8268-A-2 and F8268-A-3 has been 
elucidated by Marfey’s method. The locations of other amino acids 
appearing in the HPLC trace were noted and future work centered on the 
synthesis of the other amino acids will help confirm the configurations of the 
remaining amino acid units.  
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Part 2 New pyrones from F8268 
 
3.5 HPLC Studies of F8268-3 Series Compounds from the 
Larger Scale Extraction of Aspergillus sp. 
 
The MeOH-soluble material from the larger scale fermentation of the 
Aspergillus sp. (F8268) was concentrated and fractionated on a Sephadex 
LH-20 column. In the third fraction four peaks were detected (Figure 3.38) 
that showed very similar UV chromophores (Figure 3.39). The four peaks 
were separated by analytical HPLC by applying a linear gradient (20-85% 
ACN/H2O/0.05% formic acid/water; 20 min, see Experimental 8.3.1.5). By 
repetitive use of an analytical HPLC column, compounds F8268-3-3 (18.18 
mins), F8268-3-4 (18.77 mins), F8268-3-6 (23.45 mins) and F8268-3-7 
(24.63 mins) were obtained in good yields (1.5, 1.1, 2.4 and 1.1 mg 
respectively). 
 
Figure 3.38: HPLC chromatogram of fraction 3 
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The UV spectra of these four compounds (Figure 3.39) were very similar to 
the spectrum of NF00659A3
98,99 (Figure 3.6) which had been identified in 
the initial analysis of the earlier fungal sample of F6878 (see Section 3.2). 
Low and high resolution ESI-MS and 1H NMR spectra were obtained on the 
four samples which showed that these four compounds were related to the 
known compound NF00659A3, but had not previously been reported in the 
literature. Structures were assigned from the 1D- and 2D- NMR spectra 
obtained using the CapNMR probe, ESMS data as well as by comparison 
with the data for the known compound. The relative stereochemistries were 
determined using NOESY experiments. 
 
Figure 3.39: UV profiles of the four related peaks from fraction 3 
 
3.6 Structural Elucidation of F8268-3 Series Compounds 
 
3.6.1 Structural elucidation of F8268-3-6 
 
F8268-3-6 was first studied because it showed the same molecular mass as 
NF00659A3 (Figure 3.6). The molecular formula of F8268-3-6 was 
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determined as C29H42O7 from the HRESIMS (MH
+ 503.3054). There were 
some differences between the proton spectrum of F8268-3-6 (Figure 3.40) 
and that of the known compound (NF00659A3). The major difference was 
that the two methyl signals at around 1 ppm for NF00659A3 had became a 
single signal in F8268-3-6. There were also other chemical shift changes for 
other signals in the spectra (see Table 3.7). These suggested that F8268-3-6 
had the same structure as NF00659A3, but a different stereochemistry. 
However, the known compound NF00659A3, which had previously been 
isolated from F6878, unfortunately was not observed in the extract of F8268.    
 
Figure 3.40: The 
1
H NMR spectrum of F8268-3-6 (80 µg) in CD3OD from 
CapNMR 
 
From the COSY and TOCSY spectra, the arrangement of protons in the ring 
systems were readily established. In the seven membered ring I (see Figure 
3.43), the proton (δH 4.95, H3) coupled to a methylene group (δH 2.05, 1.60, 
2H2) in the COSY spectrum and was further correlated to another CH2 group 
(δH 1.42, 1.50, 2H1). In the six membered ring II, the proton (δH 3.66, H5) 
was coupled to a methylene group (δH 1.71, 2H6) and further correlated to 
another methylene group (δH 1.45, 2.37, 2H7). In the ring III, the proton (δH 
4.38, H12) coupled to a CH2 group (δH 1.83, 2.09, H11) was further correlated 
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to a methine proton (δH 1.76, H9). Furthermore, rings III and IV were joined 
by CH (δH 1.81, H14) and CH2 (δH 2.71, 2.93, H15) groups which were also 
coupled. All seven singlet methyl groups were compared to the proton data 
of the known compound and compared, as shown in Table 3.7. 
 
Position NF00659A3 δ
1
H, ppm F8268-3-6 δ
1
H, ppm Key NOESY 
1 1.46 (1H, m) 1.42 (1H, m)  
1' 1.56 (1H, m) 1.50 (1H, m)  
2 1.49 (1H, m) 1.60 (1H, m)  
2' 2.02 (1H, m) 2.05 (1H, m)   
3 4.82 (1H, s) 4.95 (1H, s) H-5, 19 
5 3.65 (1H, dd) 3.66 (1H, dd) H-3, 17, 19 
6 1.71 (2H,m) 1.71 (2H, m)  
7 1.40 (1H, m) 1.45 (1H, m)  
7' 2.43 (1H, m) 2.37 (1H, m)  
9 1.81 (1H, m) 1.83 (1H, m) H-12, 20 
11 1.72 (1H, m) 1.75 (1H, m)  
11' 2.10 (1H, m) 2.09 (1H, m)  
12 4.30 (2H, s) 4.38 (2H, s) H-9 
14 1.80 (1H, m) 1.81 (1H, m) H-17 
15 2.69 (1H, d) 2.71 (1H, d)  
15' 2.86 (1H, t) 2.93 (1H, t)  
16 4.43 (1H, d) 4.50 (1H, d)  
16' 4.94 (1H, s) 4.91 (1H, s)  
17 0.97 (3H, s) 1.00 (3H, s) H-5, 14 
18 1.19 (3H, s) 1.18 (3H, s)  
19 1.21 (3H, s) 1.21 (3H, s) H-3, 5 
20 0.99 (3H, s) 0.99 (3H, s) H-9 
6'' 1.84 (3H, s) 2.21 (3H, s)  
7'' 2.16 (3H, s) 1.87 (3H, s)  
22 2.02 (3H, s) 2.03 (3H, s)   
Table 3.7: 
1
H NMR and key NOESY data of F8268-A-6 compared to the 
1
H 
data of NF00659A3 (data from F6878) in CD3OD 
 
The relative stereochemistry of F8268-3-6 was elucidated from the observed 
NOESY correlations of H-5 to H-3, H-17, H-19 and H-17 to H-14 (Figure 
3.41). Therefore, these protons were all oriented on the same side of the ring 
system. Furthermore, correlations of H-9 to H-11, H-12, and H-20, but not to 
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H-17 indicated that H-9, H-12 and H-20 were on the same side of the ring 
system, but opposite to that of H-3, H-5, H-14, H-17 and H-19. The 
similarity of the chemical shift of H-17 and H-20 initially caused some 
difficulty with the assignments, but a careful analysis of the NOESY 
spectrum enabled these two signals to be distinguished (Figure 3.41). The 
energy-minimised (MM2) model created using CHEM 3D software for the 
structure with stereochemistry shown in Figure 3.42, showed that the 
distances through space (Å), between protons showing NOESY correlations 
were all less than 3 Å, thus establishing the relative stereochemistry for 
F8268-3-6 (Figure 3.43). 
 
Figure 3.41: NOESY spectrum and key correlations of F8268-3-6 
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Figure 3.42: Key NOE correlations of F8268-3-6 
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Figure 3.43: Structure of F8268-3-6  
 
3.6.2 Structural elucidation of F8268-3-3 
 
The MH+ ion for F8268-3-3 by HRESIMS was measured as m/z 461.2959, 
corresponding to the molecular formula C27H40O6. From the proton NMR 
spectrum (Figure 3.44), there was a singlet methyl group at ~δH 2.0 missing 
when compared to the spectrum of F8268-3-6 (Figure 3.40). Taking into 
account the difference in molecular formula, it was concluded that the acetyl 
group at position 3 was missing. The change in 1H chemical shift of H-3 
from 4.95 ppm in F8268-3-6 to 3.75 ppm in F8268-3-3 was in keeping with 
the change from an OAc to an OH group (see all 1H NMR data in Table 3.8). 
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Figure 3.44: The 
1
H NMR spectrum of F8268-3-3 (28 µg) in CD3OD from 
CapNMR 
 
Position δ
1
H, ppm Key NOESY Position δ
1
H, ppm Key NOESY 
1 1.41 (1H, m)  14 1.80 (1H, m) H-17 
1' 1.54 (1H, m)  15 2.70 (1H, d)  
2 2.06 (2H, m)   15' 2.90 (1H, t)  
3 3.75 (1H, d) H-5, 19 16 4.50 (1H, s)  
5 3.60 (1H, d) H-3, 17, 19 16' 4.80 (1H, s)  
6 1.69 (2H, m)  17 0.96 (3H, s) H-5, 14 
7 1.42 (1H, m)  18 1.10 (3H, s)  
7' 2.36 (1H, m)  19 1.29 (3H, s) H-3, 5 
9 1.76 (1H, m) H-12, 20 20 0.98 (3H, s) H-9 
11 1.82 (1H, m) H-12 6'' 1.88 (3H, s)  
11' 2.06 (1H, m)  7'' 2.21 (3H, s)  
12 4.40 (2H, s) H-9, 11    
Table 3.8: 
1
H NMR and key NOESY data of F8268-3-3 
 
The relative stereochemistry of F8268-3-3 was obtained from NOESY 
correlations of H-5 to H-3, H-17, H-19 and H-17 to H-14, while H-9 had 
correlations to H-12 and H-20. The energy-minimised (MM2) model for the 
structure shown in Figure 3.45 showed that the distances through space (Å), 
between protons showing NOESY correlations were all less than 3 Å. 
Therefore, F8268-3-3 (Figure 3.46) had the same relative stereochemistry as 
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that determined for F8268-3-6.  
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Figure 3.45: Key NOE correlations of F8268-A-3 
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Figure 3.46: Structure of F8268-3-3 
 
3.6.3 Structural elucidation of F8268-3-4 
 
The molecular formula of F8268-3-4 was established as C27H40O5 from the 
HRESIMS spectrum (MH+ 445.2935). This corresponds to one less oxygen 
atom than that noted for F8268-3-3. There were three possibilities; firstly 
loss of the OH group in ring I, secondly loss of the OH group from ring III, 
or thirdly from the pyrone ring. The latter possibility was excluded as no 
new sp2-hydrolised proton signal had appeared in the proton spectrum 
(Figure 3.47). The signal for the methine group (δH 3.72, H3) in ring I had 
not changed significantly from that observed in F8268-3-3 (δH 3.75) which 
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indicated the change had most likely arisen in ring II. The exocyclic 
methylene protons at C16 had moved upfield to 4.20 and 4.47 ppm 
compared to those in F8268-3-3 (δH 4.50, 4.80) in keeping with the loss of 
the adjacent OH group. Further evidence came from the COSY spectrum 
(Figure 3.48). H-9 (δH 1.75) coupled to H-11,11’ (δH-11 1.47, δH-11’ 1.56) 
which were further coupled to a CH2 (δH-12 2.07, δH-12’ 2.46) group, not a 
CH group. All other spin systems and chemical shifts were very similar to 
those recorded for F8268-3-3. The proton data are given in Table 3.9. 
 
Figure 3.47: The 
1
H NMR spectrum of F8268-3-4 (10 µg) in CD3OD from 
CapNMR 
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Figure 3.48: The COSY spectrum of F8268-3-4 in CD3OD and key 
correlations 
 
Position δ
1
H, ppm Key NOESY Position δ
1
H, ppm Key NOESY 
1 1.41 (1H, m)  14 2.05 (1H, m) H-17 
1' 1.51 (1H, m)  15 2.52 (1H, dd)  
2 2.02 (2H, m)   15' 2.77 (1H, t)  
3 3.72 (1H, d) H-5, 19 16 4.20 (1H, s)  
5 3.65 (1H, d) H-3, 17, 19 16' 4.47 (1H, s)  
6 1.67 (2H, m)  17 1.00 (3H, s) H-5, 14 
7 1.38 (2H, m)  18 1.09 (3H, s)  
9 1.75 (1H, m) H-20 19 1.28 (3H, s) H-3, 5 
11 1.47 (1H, m)  20 0.97 (3H, s) H-9 
11' 1.56 (1H, m)  6'' 1.93 (3H, s)  
12 2.07 (1H, s)  7'' 2.21 (3H, s)  
12' 2.46 (1H, m)     
Table 3.9: 
1
H NMR and key NOESY data of F8268-3-4 
 
From NOESY correlations the relative stereochemistry was shown as being 
the same as F8268-3-3, the key NOE correlations and structure are shown in 
Figure 3.49 and 3.50.  
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Figure 3.49: Key NOE correlations of F8268-3-4 
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Figure 3.50: Structure of F8268-3-4 
 
3.6.4 Structural elucidation of F8268-3-7 
 
F8268-3-7 had a molecular formula of C29H42O6 as determined from the 
HRESIMS spectrum (MH+ 487.3023). This corresponds to one less oxygen 
atom than that of F8268-3-6, but one acetyl group more than that of 
F8268-3-4. Therefore, the possibility was that F8268-3-7 had ring I similar 
to F8268-3-6 and ring III similar to F8268-3-4. The chemical shift of H-3 
was 4.93 ppm which was very similar to that in F8268-3-6 (Figure 3.51). 
Furthermore, the double bond protons signals (δH-16 4.21 and δH-16’ 4.47) 
were similar to those observed in F8268-3-4. COSY (Figure 3.52) and 
TOCSY (Figure 3.53) correlations from H-9 (δH 1.76) to H-11, 11’ (δH-11 
1.47, δH-11’ 1.57) and further to H-12, 12’ (δH-12 2.07, δH-12’ 2.47) were 
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similar to those noted for F8268-3-4 in ring III. Therefore, the structure of 
F8268-3-7 was established as being derived from F8268-3-6 by the loss of 
the 12-OH group. The proton NMR data are shown in Table 3.10. 
 
Figure 3.51: The 
1
H NMR spectrum of F8268-3-7(12 µg) in CD3OD from 
CapNMR 
 
 
Figure 3.52: The COSY spectrum of F8268-3-7 in CD3OD and key 
correlations 
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Figure 3.53: The TOCSY spectrum of F8268-3-7 in CD3OD and key 
correlations 
 
Position δ
1
H, ppm Key NOESY Position δ
1
H, ppm Key NOESY 
1 1.48 (1H, m)  14 2.07 (1H, m) H-17 
1' 1.56 (1H, m)  15 2.53 (1H, dd)  
2 2.06 (1H, m)  15' 2.77 (1H, t)  
2' 2.53 (1H, m)   16 4.21 (1H, s)  
3 4.93 (1H, d) H-5, 19 16' 4.47 (1H, s)  
5 3.68 (1H, d) H-3, 17, 19 17 1.03 (3H, s) H-5, 14 
6 1.41 (1H, m)  18 1.17 (3H, s)  
6' 1.69 (1H, m)  19 1.19 (3H, s) H-3, 5 
7 2.30 (2H, m)  20 0.99 (3H, s) H-9 
9 1.76 (1H, m) H-20 6'' 1.93 (3H, s)  
11 1.47 (1H, m)  7'' 2.20 (3H, s)  
11' 1.57 (1H, m)  22 2.03 (3H, s)  
12 2.07 (1H, s)     
12' 2.47 (1H, m)     
Table 3.10: 
1
H NMR and key NOESY data of F8268-3-7 
 
As with the other members of the series the relative stereochemistry of 
F8268-3-7 was obtained from the NOESY correlations and the 
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energy-minimised (MM2) model of the structure given in Figure 3.54. The 
structure is shown in Figure 3.55. 
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Figure 3.54: Key NOE correlations of F8268-3-7 
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Figure 3.55: Structure of F8268-3-7 
 
3.6.5 Discussion of F8268-3 series compounds 
 
These four compounds are all reported here for the first time, however, a 
stereoisomer of F8268-3-6 (NF00659A3) had been previously reported,
98,99 
but without stereochemistry being assigned. Unfortunately, it has not been 
possible to assign the stereochemistry for NF00659A3 as it was not seen in 
the second extract F8268. 
This is a good example illustrating the power of CapNMR in dereplication 
studies especially when studying related minor compounds. In this case, the 
structure of F8268-3-6 was first established, and this was followed by the 
elucidation of the other three new compounds.  
All compounds showed good IC50 activities in the P388 assay (Table 3.11). 
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From the structural features, it is noticed that when the position 3 in ring I is 
occupied by an acetyl group rather than a hydroxyl group, there is an 
increase in the activity from 5 µg/mL to 0.2 µg/mL. A similar change was 
noted for the F8268-3-4 to F8268-3-7 (4.2 to 0.15 µg/mL)   
 R1 R2 IC50 (ng/mL) IC50 (nM) 
F8268-3-3 OH OH 5271 11459 
F8268-3-4 OH H 4154 9356 
F8268-3-6 OAc OH 193 384 
F8268-3-7 OAc H 147.9 304 
O
O
H
O
R1
H
H
H
OH
R2H
 
Table 3.11: IC50 values of F8268-3 series compound 
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Part 3 New diketopiperazines from 
F7474 
 
3.7 HPLC Studies of F7474-D3 and D11  
 
Two peaks (well D3 13.50 mins and D11, 11.39 mins Figure 3.56 and 3.57) 
were isolated using the microtitre plate method in the initial small-scale 
Aspergillus sp. culture (F6878). Searches of the in-house UV database 
revealed that none of the peaks shown in the HPLC trace matched any 
known compound. Also, searches of the AntiMarin database with the 
features obtained from EIMS and 1H experiments (F6878-D11: mass 381 Da, 
a 1,2-disubstituted benzene ring and a 1,4-disubstituted benzene ring and 2 
N-Me groups; F6878-D3: mass 426 Da, 2 doublet methyl groups and a 
1,2-disubstituted benzene ring) resulted in no hits. The Aspergillus sp. was 
re-grown on a large scale to allow a full chemical investigation. The new 
codes for these two peaks were F7474-D11 (3.1 mg) and F7474-D3 (2.5 mg). 
These two compounds were purified by mult injections from analytical 
HPLC using standard procedure (see Experimental 8.3.1.2). 
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Figure 3.56: HPLC chromatogram of the crude extract of F6878. UV 
detection with ELSD comparison 
 
 
Figure 3.57: UV profiles overlay of F6878-D3 and D11 
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3.8 Structural Elucidation of F7474-D3 
 
A pure compound was isolated from the D3 well of the microtitre plate 
obtained from the HPLC separation of the F7474 extract. From the 
HRESIMS (MH+ 427.2326) and a count of the number of carbons from the 
13C NMR experiment (Figure 3.58), a molecular formula of C23H30N4O4 was 
established, corresponding to eleven degrees of unsaturation. The presence 
of a 1,2-disubstituted benzene ring was indicated by the appearance of 2 
doublet and 2 triplet aromatic signals in the 1H spectrum (Figure 3.59). This 
aromatic ring contributed 4 of the degrees of unsaturation. Furthermore, 
there were three carbonyl carbons from the 13C NMR experiment (Figure 
3.58) which contributed another three degrees of unsaturation. The singlet 
peaks at 6.2, 7.6 and 8.4 ppm in the 1H spectrum (Figure 3.59) were not 
observed when the spectrum was obtained in CD3OD solvent indicating that 
these signals arose from exchangeable protons. As there were no other 
double bond signals in the 1H and 13C NMR spectra, F7474-D3 therefore 
contained another four rings.  
 
Figure 3.58: 
13
C NMR spectrum of F7474-D3 in DMSO 
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Figure 3.59: 
1
H NMR spectrum of F474-D3 in DMSO from regular probe 
 
 
Figure 3.60: COSY spectrum of F7474-D3 in DMSO 
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Figure 3.61: TOCSY spectrum of F7474-D3 in DMSO 
 
From the COSY (Figure 3.60) and TOCSY (Figure 3.61) experiments, a 
leucine unit (Figure 3.62) was readily identified. An NH (δH 8.46) coupled to 
an α-proton (δH-3 3.73) with the α-proton on-coupled to a methylene group 
(δH-24 1.51, 1.57). This CH2 group was in turn coupled to a CH group (δH-25 
1.73) and finally coupled to two methyl groups (δH-26 0.87 and δH-27 0.91). 
The HMBC experiment also agreed with the leucine features. The α-proton 
had H,C-correlations to the carbonyl group (δC-4 169.3), and the carbons of 
the CH2 (δC-24 42.6) and CH (δC-25 24.38) groups. The key COSY and 
HMBC correlations are shown in Figure 3.60. 
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Figure 3.62: The key COSY and HMBC correlations of the leucine unit 
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Another amino acid unit was elucidated as a tryptophan-like unit which 
incorporated the initially recognised 1,2-disubstituted aromatic ring (Figure 
3.63). The α-proton (δH-6 4.22) was coupled to a CH2 group (δH-7 2.22 2.38) 
located at the β-position. (COSY experiment, Figure 6.8). From the HMBC 
experiment, the NH showed H,C-correlations to C-1 (δC-1 168.1), C-6 (δC-6 
51.6) and C-7 (δC-7 40.6). The 1,2 substituted benzene unit was elucidated 
from the 1H experiment (Figure 3.59, 2 doublets and 2 triplets). The proton 
at position 7 had long range H,C coupling to an aromatic C (δC-9 138.2), 
while the H-23 proton (δH-23 4.63) had H,C-correlations to C-8 (δC-8 78.2) 
and C-7 (δC-7 40.6). These key correlations are shown in Figure 3.63. 
Because the sub-structure shown in Figure 3.63 contained two rings, there 
were still another three rings to be accounted for in F7474-D3. 
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Figure 3.63: The key COSY and HMBC correlations of the tryptophan type 
unit 
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Figure 3.64: HMBC spectrum of F7474-D3 in DMSO 
 
The partial structures shown in Figure 3.62 and 3.63 were joined together as 
a diketopiperazine by analysing the HMBC experiment (Figure 3.64), which 
showed that the α-proton and the NH group of the leucine unit (Figure 3.62) 
had H,C-correlations to the carbonyl group at position 1 in Figure 3.63. The 
NH group in Figure 3.63 had a H,C-correlation to the carbonyl group at 
position 4 in Figure 3.62. Therefore, those two amino acid units were joined 
though a six membered ring (Figure 3.65) accounting for the third ring.  
H
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Figure 3.65: The key HMBC correlations of the six membered ring 
 
The remaining CH group and four CH2 groups required to be assembled to 
accommodate the remaining two rings. A TOCSY experiment (Figure 3.61) 
showed that these remaining groups were arranged in a chain. The CH group 
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(δH-2’’ 3.18) showed a H,C-correlation to the carbonyl group (δC-16 172.5). 
Therefore, the third part of F7474-D3 was elucidated as a pipecolic acid unit, 
for which the key correlations are shown in Figure 3.66. There was now 
only one ring left to be accounted for. 
N
O
Key TOCSY correlations
Key HMBC correlation
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Figure 3.66: The key TOCSY and HMBC correlations of the pipecolic acid 
 
A search in SciFinder using the pipecolic acid and diketopiperazine units as 
substructures located the compound lumpidin101 (Figure 3.67) having a very 
similar type of structure to that so far established for F7474-D3, except that 
the leucine unit of F7474-D3 is replaced by a phenylalanine unit in lumpidin. 
The pipecolic acid is joined up to the tryptophan though a five membered 
ring, thus accounting for all the required degrees of unsaturation. The 
chemical shift of the carbonyl group (δC-16 172.5) at position 16 in Figure 
3.66 was considered as adjacent to N. The chemical shift of the proton at 
position 23 in Figure 3.68 (δH-23 4.63) also indicated it as being adjacent to 
2xN atoms. The proton at position 23 had a long range H,C-correlation to 
C-16 further supporting the structure proposed in Figure 3.68.  
Finally, an OH group as required to complete the molecular formula was 
connected to C-8, as seen in lumpidin. Support for this was provided by a 
long range H,C-correlation to C-7 from the OH proton in the HMBC 
experiment run in DMSO-d6 (Figure 3.64).  
 
The structure of F7474-D3 and some important HMBC correlations are 
shown in Figure 3.68. The complete assignments of the 1H chemical shifts, 
together with the 13C chemical shifts from the 13C NMR, HMBC and HSQC 
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experiments (Figure 3.58, 3.64 and 3.69), together with the 1H NMR data 
reported for lumpidin101 are shown in Table 3.12. 
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Figure 3.67: The structure of lumpidin 
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Figure 3.68: The structure of F7474-D3 and key HMBC correlations for 
completing the structure assignment 
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Figure 3.69: HSQC spectrum of F7474-D3 in DMSO 
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 Lumipidin
101
 F7474-D3 
Position δ
1
H,ppm 
δ
1
H, ppm, multiplicity, 
(JHH Hz) 
δ
13
C, 
ppm COSY HMBC 
1   168.1   
2 8.42 8.46 d (3.8)  3 1,3,6 
3  3.73 m 53.9 2,24,24' 1,4,24,25 
4   169.3   
5 7.37 7.59 s   1,4,6,7 
6 3.07 4.22 dd (9.9,2.0) 51.6 7,7' 4,7,8 
7 2.22 2.38 dd (9.9,15.0) 40.6 6,7' 4,6,8,23 
7' 2.08 2.22 dd (15.0,2.0)  6,7 1,6,8,9,23 
8   78.2   
9   138.2   
10 7.38 7.47 d (7.4) 125.7 11 8,9,12 
11 7.12 7.14 t (7.4) 125.1 10,12 10,12,13,14 
12 7.32 7.34 t (7.4) 130.2 11,13 10,14 
13 7.37 7.40 d (7.4) 114.9 12 11,14 
14   137.0   
15      
16   172.5   
17 3.18 3.18 m 66.9 18a,18b 16,17 
18 1.82 1.85 m 25.6 17,18'  
18' 1.31 1.34 m  17,18  
19 1.83 1.79 m 23.7 19'  
19' 1.30 1.26 m  19  
20 1.68 1.56 m 24.7 20',21'  
20' 1.44 1.49 m  20  
21 2.48 2.99 brd (10.8) 49.2 21'  
21' 2.05 2.48 ddd (10.8,10.8, 3.1)  20,21  
22      
23 4.25 4.63 d (1.6) 84.6  7,8,9,21 
24 3.11 a: 1.51 m 42.6 3,24',25 3,25,26,27 
24' 2.91 b: 1.57 m 42.6 3,24,25 3,25,26,27 
25  1.73 m 24.4 24,24',26,27 3,24,26,27 
26  0.87 d (6.6) 22.37 4 24,25,27 
27  0.91 d (6.6) 23.39 4 24,25,26 
28  6.34 s    7 
Table 3.12: NMR data of F7474-D3 and Lumipidin both in DMSO-d6 
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3.8.1 Relative stereochemistry of F7474-D3 
 
F7474-D3 has five stereocenters, and as it is likely to be biosynthesised from 
L-tryptophan and L-leucine, this would result in S configurations at both 
position 3 and position 6 in Figure 3.68. 
Assuming that the configuration at position 6 is S, the relative 
stereochemistry at positions 8 and 23 can be established based on a number 
of the observed NOE correlations (Figure 3.70 and 3.71). H-7’ correlated to 
both H-6 and H-23. Also H-6 and H-23 have correlations to each other. 
Furthermore, H-7' had a large geminal coupling to H-7 (15 Hz) and a small 
coupling to H-6 (2 Hz) while H-7 had a large coupling to H-6 (9.9 Hz). 
These correlations were consistent with the inter-proton distances found in 
an energy-minimised structure (Chem3D Figure 3.72 for F7474-D3) These 
data taken together established the relative configurations at C-8 and C-23 as 
8R and 23S. 
In the case of lumpidin, no correlations for H-17 were reported, and it was 
assumed as having an S configuration at position 17.101 In this work, 
correlations between H-17 and H-23 clearly established the configuration at 
position 17 as also being S. Furthermore H-21’ had a large geminal coupling 
to H-21 (10.8 Hz) and a large coupling (10.8 Hz) and a small coupling (3.1 
Hz) to the two protons at position 20 while H-21' had a very small coupling 
to the equatorial proton on 21. Therefore H-21' was an axial proton while 
H-21 was equatorial (Figure 3.72). 
The chemical shifts of two protons at position 21 of the known compound 
lumpidin were different from the two protons of F7474-D3 at the same 
position. (2.05 and 2.48 ppm for lumpidin; 2.48 and 2.99 ppm for 
F7474-D3). The minimised Chem3D structure for lumpidin had a lower 
energy level when the phenylalanine ring was close to the pipecolic acid ring 
which would be expected to affect the chemical shifts of H-21 of lumpidin. 
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The relative configuration of F7474-D3 was established as 3S*, 6S*, 8R*, 
17S*, 23S*. 
Figure 3.70: Key NOE correlations from ROESY experiment in CD3OD 
 
 
Figure 3.71: ROESY Spectrum of F7474-D3 in CD3OD 
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Figure 3.72: F7474-D3 Chem3D modelling and Key NOE correlations 
 
3.8.2 Preparation and analysis of Marfey derivatives for 
F7474-D3 
 
The absolute configurations of the amino acid units were determined by acid 
hydrolysis followed by derivatization with Marfey’s reagent 
(Nα-(2,4-dinitro-5-fluorophenyl)-L-alaninamide)100 and subsequent HPLC 
analysis (see Experimental 8.3.2), comparing the chromatograms with those 
of derivatives of the commercially available D,L-and L-leucine. The leucine 
was found to be of (R)-configuration (Figure 3.73) allowing assignment of 
the absolute stereochemistry of the stereocenter at 6 as R. The absolute 
stereochemistry of F7474-D3 was therefore (3R,6R,8S,17R,23R) as shown in 
Figure 3.68 and Figure 3.72. 
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Figure 3.73: (a) HPLC chromatograms for Marfey’s derivatives of amino 
acids from the hydrolysis of F7474-D3; (b) D,L-Leucine (c) L-Leucine 
refernce amino acids
100
 
 
3.9 Structural Elucidation of F7474-D11 
 
The other diketopiperazine isolated was F7474-D11. A HRESI mass of 
382.1744 (MH+) was obtained for F7474-D11, giving a molecular formula 
C21H23N3O4. 
 
From the 1H NMR spectrum (Figure 3.74) obtained using CapNMR it was 
possible to assign a 1,2-disubstituted benzene ring (2 doublet, 2 triplet 
aromatic H signals) and a 1,4-disubstituted benzene (2 doublet aromatic 
signals with an integral of 4 H). 
Chapter 3              Compounds from a Malaysian Fungal Endophyte 
 
105 
 
Figure 3.74: 
1
H NMR spectrum of F7474-D11 (12 µg) in CD3OD from 
CapNMR 
 
An evaluation of the COSY and HMBC spectra (Figure 3.75 and 3.76) gave 
the correlations in the substituted benzene rings as shown in Figure 3.77 
(ring I) and Figure 3.78 (ring II). 
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Figure 3.75: COSY spectrum of F7474-D11 in CD3OD 
 
 
Figure 3.76: HMBC spectrum of F7474-D11 in CD3OD 
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Figure 3.77: The key COSY and HMBC correlations of ring I in F7474-D11 
 
From the HMBC experiment, H-6 (δH 7.26) had a long-range 
H,C-correlation to C-4 (δC 198.2) and N-Me (δH 2.87) had
  a 
H,C-correlation to C-10 (δC 151.9). These suggested that ring I was 
substituted by a carbonyl group and an N-Me. Furthermore, two protons 
from the CH2 group (δH 1.42 and 2.90) also had H,C-correlations to C-4. 
These methylene protons were coupled to proton (δH 4.38) characteristic of 
an α-proton in an α-amino acid from the COSY experiment. Therefore, the 
CH2 would be at the β position and adjacent to the carbonyl group (C-4). 
The structure of ring I and the key COSY and HMBC correlations are shown 
in Figure 3.77. 
Further COSY and HMBC correlations suggested the structure of another 
spin system as shown in Figure 3.78. 
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Figure 3.78: The COSY and HMBC correlations of ring II in F7474-D11 
 
H-3'' showed H,C-correlations to C-5'' and C-9'' on the benzene ring and 
H-5'' and H-9'' showed HMBC correlations to another substituted carbon 
C-7'', the chemical shift of which (δC 157.4) suggested it had an OH group 
attached. 
 
H-3'' had COSY connections to a proton (δH 4.29 H-2'') which had HMBC 
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correlations to an N-Me group (δH 3.15, δC 37.1) and a carbonyl group (δC 
167.4), suggesting that H-2'' was an α-proton of an α-amino acid. All of the 
features indicated the presence of N-Me-tyrosine. 
 
Considering the molecular formula and together with HMBC correlations, a 
diketopiperazine structure for F7474-D11 was proposed (Figure 3.79), in 
which the other amino acid derivative was Me-kynurenine.  
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Figure 3.79: Structure of F7474-D11 
 
The complete assignments of the 1H chemical shifts, together with the 13C 
chemical shifts from the 13C NMR, HSQC and HMBC experiments (Figure 
3.80, 3.81 and 3.76), are shown in Table 3.13. 
 
Figure 3.80: 
13
C NMR spectrum of F7474-D11 in CD3OD 
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Figure 3.81: HSQC spectrum of F7474-D11 in CD3OD 
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Position δ
13
C, ppm 
δ
1
H, ppm,  
multiplicity, (JHH Hz) COSY HMBC 
1-CO 167.1    
2-CH 50.9 4.38 (d 9.5) 3 1,1'',3 
3-CH2 43.8 1.42 (dd 18.1, 9.5) 2,3' 2,4 
3'- CH2        2.9 (d 18.1) 2,3  
4-CO 198.2    
5-C 116.4    
6-CH 131.8 7.26 (d 8.0) 7 4,8,10 
7-CH 114.3 6.63 (t 8.0) 6,8 5,9 
8-CH 135.2 7.38 (t 8.0) 7,9 6,10 
9-CH 111.0 6.70 (d 8.0) 8 5,7 
10-C 151.9    
11-CH3 28.0 2.87 (s)  9,10 
12-CH3 32.1 3.14 (s)  1,2'' 
1''-CO 167.4    
2''-CH 62.9 4.29 (s)  3'' 1,12,3'',4'' 
3''-CH2 34.7 3.15 (d 4.0) 2'' 4'',5'',9'' 
4''-C 125.3    
5''-CH        131.5 6.93 (d 8.02) 6'' 3'',7'',9'' 
6''-CH 115.4 6.73 (d 8.02) 5'' 4'',7'',8'' 
7''-C 157.4    
8''-CH 115.4 6.73 (d 8.02) 9'' 4'',6'',7'' 
9''-CH 131.5 6.93 (d 8.02) 8'' 3'',5'',7'' 
Table 3.13: NMR data of F7474-D11 
 
3.9.1 Preparation and analysis of Marfey derivatives for 
F7474-D11 
 
The absolute configurations of the amino acid units were determined by acid 
hydrolysis followed by derivatization with Marfey’s reagent 
(Nα-(2,4-dinitro-5-fluorophenyl)-L-alaninamide)100 and subsequent HPLC 
analysis (see Experimental 8.3.2), comparing the chromatograms with those 
of derivatives of the commercially available amino acid N-Me-tyrosine or 
synthetic amino acid Me-kynurenine. Both of the amino acid units were 
found to be of (S)-configuration. The absolute configuration of F7474-D11 
is shown in Figure 3.82.  
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Figure 3.82: Absolute configuration of F7474-D11 
 
Examples of the HPLC results for Marfey’s derivatives of the commercial 
and synthetic reference amino acid residues are given in Figure 3.83 and 
3.84. 
 
Figure 3.83: (a) HPLC chromatograms for Marfey’s derivatives of amino 
acids from the hydrolysis of F7474-D11; (b) and (c) Me-kynurenine 
reference amino acids 
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Figure 3.84: HPLC chromatograms for Marfey’s derivatives of amino acids 
from the hydrolysis of F7474-D11 (a) and N-methyl-tyrosine reference amino 
acid (b) 
 
3.9.2 Synthesis of N-Me-kynurenine 
 
As N-Me-kynurenine is a rare amino acid, it was necessary to synthesise 
both D and L N-Me-kynurenine from the commercially available D and L 
kynurenines (Figure 3.85). Kynurenine was first protected with a BOC 
group, followed by the methylation under standard conditions (NaBH3CN, 
CH2O in ACN). Finally, the BOC protection group was removed by TFA. 
The products were purified by HPLC.   
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Figure 3.85: Synthesis of the D- and L-N-Me-kynurenines 
 
3.10 Discussion of F7474 Diketopiperazines 
 
F7474-D3 and D11 were not active in any bioassay, but were chosen to 
study because they were easily collected using the MT plate method and 
established as new compounds after CapNMR experiments and AntiMarin 
searching. This was a further indication of CapNMR as a very powerful tool 
for targeting new natural products. Both of the diketopiperazines showed 
very interesting structural features. The only structure which was similar was 
lumpidin.101 However, lumpidin was only reported with relative 
stereochemistry. From the absolute stereochemistry of the leucine moiety in 
F7474-D3, determined by Marfey’s method, the overall absolute 
stereochemistry of F7474-D3 was determined.  
F7474-D11 contained the unusual amino acid N-Me-kynurenine, for which 
the synthesis is described here for the first time. 
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Chapter 4 
 
 
 
F7855, a Malaysian Fungal 
Endophyte 
 
 
 
4.1 General Introduction 
 
The lasiodiplodins are a group of naturally occurring compounds that related 
to orsellinic acid (2,4-dihydroxy-6-methylbenzoic acid). Zearalenone and 
resorcylide are also typical examples (Figure 4.1).  
O
O
OOH
HO
O
O
HO
O
O
O
O
OH
HO
               
Lasiodiplodin           Zearalenone             Resorcylide 
Figure 4.1: Naturally occurring orsellinic acids 
 
Lasiodiplodin and its relatives were reported mainly as being isolated from 
endophytic fungi.102,103 One example is Lasiodiplodia theobromae, a fungus 
whose culture filtrate inhibits the growth of higher plants.103 These 
lasiodiplodins are known to be very efficient inhibitors of prostaglandin 
biosynthesis, and exhibit significant anti-leukemic and potato micro-tuber 
inducing activities.103-106 
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4.2 Introduction 
 
The endophytic fungus Kurzii sp. (F7855) was collected from plant roots 
from Malaysia. The extraction work was done by Sultan Sadia from 
Malaysia. The extract was then sent to the University of Canterbury, New 
Zealand for chemical investigation.  
 
4.3 Preliminary Investigations 
 
An aliquot of the crude extract of F7855 (3.7 mg) was analysed on reverse 
phase C18 HPLC using the standard gradient (See experimental 8.4.1). 
HPLC (Figure 4.2) revealed that the extract containing seven related 
compounds, as judged by the similarity of their UV profiles (Figure 4.3). 
Based on the HPLC profile the assumption was made that the seven related 
compounds each contained a highly conjugated π-electron system. 
 
Figure 4.2: HPLC chromatogram of the crude extract of F7855. UV 
detection with ELSD comparison 
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Figure 4.3: UV profiles of the seven peaks from F7855 
 
A search of the in-house UV database suggested that these compounds were 
lasiodiplodins. This was based on the UV profile and the relative retention 
times under the standard gradient conditions. All compounds also showed 
very similar features in their 1H spectrum. Take F7855-7 as an example 
(Figure 4.4), which contained a doublet methyl signal, two singlet aromatic 
H signals, but no O-Me signal. The UV and proton NMR spectral features 
confirmed they were all de-O-methyl-lasiodiplodins. 
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Figure 4.4: The 
1
H spectrum of the major peak F7855-7 (328 µg) in CD3OD 
from CapNMR 
 
The MT plate of F7855 was sent for bioactivity testing, and all seven peaks 
showed excellent P388 activity, therefore, they were chosen for further 
investigation and all compounds were purified by manual collection from 
analytical HPLC by using the standard gradient based on the total weight  
of the crude extract (3.7 mg) (see Experimental 8.4.1). 
 
4.4 Structural Elucidation of F7855-7 
 
The major peak was named as F7855-7. The low resolution ESIMS gave an 
apparent molecular ion M+ 278 Da. A search was carried out in the 
AntiMarin database based on the molecular mass and 1H NMR (Figure 4.5) 
features (only one doublet Me group). There were three hits (Figure 4.6) of 
which de-O-methyl-lasiodiplodin107 had spectroscopic data in agreement 
with that for F7855-7. 
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Figure 4.5: AntiMarin search profile for F7855-7 
 
 
Figure 4.6: AntiMarin search result for F7855-7 
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Syntheses of the parent compound lasiodiplodin has been published and had 
confirmed the (R) configuration at C-3 in natural lasiodiplodin and 
de-O-methyl lasiodiplodin.108-111 The stereochemistry of F7855-7 was 
assumed to be (R) (Figure 4.7).  
OH
HO
O
O
3
61012
14
 
Figure 4.7: The Structure of F7855-7 
 
4.5 Structural Elucidation of F7855-2 and F7855-5 
 
F7855-2 and F7855-5 were the next two compounds characterised. Their 
molecular weights (294 Da and 292 Da respectively) implied that F7855-2 
had one OH group more than F7855-7 (MR 278 Da), while F7855-5 
contained an additional carbonyl group.  
A search of AntiMarin based on the lasiodiplodin skeleton, MW 294 Da and 
1 doublet methyl group (Figure 4.9) yielded one hit only. This structure 
contained an OH group at position 5 (Figure 4.10). However, the literature 
1H NMR data for this structure103 did not match the values obtained for 
F7855-2. But in the same paper, there was a structure listed with the OH 
group at position 6 rather than 5. The literature values for this compound 
corresponded well with those obtained for F7855-2. Therefore, F7855-2 was 
characterised as the known compound 6-hydroxy-de-O-methyl-lasiodiplodin 
(Figure 4.11)103 and the stereochemistry was considered as the same as that 
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shown in the paper. 
 
Figure 4.8: The 
1
H spectrum of F7855-2 (16 µg ) in CD3OD from CapNMR 
 
 
Figure 4.9: AntiMarin search profile for F7855-2 
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Figure 4.10: AntiMarin search result for F7855-2 
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Figure 4.11: The structure of F7855-2 
 
Using a similar strategy the data for F7855-5 was searched for in the 
AntiMarin database, and yielded three hits (Figure 4.14), all containing the 
same structure (Figure 4.14). 
F7855-5 was thus identified as the known compound 
6-oxo-de-O-methyl-lasiodiplodin (Figure 4.15) based on a comparison of the 
measured spectroscopic data with those in the literature.102 
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Figure 4.12: The 
1
H spectrum of F7855-5 (5µg) in CD3OD from CapNMR 
 
 
Figure 4.13: AntiMarin search profile for F7855-5 
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Figure 4.14: AntiMarin search result for F7855-5 
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Figure 4.15: The structure of F7855-5 
 
4.6 Structural Elucidation of F7855-4 
 
Compound F7855-4 was obtained as a white powder. The molecular formula 
C16H22O5 was suggested from the HRESIMS (MH
+ 295.1543) in 
combination with the NMR spectral data. Compared with F7855-7 (Figure 
4.7), F7855-4 contained an additional OH group. As the molecular formula 
was the same as that of F7855-2 (Figure 4.11) and the 1H NMR data 
comparable, the only difference between them was the position of the OH 
group. In the COSY spectrum of F7855-4 (Figure 4.17), the carbinol proton 
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(δH-4 4.11) gave a clear correlation to H-3 (δH 5.15) which further correlated 
to a doublet methyl group (δH-17 1.37). This correlation required that the OH 
group be at the C-4 position. 
 
Figure 4.16: The 
1
H NMR spectrum of F7855-4 (12 µg) in CD3OD from 
CapNMR 
 
Figure 4.17: COSY spectrum of F7855-4 and key correlation of H-3 and 
H-4 
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The relative configuration between the C-3 methyl and the C-4 hydroxyl 
groups was determined as cis. This was based on the coupling constant 
(3JHH=2.6 Hz) between H-3 and H-4 in the 
1H NMR spectrum (Figure 4.18) 
allowing assignment of F7855-4 as (3R,4R)-4-hydroxy-de-O-methyl- 
lasiodiplodin (Figure 4.19), a previously unreported compound. The NMR 
data is shown in Table 4.1. 
 
Figure 4.18: The coupling constant of H-3 to H-4 in F7855-4 derived from 
the signal for H-3 
 
OH
HO
O
O
OH
3
4
17
 
Figure 4.19: The structure of F7855-4 
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Position δC, ppm δH, ppm, multiplicity, (JHH Hz) 
3-CH 76.0 5.15 (dq) 
4-CH 69.4 4.09 (m) 
5-CH2 30.1 1.59, 1.90 (m) 
6-CH2 26.7 1.44, 1.53 (m) 
7-CH2 22.1 1.47, 1.63 (m) 
8-CH2 23.0 1.47, 1.63 (m) 
9-CH2 30.1 1.57, 1.79 (m) 
10-CH2 32.9 2.31, 3.11 (m) 
12-CH 100.7 6.15 (d, 2.2) 
14-CH 110.3 6.19 (d, 2.2) 
17-CH3 18.5 1.37 (d, 6.5) 
Table 4.1: NMR data for F7855-4 in CD3OD 
 
4.7 Structural Elucidation of F7855-6 
 
The molecular formula of F7855-6 C16H20O4, again from HRESIMS data 
(MH+ 277.1476) and a proton count from the 1H NMR spectrum, was two 
hydrogens less than that of de-O-methyl-lasiodiplodin (F7855-7). The 
1H-spectrum (Figure 4.20) of F7855-6 clearly showed two more signals (δH 
5.63, δH 6.83) in the olefinic region when compared with the 
1H-spectrum of 
F7855-7 (Figure 4.4). In the COSY spectrum (Figure 4.21) of F7855-6, the 
proton at δH 6.83 had correlated only with the other double bond proton at δH 
5.63 which in turn was also correlated to H-8 (δH 2.25). This positioned the 
double bond as adjacent to the aromatic ring (δH-9 5.63 and δH-10 6.83).  
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Figure 4.20: The 
1
H spectrum of F7855-6 (7 µg) in CD3OD from CapNMR 
 
 
Figure 4.21: The COSY spectrum of F7855-6 and key correlations  
 
The coupling constant (3JH9-H10= 15.7 Hz see Figure 4.22) confirmed the 
trans configuration of the olefinic protons. Therefore, the structure of 
compound F7855-6 was established as (E)-9-etheno-de-O-methyl- 
lasiodiplodin (Figure 4.23), another previously unreported compound. The 
NMR date is shown in Table 4.2. 
Chapter 4                  F7855, a Malaysian Fungal Endophyte 
 
128 
    
Figure 4.22: The coupling constant of H-9 to H-10 in F7855-6 derived from 
the signal for H-10 
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Figure 4.23: The Structure of F7855-6 
 
Position δC, ppm δH, ppm, multiplicity, (JHH Hz) 
3-CH 72.4 5.22 (m) 
4-CH 32.4 1.74 (m) 
5-CH2 19.7 1.38, 1.75 (m) 
6-CH2 27.7 1.51 (m) 
7-CH2 25.0 1.57, 1.64 (m) 
8-CH2 30.0 2.28 (m) 
9-CH 130.0 5.62 (ddd, 5.3, 8.3, 15.7) 
10-CH 133.1 6.81 (d, 15.7) 
12-CH 107.8 6.25 (d, 2.2) 
14-CH 101.2 6.18 (d, 2.2) 
17-CH3 18.3 1.35 (d, 6.4) 
Table 4.2: NMR data of F7855-6 in CD3OD 
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4.8 Discussion 
 
This work on F7855 provided a good example of an extract containing 
known compounds (F7855-2,5,7) which could be quickly characterised from 
the UV data and by using AntiMarin. It also contained two new compounds 
(F7855-4,6) which were characterised as analogs of the known compounds. 
These examples all showed the power of CapNMR as these compounds 
were each present in amounts of less than 20 µg, isolated from the original 
3.7 mg extract. 
The remaining two compounds F7855-1 and F7855-3 from the series (as 
seen in the HPLC chromatogram Figure 4.2) each had the same molecular 
mass as for F7855-4, but did not yield any hits against any known literature 
compound. They were therefore considered as also being new compounds. 
The problem of determining structures for these two compounds was 
establishing the position of the hydroxyl group. Unfortunately, the very low 
yield for each of these two compounds (less than 10 µg) did not permit the 
acquisition of TOCSY spectra of suitable quality to permit structure 
solutions for F7855-1 and F7855-3. 
As the two new compounds F7855-4, F7855-6 were obtained in amounts of 
less than 20 µg each, it was not possible to assign absolute stereochemistry 
based on optical rotation or CD data. However, there were examples in the 
literature of successful syntheses of lasiodiplodin which confirmed the (R) 
configuration at C-3 in natural lasiodiplodin and de-O-methyl 
lasiodiplodin,108-111 thus suggesting a (3R) configuration in these new 
lasiodiplodins. 
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Chapter 5 
 
 
 
F7090, a New Zealand Fungal 
Endophyte 
 
 
 
5.1 General Introduction 
 
The ergochromes (synonyms ergoflavin, ergochrysin, secalonic acids) 
(Figure 5.1) are an important group of biologically highly active mycotoxins, 
produced by a variety of microorganisms.112 These fungal metabolites, 
named ergoflavins, were first isolated in pure form from Claviceps purpurea 
(ergot) in 1958.113 At present, at least twenty-two members of the 
ergochrome family have been isolated and structurally identified.114 They are 
dimers of six different monoxanthones (hemisecalonic acids A-F), and 
ergochrome diversity is attributable to different homo- and heterodimers of 
these six monomeric units.112 The secalonic acids usually contain a 
2,2'-linkage,112,115 while another class of dimers, the eumitrins,116,117 and 
isoergochrysin,118 are coupled through the 4,2' positions. 
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Figure 5.1: Examples of some ergochromes 
 
5.2 Introduction 
 
F7090 was an unknown endophytic fungus, and the extraction of a culture of 
this fungus was first carried out by Wenxu Jiao in the UC Marine Group. It 
was selected for CapNMR investigation because it contained two peaks 
which had identical UV spectra. 
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5.3 Preliminary Investigations 
 
The P388 quick screen micro-assay was obtained for the crude extract 
(F3772, 1 mg) before an in-depth investigation was carried out. It was found 
that F3772 showed strong P388 activity (95% growth inhibition).  
An aliquot of the extract was chromatographed on reverse phase C18 HPLC 
using the standard gradient (see Experimental 8.5.1) to obtain a visual 
profile of the extract. HPLC of this extract showed two clean peaks with 
identical UV profiles. Based on the HPLC profile the assumption was made 
that the two related compounds each contained a highly conjugated system, 
consistent with the intense yellow colour of the extract and absorbance in the 
yellow region of the UV-visible spectrum. No matches for these compounds 
were found in the UV library and an AntiMarin search using features from 
the 1H CapNMR spectra did not yield any known compounds. Therefore, the 
sample was re-grown on a larger scale (by Gill Ellis) for further study. The 
new code was F7090, and the HPLC chromatogram and UV profiles of the 
extract of this re-culturing, are shown in Figures 5.2 and 5.3.  
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Figure 5.2: HPLC chromatogram of the crude extract of F7090. UV 
detection with ELSD comparison 
 
 
Figure 5.3: UV profiles of F7090-A and F7090-B 
 
Neither F7090-A nor F7090-B were in the bioactive region. The active peak 
collected from MT plate in wells F11 and F12 gave four singlet aromatic 
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signals and a singlet methyl signal at around 2.45 ppm (Figure 5.4). 
AntiMarin database searching and 1H NMR simulation from the ACD NMR 
predictor found that this corresponded to the known compound frangulic 
acid (Figure 5.5).119 
 
Figure 5.4: The 
1
H spectrum of F7090-F11,12 from CapNMR 
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Figure 5.5: The Structure of Frangulic acid 
 
5.4 Chromatography of F7090 Extract 
 
Before attempting chromatography, the extract was partitioned with 
MeOH/pet. ether. The MeOH soluble material (84.4 mg) was found to 
contain the two compounds in question. Due to the simple nature of the 
MeOH fraction, chromatography was kept to the bare minimum, with 
semi-preparative HPLC being the only form of chromatography carried out 
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in order to obtain each of the two compounds in a sufficiently pure form 
F7090-A (1.6 mg) and F7090-B (1.1 mg) from a portion of the extract (20 
mg) (see Experiment 8.5.1). 
 
5.5 Structural Elucidation of F7090-A 
 
F7090-A was obtained as yellow oil, and the molecular formula was 
elucidated as C32H34O16 from HRESIMS (MH
+ 675.1943). The 1H spectrum 
was not complex, containing only a doublet methyl, a methoxyl group and a 
1,2,3,4-tetrasubstituted benzene ring as searchable features (Figure 5.6, 5.7). 
However, no hits were obtained from the AntiMarin database. 
 
Figure 5.6: The 
1
H spectrum of the major peak F7090-A from CapNMR 
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Figure 5.7: AntiMarin search profile for F7090-A 
 
F7090-B was obtained as a yellow oil, and had the same molecular formula 
as F7090-A (HRESIMS, MH+ 675.1925). The 1H spectrum of F7090-B was 
more complex than that for F7090-A (Figure 5.8). In the proton spectrum of 
F7090-B all the signals for F7090-A were doubled which suggested these 
two compounds were dimers, with F7090-A being a symmetric dimer and 
F7090-B an asymmetric dimer. 
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Figure 5.8: The 
1
H spectrum of the major peak F7090-B from CapNMR 
 
With the assumption that F7090-A was dimer, the AntiMarin search method 
was changed to include two doublet methyl groups, two methoxyl groups 
and two 1,2,3,4-tetrasubstituted benzenes as well as the mass (Figure 5.9). 
Only one result was found which was the dimer ergochrome DD (2,2') 
(Figure 5.10).  
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Figure 5.9: AntiMarin search profile for F7090-A and F7090-B 
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Figure 5.10: AntiMarin search result for F7090-A and F7090-B 
 
In addition to the obvious 1H NMR features there were another two 
methylene groups and two methine groups (HSQC-DEPT experiment, 
Figure 5.12) in each half of F7090-A. However, in ergochrome DD there 
was one methylene group and three methine groups in each half. From the 
COSY experiment on F7090-A (Figure 5.13), a CH (δH-5 4.08) adjacent to an 
OH group was coupled to a CH (δH-6 2.32). H-6 was further coupled to a 
CH3 (δH-11 1.09) and to a CH2 (δH-7A, 7B 2.30, 2.52). This fragment (Figure 
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5.11) is the same as for the known compound ergochrome DD (2,2').  
HC
CH2
OH
CH3
Key COSY correlation
δH-5: 4.08
δH-6: 2.32
δH-11: 1.09
δH-7A, 7B: 2.30, 2.52
 
Figure 5.11: Key correlations of partial structure of F7090-A 
 
 
Figure 5.12: HSQC-DEPT spectrum of F7090-A from CapNMR 
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Figure 5.13: COSY spectrum of F7090-A with key correlations from 
CapNMR 
 
The groups attached at position 5 and 7 were confirmed by an HMBC 
experiment (Figure 5.16) in which the CH2 at position 7 had 
H,C-correlations to C-5, C-6, and C-11. However, H-7 also had a 
H,C-correlation to a carbonyl group (δC 175.4). The chemical shift of this 
carbonyl group indicated it was further attached to an OH group. Therefore 
this carboxyl group was situated at position 8 (Figure 5.14). 
HC
OH
CH3
OH
O
δC-5: 77.6
δC-6: 33.7
δC-8: 175.4
δC-11: 15.4
Key HMBC correlation
 
Figure 5.14: Key HMBC correlations from H-7 of F7090 
 
The CH group at position 5 had H,C-correlations from the HMBC spectrum 
which indicated that it was in a very similar environment to that found in 
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ergochrome DD. H-5 showed correlations to a quaternary carbon (δC-10a 89.9) 
and a carbonyl group (δC-12 172.9). However, H-5 also had a H,C-correlation 
to the C-8 methylene group (δC-8a 40.1). The 
1H chemical shifts of this CH2 
group (δH-8aA, 8aB 3.17 3.40) indicated proximity to the carbonyl group at 
position 9. Further evidence came from the H,C-correlation from H-8aA to 
C-9a (δC 109.0), C-9 (δC 199.0), C-10a (δC 89.9), C-5 (δC 77.6) and C-12 (δC 
172.9). These key correlations are shown in Figures 5.15 and 5.16. 
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Figure 5.15: Key HMBC correlations from H-8 and H-5 of F7090-A 
 
Figure 5.16: HMBC spectrum of F7090-A with key correlations  
 
 
Chapter 5                F7090, a New Zealand Fungal Endophyte 
 
142 
The structure of F7090-A was thus characterized as the symmetric dimer 
shown in Figure 5.17. The complete assignments of the 1H chemical shifts, 
together with the 13C chemical shifts from the 13C NMR, HSQC and HMBC 
experiments (Figure 5.18, 5.12 and 5.16), are shown in Table 5.1.  
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Figure 5.17: The Structure of F7090-A 
 
A structure with 4/4' coupling of both halves would also have matched the 
NMR information, including the HMBC correlations. However, the 2/2' 
assignment was made based on the observation that 2/2' coupling in the 
ergochrome series of compounds (>10) was predominant.112,115 In the range 
of structures in the ergochrome series just two with 4/4' couplings were 
observed. 
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Figure 5.18: 
13
C Spectrum of F7090-A from 300MHz regular NMR 
 
Position δ
13
C, ppm 
δ
1
H, ppm,  
multiplicity, (JHH Hz) COSY HMBC 
1-C 161.4    
2-C 119.2    
3-CH 142.5 7.47 (d, 8.6) H-4 C- 2, 4, 4a 
4-CH 109.0 6.63 (d, 8.6) H-3 C-1, 2, 9, 9a 
4a-C 160.8    
5-CH 77.6 4.08 (brs) H-6 C-7, 8a,10a,11,12 
6-CH 33.7 2.32 (m) H-5, 7A, 7B, 11 C-5, 7, 8, 11 
7-CH2 42.9 (A):2.30 (m) H-6, 7B C-5, 6, 8, 11 
 42.9 (B):2.52 (m) H-6, 7A C-5, 6, 8, 11 
8-CO 175.4    
8a-CH2 40.1 (A): 3.17 (d, 17.3) H-8aB C-5, 9, 9a,10a,12 
 40.1 (B): 3.40 (d,17.3) H-8aA  
9-CO 199.0    
9a-C 109.0    
10a-C 89.9    
11-CH3 15.4 1.09 (d, 6.4) H-6 C-5, 6, 7 
12-CO 172.9    
13-CH3 53.8 3.70 (s)   
Table 5.1: NMR data of half part of F7090-A in CD3OD 
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5.6 Structural Elucidation of F7090-B 
 
F7090-B had the same MF as F7090-A, and all the 1H signals (Figure 5.9) 
were doubled from those in F7090-B (Figure 5.6). Therefore, it was assumed 
that F7090-B was an asymmetric dimer with comparable connectivities as 
seen in F7090-A. 
The HSQC-DEPT experiment (Figure 5.19) indicated the protons coming 
from both sides were in very similar environments as the 13C signals were 
very similar. This was also evidence suggesting that each side of the dimer 
had the same connectivities. 
Figure 5.19: HSQC-DEPT spectrum of F7090-B from CapNMR 
 
From the COSY experiment (Figure 5.20), the two chain systems were 
clearly shown. H-5 (δH 4.04) was adjacent to an OH and coupled to H-6 (δH 
2.33). H-6 was further coupled to H-11 (δH 1.08) and a CH2 group (δH-7A, 7B 
2.32, 2.55). On the other side, H-5' (δH 3.85) coupled to H-6' (δH 2.19), and 
H-6' coupled to H-11' (δH 0.85) and a CH2 group (δH-7'A, 7'B 2.08, 2.44). 
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Figure 5.20: COSY spectrum of F7090-B from CapNMR 
 
The HMBC correlations for F7090-B (Figure 5.22) were not as clear as 
those observed for F7090-A. There were no signals showing correlations 
from H-5 (H-5') to C-8a (C-8'a). However, H-8aA (δH 3.18) showed 
H,C-correlations to C-9 (δC 196.9) and C-9a (δC 107.7). Similarly, H-8'aA 
(δH 3.16) showed H,C-correlations to C-9' (δC 196.9) and C-9'a (δC 107.4). 
This proved that the C-8 methylene group was at the same place as in 
F7090-A (Figure 5.21) leading to the conclusion that F7090-A and F7090-B 
had the same connectivity. 
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Figure 5.21: Key HMBC correlations from H-8aA of F7090-B 
 
Chapter 5                F7090, a New Zealand Fungal Endophyte 
 
146 
 
Figure 5.22: HMBC spectrum of F7090-B with key correlations  
 
The complete assignments of the 1H chemical shifts, together with the 13C 
chemical shifts from the HSQC and HMBC experiments (Figure 5.19 and 
5.22), are shown in Table 5.2. 
 
There are at least two possible explanations for the observed asymmetry in 
the chemical shifts between the two halves of F7090-B. Firstly, the relative 
stereochemistry of the two halves was different. This was not considered 
highly probable as it likely to have been the identical monomer involved in 
the phenol-coupling process that resulted in the production of F7090-B. A 
more likely explanation was that F7090-B arose from an asymmetric 
coupling. That is a 4-2' coupling of the identical monomer unit (Figure 
5.23). 
Chapter 5                F7090, a New Zealand Fungal Endophyte 
 
147 
O
O
O
OHOH
OH
O
O
2'
3'
4'
4a'
10a'
8a' 9a'
O
O
OH
O
O
HO
O
OH
4
 
Figure 5.23: The Structure of F7090-B 
 
Certainly two pairs of vicinally coupled aromatic protons were observed (δ 
6.55, 7.73 J=8.8 Hz; δ 6.66, 7.74 J=8.8 Hz). There are literature 
examples118,120 of 2/2' and 4/4' couplings in comparable systems (Figure 
5.24). 
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Figure 5.24: The Structures of 2/2' and 4/4' compounds  
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Analysis of the data suggested that in the 2/2' case the relevant aromatic 
protons (H-3; H-4) are downfield relative to the comparable protons in the 
4/4' situation (H-2; H-3). If this chemical shift analogy is applied to F7090-B 
it suggests that the δ6.55/7.33 pair belong to a 4 coupled monomer and that 
the δ6.66/7.74 pair are from a 2 coupled monomer. A full analysis of the 
HMBC spectrum for F7090-B gave acceptable results (see Figure 5.23 and 
Table 5.2). The ACD calculated 13C and 1H NMR spectral data were useful 
in confirming these assignments. The data for the 2/2' dimer F7090-A (Table 
5.1) was in keeping with this assignment of an asymmetrical 4/2' dimer. The 
stereochemistries of the two monomerre units were unresolved, but have 
been assumed to be identical in the two monomers. 
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Position δ
13
C, ppm 
δ
1
H, ppm,  
multiplicity, (JHH Hz) COSY HMBC 
1-C     
2-C 117.0    
3-CH 141.3 7.33 (d, 8.6) H-4 C- 2', 4a 
4-CH 109.0 6.55 (d, 8.6) H-3 C-2, 4a, 9a 
4a-C 159.3    
5-CH 75.8 4.04 (d, 2.04) H-6 C-6, 7, 10a, 11, 12 
6-CH 31.4 2.33 (m) H-5, 7A, 7B, 11  
7-CH2 40.4 A:2.32 (m) H-6, 7B  
 40.4 B:2.55 (m) H-6, 7A C-5, 6 
8-CO 175.5    
8a-CH2 40.9 A:3.18 (d, 17.2) H-8aB C-9, 9a 
 40.9 B:3.38 (d, 17.2) H-8aA  
9-CO 196.9    
9a-C 107.7    
10a-C 88.0    
11-CH3 13.3 1.08 (d, 6.4) H-6 C-5, 6, 7 
12-CO 171.1    
13-CH3 52.2 3.70 (s)   C-12 
1'-C 160.9    
2'-CH 107.4 6.66 (d, 8.6) H-3' C-4', 4'a, 9', 9'a 
3'-CH 141.3 7.74 (d, 8.6) H-2' C-2, 4', 2'a 
4'-C 115.4    
4a'-C 157.1    
5'-CH 76.4 3.85 (d, 3.0) H-6' C-6',7',10'a,11',12' 
6'-CH 31.6 2.19 (m) H-5',7'A,7'B,11'  
7'-CH2 39.9 A:2.08 (dd, 6.8 7.9) H-6', 7'B C-8', 11' 
 39.9 A:2.44 (dd, 6.8 7.9) H-6', 7'A C-5', 6', 8', 4a' 
8'-CO 175.5    
8'a-CH2 39.9 A:3.16 (d, 17.2) H-8'aB C-9', 9a' 
 39.9 B:3.30 (d, 17.2) H-8'aB  
9'-CO 196.9    
9'a-C 107.4    
10'a-C 88.0    
11'-CH3 13.3 0.85 (d, 6.4) H-6' C-5', 6', 7' 
12'-CO 170.7    
13'-CH3 52.0 3.66 (s)   
Table 5.2: NMR data of F7090-B in CD3OD 
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5.7 Discussion 
  
F7090-A and F7090-B appeared as dimers and each has three stereogenic 
centres in each half of the structure. There are no compounds published that 
have structures comparable to F7090-A and B with an open chain structure. 
Because both F7090-A and F7090-B had open chain systems containing the 
three stereogenic centres it was not possible to establish the relative 
stereochemistries using coupling constants from 1H NMR experiments. 
However, from the 1H NMR experiments, F7090-A was assigned as having 
the same stereochemistry in both halves of the dimer, and it has been 
assumed that this also applies to F7090-B. In an attempt to address the 
stereochemistry issues, a sample of F7090-A was reacted with (R) and 
(S)-Mosher acid derivatives. Unfortunately, these reactions were 
unsuccessful, possibly for steric reasons, so the stereochemistry at the three 
chiral centres remains unassigned.  
During the structural elucidation, all of the NMR experiments for F7090-A 
and B were first attempted utilising CapNMR, however the lack of some key 
HMBC correlations made the structural elucidation difficult. Therefore, 
larger amounts of the compounds were obtained from the extract and HMBC 
experiments were then carried out on the regular probe which gave the key 
correlations to prove the open chain as showed in Figure 5.15 and 5.21. 
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Chapter 6 
 
 
 
Biosynthetic study of 
Tetrahydrofurans from a New 
Zealand Fungus 
 
 
 
6.1 Introduction 
 
In 2007, two members of Marine Group identified two related compounds 
from two fungal extracts. Ms Sunita Chamyuang isolated the known 
compound 2-(buta-1',3''-dienyl)-3-hydroxy-4-(penta-1',3''-dienyl) tetrahydro- 
furan from the New Zealand fungus Chaetomium globosum. Ms Francine 
Smith also isolated this compound (tetrahydrofuran A, given the new 
numbering system for convenience of later descriptions, Figure 6.1) as well 
as a new compound (tetrahydrofuran B) from an extract of an unidentified 
New Zealand fungus.121  
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Figure 6.1: Structures of tetrahydrofuran A and tetrahydrofuran B 
 
Saito et al.122 have described the biosynthesis of tetrahydrofuran A. This 
occurs via an epoxide rearrangement of the polyketide precursor (Figure 6.2). 
Saito et al. had used labelling experiments to illustrate that the 
tetrahydrofuran compound was derived from seven acetate groups. This 
resulted in a 14 carbon precursor, followed by decarboxylation to give the 13 
carbon skeleton. The implications of Saito’s biosynthetic scheme thus 
required the terminal methyl group of tetrahydrofuran A to have arisen from 
C2 of acetate by a series (presumably) of oxidative steps on the C-1 methyl 
group resulting in the C-1 carboxyl group.  
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Figure 6.2: Biosynthetic pathways found for Tetrahydrofuran A and 
proposed for Tetrahydrofuran B
121
 
 
In this work, biosynthetic studies on the formation of the tetrahydrofuran A 
as well as the tetrahydrofuran B were undertaken using CapNMR 
methodology to explore the relationship between these two metabolites, and 
to establish the suitability of using this technique to study biosynthetic 
pathways on a very small scale.  
 
6.2 Preliminary Investigations 
 
The original culture medium for F5048 was SDY (Sabouraud Dextrose Yeast) 
broth. A time-course experiment was initially carried out to ascertain 
whether both the known compound (tetrahydrofuran A) and the new 
compound (tetrahydrofuran B) were produced, and to establish the stage of 
fungal growth when production of those two compounds was initiated and 
when large quantity production started. This information was important 
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because if precursors are added too early in the fermentation, it can lead to a 
too high incorporation which can cause problems in the interpretation of 
NMR data when using doubly labelled precursors. The opposite problem can 
arise if the precursors are added too late. That is, the rate of incorporation 
could be too low, which would impede the interpretation of the NMR data, 
as it is now difficult to distinguish labelled from non-labelled carbons. 
Time-course experiments (see Experimental 8.6.1) were carried out using 
both small culture volume and large culture volume under static and shake 
conditions. It was only under static conditions that tetrahydrofuran B was 
produced. The production of the metabolites was monitored daily by HPLC 
analysis, using the “standard gradient” (see Experimental 8.6.2). The static 
small culture started producing the known compound from day 2 and started 
producing the new compound from day 4 and displayed maximum 
production of both compounds, after 9 days (Figure 6.3, UV profiles of these 
two compounds in Figure 6.4).  
 
Figure 6.3: Stacked HPLC chromatograms from the static, small volume 
time-course experiments, clearly showing increases in tetrahydrofuran A 
and tetrahydrofuran B with time 
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Figure 6.4: UV profiles of tetrahydrofuran A and tetrahydrofuran B 
 
The decision was made to use small volume static conditions for the 
biosynthetic experiments. This was based on the shorter time period 
involved. It was also decided that due to the almost immediate production of 
large amounts of tetrahydrofuran A in the liquid culture, the 
isotopically-labelled precursors would be added at the start of the 
fermentation. 
 
6.3 Aims of the Biosynthetic Investigation 
 
The biosynthesis of the tetrahydrofuran A had already been described by 
Saito et al.121. The key steps established were that the compound was of 
polyketide origin and that the key migration step shown in Figure 6.2 was 
proved. The aims of this re-investigation of the biosynthesis of 
tetrahydrofuran A were three-fold: 
· to show the potential role for CapNMR spectroscopy in small-scale 
biosynthetic experiments. This was the prime aim as this would 
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considerably reduce the cost of biosynthetic experiments. 
· to establish the biosynthetic origins of the new compound (tetrahydrofuran 
B). 
· to isolate and characterise possible intermediates between tetrahydrofuran 
A and B. 
The 2D 13C-13C INADEQUATE (Incredible Natural Abundance DoublE 
QUAntum Transfer Experiment) NMR experiment is useful for determining 
which 13C signals in a 13C NMR spectrum arise from neighboring carbons.123 
However, it is a very insensitive experiment as only 0.01% of the adjacent 
carbon pairs are simultaneously excited at natural abundance. Use of this 
experiment is a last resort when all else fails. If 13C labelling in the 
biosynthesis studies enriches the sample to about 10% 13C then the 
INADEQUATE experiment can be run at normal sample concentrations. At 
natural abundance, it is necessary to use between 100 and 500 mg of sample. 
However, with CapNMR it was hoped to demonstrate the use of this 2D 
experiment based on 200 µg 13C labelled sample. 
 
6.4 Fermentation and Isolation 
 
It was decided that [2-13C]-acetate would best serve to demonstrate the 
biosynthetic origins of tetrahydrofuran B, while to demonstrate the utility of 
the CapNMR approach, studies would also be carried out using 
[1,2-13C2]-acetate with the view of attempting an INADEQUATE 
experiment. The fungus F5048 was therefore grown with [2-13C]-acetate, (1 
mg/mL, 15 mL of liquid media, 30 vials), and in another duplicated 
experiment with [1,2-13C2]-acetate. Preparation of the labelled acetate 
inoculums is detailed in the Experimental section for this chapter (see 
Experimental 8.6.2) 
Nine days after inoculation, the cultures were extracted with EtOAc using 
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the standard protocol (Section 8.1.2, Experimental). Purification of the 
resultant extracts by semi-preparative HPLC yielded pure tetrahydrofuran A 
from each culture, and also tetrahydrofuran B. Unfortunately, it was not 
possible to obtain tetrehydrofuran B in high purity. 
 
6.5 Biosynthetic Studies on Tetrahydrofuran A 
 
Results from the [2-13C]-acetate labelled tetrahydrofuran A were used to 
compare against the previous biosynthetic studies by Saito et al.,121 and 
these also serve to describe and demonstrate the strength of the CapNMR 
methodology by use of the HSQC and HMBC experiments to assist in the 
interpretation. 
Ethyl acetate extraction was carried out on one fermentation vial (15 mL) to 
give the crude extract (0.8 mg). This entire sample was injected into the 
analytical HPLC column and using the standard gradient, the eluate was 
collected into a microtitre plate. Tetrahydrofuran A was concentrated into 
wells F7 and F8. This single collection was injected into the CapNMR probe 
and from this, all NMR spectra including 1D and 2D NMR experiments 
were collected. 
The overall incorporation of the labelled acetate was calculated as 40%. This 
was achieved by integration of the natural abundance peak and the satellites 
from the 1H spectrum (Figure 6.5). It was estimated that the NMR 
measurement were carried out on 26 µg of labelled sample. The compound 
was perhaps not as pure when compared with the 1H spectrum of the original 
unlabelled sample (Figure 6.6), but the situation is complicated due to the 
additional 1JCH couplings possible and notably apparent in the 
1H NMR 
spectrum. 
The ESI-Mass spectrum (Figure 6.7) also indicated that the F5048-Peak 2 
was labelled with up to seven 13C atoms as there were eight signals from 207 
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(MH+) to 214 (MH++7). It was a surprising result to establish that ~15% of 
the sample had had seven acetate/malonate units incorporated. 
 
Figure 6.5: The 
1
H spectrum of [2-
13
C]-acetate labelled tetrahydrofuran A 
from CapNMR 
 
 
Figure 6.6: The 
1
H spectrum of unlabelled tetrahydrofuran A 
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Figure 6.7: The ESI-Mass spectrum of [2-
13
C]-acetate labelled 
tetrahydrofuran A 
 
Not unexpectedly an excellent 13C NMR spectrum was obtained from this 
sample. Just 256 scans for the 13C NMR experiment gave a very clear 
spectrum (Figure 6.8). All of the seven anticipated labelled carbons were 
visible. More interestingly was the coupling between C-5 and C-6 was 
observed, observed as a triplet, which is in agreement with the 
rearrangement described by Saito et al.122 by which C-5 and C-6 become 
accidentally adjacent to each other by the required rearrangement. 
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Figure 6.8: The 
13
C spectrum of [2-
13
C]-acetate labelled tetrahydrofuran A 
from CapNMR acquired in 45 minutes 
 
The HSQC experiment (Figure 6.9) also gave excellent results. This was 
obtained in just 12 minutes. The spectrum clearly and unambiguously 
indicated which carbons in the tetrahydrofuran A had originated from 
[2-13C]-acetate. This is an additional bonus from this approach as it was not 
necessary to obtain the 13C NMR spectrum to ascertain the locations of the 
13C labels. The volume of the correlation peak was proportional to the extent 
of labelling at a given carbon. By appropriate adjustment of signal 
levels/acquisition time it was possible to distinguish labelled sites from 
non-labelled sites. With extreme labelling, as in this case, the distinction was 
obvious, but examination of other labelled samples indicated this distinction 
was still obvious down to labelling at around 2x natural abundance.124   
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Figure 6.9: The HSQC spectrum of [2-
13
C]-acetate labelled tetrahydrofuran 
A from CapNMR  
 
From the HMBC experiment (Figure 6.10) the various 2JH-C and 
3JH-C 
couplings were observed for the labeled sample. A problem in the original 
structural assignment was that H-8 and H-13 had the same chemical shift 
and this is obvious in the HMBC with H-8 and H-13 showing correlations as 
expected to C-5, C-6, C-8 and C-10. In the spectrum there was no indication 
of couplings to non-labelled carbons (eg. H13/C7 or H8/C9). Therefore, H-8 
and H-13 were both correlated to C-5 and C-6, however H-13 was correlated 
to C-8 and H-8 had correlation to C-10. These correlations are summarised 
in Figure 6.11 
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Figure 6.10: The HMBC spectrum of [2-
13
C]-acetate labelled 
tetrahydrofuran A from CapNMR 
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Figure 6.11: The HMBC correlations of [2-
13
C]-acetate labelled 
tetrahydrofuran A 
 
The HMBC spectrum would be an excellent way of sorting out labelling in 
situations where there are no protons directly attached to the carbon of 
interest.124 
 
6.5.1 [1,2-
13
C2]-Acetate Studies of tetrahydrofuran A 
 
The incorporation of [1,2-13C2]-acetate was not as high as that observed for 
the [2-13C]-acetate. The overall incorporation of the labeled acetate was 20% 
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as calculated by integration of the natural abundance peak and the satellites 
from the 1H spectrum (Figure 6.12). This time over 200 µg of the compound 
was injected into the CapNMR probe for obtaining all of the 1D and 2D 
NMR experiments. The reason for such a large sample was that one of the 
planned NMR experiments was an INADEQUATE. The INADEQUATE 
experiment is the least sensitive of all of the 2D experiments. 
 
Figure 6.12: The 
1
H spectrum of [1,2-
13
C2]-acetate labelled tetrahydrofuran 
A from CapNMR 
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Figure 6.13: The 
13
C spectrum of [1,2-
13
C2]-acetate labeled tetrahydrofuran 
A from CapNMR acquired in 10 minutes 
 
The initial 13C NMR experiment was obtained with just 256 scans (10 
minutes) and showed resonances for all 13 carbons (Figure 6.13). Each 
resonance was a multiplet, typically a triplet. This splitting pattern arises 
from the use of doubly 13C-labelled acetate. Unless the acetate had been 
cleaved during biosynthesis each carbon in the individual molecule was 
“guaranteed” to have a 13C adjacent, leading to a 13C-13C coupling which is 
typically in the range 30-90 Hz. These two peaks will be in addition to that 
for the carbon at that position of natural abundance origin. Thus the 
appearance of each set of resonances is as a triplet as seen in Figure 6.14. 
1
JCC
Signals from 1 2 C acetate  [ , - ]-13 2
Natural abundance C13 signal
 
Figure 6.14: Triplet graph with explaination 
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In this example 10 of the carbon resonances appear as triplets, with the 
“outside” ([1,2-13C2]-acetate-derived) resonances being considerably larger 
than the central resonance. This is a consequence of the very high 
incorporation (20%) of label in comparison to natural abundance (1.01%). 
But, for the other three carbons, triplets were still seen, but the central 
resonance was now the larger. These are the resonances at 72.3, 118.4 and 
130.2 ppm (Figure 6.13), which are each carbons that have arisen from a 
bond cleavage of the original acetate unit. In these cases the resonance 
appears at the normal natural abundance chemical shift. But, because of the 
extent of labelling, there was a 20% probability that the individual carbons 
(C-5, C-12 and C-13) would have at least one 13C carbon adjacent (C-5//C-4 
or C-6; C-12//C-11; C-13//C-6). Triplets will still be seen, but the outside 
legs are now very much less intense.  
Normally, all of these couplings can be distinguished one from the other as 
the 1JCC couplings between any pair of carbons is unique as it is dependent 
on the hydridisation of each carbon. This normally allows 1JCC coupling 
between carbons to be recognised as they are identical. However, this was 
not possible in this case due to the similarity of some the 1JCC couplings, 
requiring the use of an INADEQUATE experiment to establish the linkages. 
 
6.5.2 [1,2-
13
C2]-Acetate INADEQUATE NMR using CapNMR 
 
The INADEQUATE NMR experiment (Figure 6.15) shows carbon-carbon 
coupling within the same acetate unit, potentially allowing the direction of 
the polyketide to be elucidated. In a natural-abundance INADEQUATE 
experiment the 1JCC couplings are detected between adjacent carbons 
throughout the whole molecule. As the probability of “finding” two 13C 
atoms adjacent to one another is very low (1:104) this is traditionally 
considered a very insensitive experiment. However, by using 
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[1,2-13C2]-acetate as a precursor molecule the couplings between C-1 and 
C-2 of these units can be more readily detected and the correlations in the 
INADEQUATE experiment are very much more intense than the 
background arising from the 13C atoms at natural abundance. Even in 
relatively heavily labelled molecules, the probability of finding two intact 
acetate units adjacent in the same molecule is still low and so individual 
acetate units can be defined. However, if the incorporation of the [1,2-13C2] 
acetate is very high, coupling between adjacent acetate units may also be 
seen and naturally, this can lead to difficulties in interpretation. In this work, 
the observed 1JCC couplings of the polyketide showed strong signals 
corresponding to couplings between the carbons of intact individual acetate 
units (red lines in Figure 6.15).  
The INADEQUATE experiment is also very useful in confirming if a given 
acetate unit has been cleaved. If a C-C bond is cleaved, 1JCC coupling is no 
longer possible resulting in singlet peaks at the same chemical shift as the 
natural abundance signal. The cleavage could come about by 
decarboxylation as in the case of C-12 (δC 118.4), or by bond migration with 
the two carbons of an acetate unit now separated (δC-4 72.3 and δC-9 130.2). 
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Figure 6.15: The INADEQUATE NMR spectrum of tetrahydrofuran A 
labelled with [1,2-
13
C2]-acetate from CapNMR 
 
From Saito’s122 previous work, five strong carbon-carbon couplings within 
acetate units were expected (Figure 6.16). These all showed as very clear 
couplings in the INADEQUATE experiment (red lines in Figure 6.14). The 
strong couplings were C-1 to C-2, C-3 to C-4, C-6 to C-7, C-8 to C-9 and 
C-10 to C-11 which were exactly the same as those reported by Saito et 
al.
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Figure 6.16: Labelling of tetrahydrofuran A, indicating the effect of 
isotopomerism 
 
The weaker couplings (blue lines in Figure 6.15) indicated those couplings 
arising from the isolated carbons (at 100% 13C abundance) coupling with 13C 
atoms in the adjacent acetate units. These couplings were C-5 to C-6, C-6 to 
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C-13 and C-11 to C-12. In the bulk sample there was just a 20% probability 
that this would happen, so the signals were considerably weaker. 
 
6.6 Biosynthetic Studies on Tetrahydrofuran B 
 
6.6.1 [2-
13
C]-Acetate study of tetrahydrofuran B 
 
Isolation of a pure sample of tetrahydrofuran B was not easy as the 
compound was present in relatively low yield and was part of a set of 
overlapping peaks. (See Figure 6.3). The lack of purity became apparent 
when the 1H NMR spectrum of tetrahydrofuran B, derived from the feeding 
of [2-13C]-acetate (Figure 6.17), was compared with that isolated by Ms 
Francine Smith during her BSc (Hons) work in 2007120 (Figure 6.18). 
 
Figure 6.17: The 
1
H spectrum of [2-
13
C]-acetate labelled tetrahydrofuran B 
from CapNMR 
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Figure 6.18: The 
1
H spectrum of unlabelled tetrahydrofuran B 
 
Reinjection of the isolated [2-13C]-labelled peak 1 into the HPLC indicated a 
single peak and the peak showed the same UV profile across the peak 
confirming that the correct compound, with a carboxylic acid group rather 
than a methyl group, had been collected (see Figures 6.19 and 6.20). 
 
Figure 6.19: The HPLC of reinjection of [2-
13
C]-acetate labelled 
tetrahydrofuran B after recovery from CapNMR 
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Figure 6.20: The UV profiles of both sides of [2-
13
C]-acetate labelled peak 
after recovery from CapNMR 
 
The 1H spectrum obtained after feeding of [1,2-13C2]-acetate also indicated 
an impure compound and like that from feeding of [2-13C]-acetate contained 
a doublet methyl group at δH 1.76 (Figure 6.21) associated with an impurity. 
The sample obtained from the [1,2-13C2]-labelled acetate was clearly of 
higher purity than that from the [2-13C]-acetate feeding experiment and was 
comparable with unlabelled tetrahydrofuran B (Figure 6.18). However, the 
sample was only collected in a relatively low yield (7 µg) and no further 
experiments could be sensibly run on such a small sample size. 
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Figure 6.21: The 
1
H spectrum of [1,2-
13
C]-acetate labelled tetrahydrofuran 
B from CapNMR 
 
Proceeding with the [2-13C]-acetate labelled sample, a 13C- NMR spectrum 
was obtained (256 scans). The anticipated 13C labelled signals (C-1, 3, 6, 8, 
9, 11, 13) were obvious (see Figure 6.22) along with a collection of 
additional signals for the impurities present in the sample. Most importantly, 
the carbonyl signal, δC-13 170.6, was labelled, which established the origin of 
the carboxyl group as having arisen by oxidation of the terminal methyl 
group. Again, C-5 and C-6 were multiplets (141.8 and 52.8 ppm, 
respectively; Figure 6.22) which indicated these two carbons were again 
accidentally coupled as a consequence of the epoxide rearrangement. 
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Figure 6.22: The 
13
C spectrum (10 min) of [2-
13
C]-acetate labelled 
tetrahydrofuran B from CapNMR 
 
The HSQC spectrum (Figure 6.23) was also obtained using a 4 scan 
increment. Besides the impurity signals, six labelled carbons were clearly 
defined in the spectrum. The identities of the six carbons are indicated on 
Figure 6.22 and these correlations match those obtained when 
tetrahydrofuran B was initially isolated. The impurity signals are marked 
with a cross. The carbonyl group of course was not apparent in the HSQC 
experiment. To directly observe the carboxyl group, an HMBC experiment 
was required. 
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Figure 6.23: The HSQC spectrum of [2-
13
C]-acetate labelled 
tetrahydrofuran B from CapNMR 
 
The HMBC experiment (Figure 6.24) required an overnight run and, in the 
circumstances, an excellent result was obtained. The most promising signals 
were H,C-correlations from H-2 (δ 5.87) and H-3 (δH 7.27) to the carbonyl 
group (δC-1 170.6). These indicated the presence of a labelled carboxyl group 
in the molecule. Other correlations involving labelled carbons were also 
obvious, as indicated in Figure 6.25. This data confirmed the HSQC results 
that [2-13C]-acetate had labeled C-3, C-5, C-6, C-8, C-10 and C-12 as 
required by the proposed biosynthetic pathway, with incorporation at C-1 
implied from the 2JCH and 
3
JCH correlations in the HMBC spectrum. 
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Figure 6.24: The HMBC spectrum of [2-
13
C]-acetate labelled 
tetrahydrofuran B from CapNMR 
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Figure 6.25: The HMBC correlations of [2-
13
C]-acetate labelled 
tetrahydrofuran B 
 
6.7 Discussion 
 
This work demonstrated the advantages of using CapNMR in biosynthetic 
studies. The CapNMR was more sensitive in detecting protons rather than 
carbons and suggested that biosynthetic experiments could be carried out on 
a small scale while still achieving excellent results, but at a considerable 
saving due to the lower demand on labelled compounds. 
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In this chapter 1D and 2D NMR spectra (including 1H, 13C, HSQC and 
HMBC) were obtained on tetrahydrofuran A (NMR data with 
tetrahydrofuran B in Table 6.1), after the incorporation of [2-l3C]-acetate and 
established that seven carbons had been labelled. This work repeated the 
experiment that Saito et al.121 had carried out in 1981, but in this case the 
fermentation volume was just 15 mL and the sample size was only 26 µg. 
Saito in his work carried out the fermentation on the 500 mL scale and 
required the isolation and purification of several mg of tetrahydrofuran A.  
 
A 2D INADEQUATE NMR experiment on [1,2-13C2]-acetate-labelled 
tetrahydrofuran A was also obtained by CapNMR even though the CapNMR 
probe is not optimized for carbon detection. This was a very successful 
experiment which was based on just 200 µg of pure sample. The experiment 
established the 13C-13C couplings between all 5 pairs of carbons originating 
from the same acetate units and confirmed the necessary bond cleavages by 
rearrangement or decarboxylation in the other two polyketide units. 
 
A [2-l3C]-acetate labelled sample of tetrahydrofuran B was used for studying 
the biosynthesis of this compound and to understand the relationship 
between it and tetrahydrofuran A. There were some problems because it was 
not possible to isolate the pure labelled compound, however these were quite 
manageable as the impurity signals were easily distinguished in the HSQC 
and HMBC experiments. These results showed that the carboxyl group had 
been derived from a methyl group during the biosynthetic process. This 
implies the following sequence of events: -CH3 → -CH2OH → -CHO → 
-CO2H. Tetrahydrofuran B has a retention time of 11.9 min in the standard 
HPLC gradient as it is more polar than the tetrahydrofuran A (16.4 min). 
The UV profile of tetrahydrofuran B differs from that of tetrahydrofuran A 
as the carboxyl group has extended the conjugation of the diene system. The 
implied intermediates on the pathway to tetrahydrofuran B are the 
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hydroxymethyl compound (intermediate A), whose UV spectrum would be 
comparable to that of tetrahydrofuran A, but would be more polar than the 
formyl compound (intermediate B), whose UV spectrum would be closer to 
that of the tetrahydrofuran B. Examination of the minor peaks between 
tetrahydrofuran B and tetrahydrofuran A (see Figure 6.26) confirmed that 
these were possible candidates with the required characteristics for the 
intermediates, but they were present in too low a concentration to allow 
NMR characterization. It is suggested that the peak at 14.5 min 
(Intermediate A) corresponds to the initial oxidation product, the 
hydroxymethyl compound (see UV spectrum on Figure 6.27) and the peak at 
15.7 min to the formyl compound (Intermediate B). The isolated pure 
compounds were examined by ESMS, but the results were inconclusive. 
 
Figure 6.26: Stacked HPLC chromatograms from the static, small volume 
time-course experiments, clearly showing increases in tetrahydrofuran A, 
tetrahydrofuran B and two intermediates 
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Figure 6.27: UV profiles of intermediates A and B respectively 
 
  Tetrahydrofuran A     Tetrahydrofuran B   
Position δC, ppm δH,ppm, Position δC, ppm δH,ppm, 
1-CH3 18.6 1.73 1-CO 169.7   
2-CH 129.7 5.64 2-CH 121 5.87 
3-CH 132.8 6.05 3-CH 145 7.27 
4-CH 134.4 6.12 4-CH 131 6.38 
5-CH 130.2 5.46 5-CH 141 6.1 
6-CH 52.7 2.8.0 6-CH 52 2.95 
7-CH 82.8 3.68 7-CH 81 3.78 
8-CH 86.6 4.05 8-CH 85 4.09 
9-CH 133.6 5.72 9-CH 132 5.74 
10-CH 134.4 6.32 10-CH 133 6.33 
11-CH 138.0 6.38 11-CH 136 6.38 
12-CH2 118.4 5.10 12-CH2 116 5.16 
12'-CH2 118.4 5.24 12'-CH2 116 5.23 
13-CH2 72.3 3.68 13-CH2 70 3.78 
13'-CH2 72.3 4.05 13'-CH2 70 4.09 
Data for tetrahydrofuran A came from the BSc (Hons) project report of Francine 
Smith.122 
13C data of F5048-tetrahydrofuran A came from 2D INADEQUATE NMR experiment 
in CD3OD 
Table 6.1: 
1
H-and 
13
C NMR chemical shifts for tetrahydrofuran A and 
tetrahydrofuran B. 
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Chapter 7 
 
 
 
Achievements and Disscusion 
 
 
 
7.1 Achievements  
 
The prime aim of my research work was to examine the viability of applying 
CapNMR technology to a natural products derepliction process. As a 
consequence much of the thesis work was based on the application of 
CapNMR technology to a study of fungal natural products. The 
achievements in the thesis can be summarised as:  
 use of CapNMR technology to improve the current dereplication 
strategies. This work was based on isolation of ~ 10 µg of pure 
compounds. 
 extrapolation from the identification of a known compound using the 
dereplication method (UV/NMR/MS/AntiMarin), to identify related, but 
new compounds in an extract. 
 use of CapNMR to study very bioactive minor components which 
would have been impossible to study using a regular NMR probe. 
 use of CapNMR to carry out biosynthetic studies based on ~ 20 µg of 
sample. 
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7.2 Discussion 
 
Application of CapNMR technology to natural products dereplication was 
carried through successfully. However, it needed extra or different thought 
processes compared with the older methods of dereplication. Since the 
sensitivity has been dramatically increased by use of the CapNMR probe, 
sample purification and separation required extra care. Also, researchers are 
now able to examine those minor peak regions which often showed better 
bioactivities. Isolation of 20 µg of pure compound was not a difficult task, so 
it should now be possible to undertake the study of a wider range and a 
greater number of samples. Therefore, an ideal research group in the future 
will be one containing researchers from different areas such as biologists for 
collecting and culturing, natural products chemists for isolation and 
elucidating the structures, synthetic chemists for study of the 
stereochemistries and synthesis of compounds and analogues.  
My final thought is that CapNMR is a technology that will lead to great 
improvements in the study of natural compounds and I hope more natural 
products groups will take advantage of this technique.
Chapter 8                          Experimental 
 
180 
Chapter 8 
 
 
 
Experimental 
 
 
 
8.1 General Methods 
 
8.1.1 Sample extraction-solid culture 
 
Fungal cultures on solid agar plates (85 mm diameter) were macerated with 
EtOAc using a stainless steel potato masher. This extraction process was 
carried out twice. The ground agar was left sitting in a third aliquot of 
EtOAc overnight. The EtOAc was filtered off from the macerated agar using 
a glass funnel plugged with glass wool. All three quantities of EtOAc were 
combined and taken to dryness on a rotary evaporator. The extract was 
transferred to a pre-weighed vial, the weight determined and then assayed 
for antitumour activity. 
 
8.1.2 Sample extraction-liquid culture 
 
Cultures were homogenised with a Waring commercial blender for ~30 sec, 
or until the mycelial mat was sufficiently macerated, then filtered through 
celite under vacuum. The filtered broth was subsequently extracted three 
times with EtOAc. The solid mycelial residue was re-suspended in EtOAc 
and extracted three times. The first two EtOAc extractions were for one hour 
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and the third overnight. All organic phases were combined and taken to 
dryness on a rotary evaporator. Both the aqueous and organic phases were 
then transferred to a pre-weighed vial, then weight determined and assayed 
for antitumour activity. 
 
8.1.3 P388 assay 
 
Prior to further investigation, crude extracts were assayed for biological 
activity against the murine leukaemia cell line P388. This assay consists of a 
serial dilution of the sample of interest followed by incubation for 72 hours 
with P388 cells. Cell viability is determined colorimetrically by the addition 
of the yellow dye MTT tetrazolium. Unhealthy or dead cells cannot 
metabolise this dye leaving a yellow colour, whereas healthy cells reduce 
this dye to MTT formazan resulting in an intense purple colour (Figure 8.1). 
N
N+
N
N
S
N N
N
H
N
S
NN
MTT Tetrazolium salt                                                MTT Formazan  
Figure 8.1: Reduction of the yellow MTT Tetrazolium salt to the purple MTT 
formazan by healthy P388 cells. 
 
The concentration of sample required to reduce cell growth by 50%, when 
compared to controls, is expressed as an 50% inhibitory concentration (IC50) 
in ng/mL. All samples were dissolved in double distilled MeOH prior to 
submission to the assay. 
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8.1.4 HPLC microtitre plate screening 
 
As part of the dereplication process all small scale extracts were initially 
examined in the HPLC microtitre plate screen. An aliquot of the crude 
extract (300 µg) was analysed by reverse phase C18 HPLC (Phenomenex 
Prodigy 5µ column; 250x4.6 mm) using the following gradient solvent 
system: 2 min at 10% ACN/H2O; a linear gradient to 75% ACN/H2O over 12 
min; isocratic at 75% for another 10 min; a linear gradient for 2 min to 
100% ACN, isocratic at 100% ACN for 4 min then returned to 10% 
ACN/H2O over 2 min and re-equilibrated for 8 min; with a flow rate 
1mL/min. The cycle lasts for 40 min, and the eluant was collected from 2.92 
min to 24.92* min into 96 well polystyrene microtitre plates, from which 50 
and 5 µL “daughter plates” were made, and then assayed for cytotoxicity 
against the P388 cell line. 
* the 0.92 min represents the time required for the sample to pass from the PAA detector 
and reach the MT plate. 
 
8.1.5 Antimicrobial assay 
 
Antimicrobial activity was detected using a zone of inhibition assay. The 
bacteria tested against were Bacillus subtilis (ATCC 19659), Escherichia 
coli (ATCC 25922) and Pseudomonas aeruginosa (ATCC 14053), The fungi 
tested against were Candida albicans (ATCC 14053), Trichophyton 
mentagrophytes (ATCC 28185) and Cladosporium resinae (Department of 
Biological Sciences, University of Canterbury). Each bacterium or fungus 
(at a known concentration) was mixed with Mueller Hinton or potato 
dextrose agar and poured in Petri dishes to produce a ‘lawn’ of 
bacterium/fungus. Samples of interest were then pipetted onto filter paper 
disks (6 mm). After evaporation of solvent, the disks were placed onto the 
above prepared seeded agar. Antibiotic controls were run for each batch: 
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gentamycin (10 µg/disk) was used for E. coli and P. aeruginosa; 
chloramphenicol (30 µg/disk) was used for B. subtilis; nystatin (100 
units/disk) was used for C. albicans, C. resinae and T. mentagrophytes. 
Antimicrobial activity was measured in millimetres as the radius of 
inhibition (mass/disk). Suitable solvent controls were used in every assay 
run. 
 
8.1.6 Mass Spectrometry 
 
High Resolution Electron Impact Mass Spectra (HREIMS) were obtained on 
a Micromass LCT TOF mass spectrometer, operating with a 4kV 
accelerating potential, 70eV and a source temperature of 250oC. 
 
High Resolution Electrospray Ionisation Mass Spectra (HRESIMS) were 
recorded on a Micromass LCT spectrometer using a probe voltage of 3200V, 
an operating temperature of 150oC and a source temperature of 80oC. The 
carrier solvent was 50:50 ACN/H2O at 20µL/minute (for direct inject mode). 
A 10 µL injection of sample was made from a 10 µg/mL sample. When 
obtaining positive ESI mass spectra some samples were protonated with 
10µL/mL formic acid prior to injection. When recording negative ESI mass 
spectra samples were deprotonated, as required, with 10µL/mL DEA prior to 
injection. 
 
8.1.7 Liquid Chromatography Mass Spectrometry (LCMS) 
 
Liquid Chromatography Mass Spectra (LCMS) were recorded on a Waters 
2790 HPLC system equipped with a Waters 996 photodiode array (PDA) 
detector coupled to a Micromass LCT spectrometer using a probe voltage of 
3200 V, an operating temperature of 150 oC and a source temperature of 40 
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oC. 10 µL of the solution was injected and the carrier gradient for the 
program was the same as shown in Experimental 7.3.2.   
 
8.1.8 Nuclear Magnetic Resonance Spectroscopy (NMR) 
 
1H, COSY, 2D NOE, ROESY, TOCSY, HSQC, HMBC and CIGAR 
experiments were recorded on a Varian INOVA 500 spectrometer at 23oC, 
operating at 500 MHz. All the NMR experiments carried out in Chapters 2, 4 
and 6 were obtained on the Varian INOVA 500 spectrometer at 23oC, 
operating at 500MHz using a Capillary probe. The 13C NMR experiments 
carried out in Chapter 3 were recorded on a Varian UNITY 300 NMR 
spectrometer, at 23oC, operating at 75 MHz. 2D NMR experiments carried 
out to study F8268-A-3 in Chapter 3 and the HMBC experiment obtained in 
Chapter 5 were obtained on the Varian INOVA 500 spectrometer at 23oC, 
operating at 500 MHz and with an inverse detection 5 mm probe. Other 
NMR experiments described in these two Chapters were all recorded on the 
Varian INOVA 500 spectrometer at 23oC, operating at 500MHz using a 
Capillary probe (Protasis, Model: V500-10-075F-05E). Chemical shifts are 
described in parts per million (ppm), on the δ scale, and referenced to the 
appropriate solvent peaks: 
CDCl3 referenced to CHCl3 at δH 7.25 ppm (
1H) and CHCl3 at δC 77.0 ppm 
(13C); 
CD3OD referenced to CHD2OD at δH 3.30 ppm (
1H) and CHD2OD at δC 
49.3 ppm (13C); 
DMSO-d6 referenced to CD3(CHD2)SO at δH 2.50 ppm (
1H) and (CD3)2SO 
at δC 39.6 ppm (
13C). 
The quantity of the compound in each well was estimated according to the 
formula: (MW/#H) × (total integral for #H)/(integral for CHD2OD) × CF, 
where MW is the actual molecular weight of the compound (ESMS), #H is 
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the number of protons included in the integration of the 1H NMR spectrum, 
and CF is the calibration factor (0.35) that had previously been determined 
from a standard solution containing quinine (30 µg in 6 µL) in the same 
CD3OD solvent. 
 
8.1.9 Optical Rotation 
 
Optical Rotation values were obtained on a Perkin Elmer 341 polarimeter at 
20oC with a wavelength of 589 nm. The specific optical rotation was then 
calculated using the following equation: 
[α]D = α /LC 
Where L is the pathlength (dm) and C is the concentration (g/L).  
 
8.1.10 Solvents 
 
HPLC grade solvents, doubly deionised Nanopure water and Milli-Q water 
were used where stated. Technical grade solvents were distilled prior to use. 
Methanol was distilled twice. 
 
8.1.11 Silanization of glass surfaces for CapNMR 
 
All items were immersed into dimethyldichlorosilane (DMDCS) solution 
(5% DMDCS in dichloromethane (DCM)) for 15 min. After pouring off the 
deactivating solution, the items were immediately rinsed with DCM. The 
items were then immediately covered with MeOH for 15-30 min. This step 
was performed immediately in order to minimize exposure to room moisture. 
The MeOH was drained off and the items dried in a 100oC oven until 
completely dry. The DMDCS solution was prepared fresh before use. 
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8.2 Experimental for Chapter 2 
 
8.2.1 Chromatography of F8095 
 
An aliquot of the crude extract of F8095 was chromatographed by reverse 
phase HPLC using a 25-85% linear gradient and assayed for cytotoxicity 
against the P388 cell line. UV-visible detection on the HPLC showed seven 
compounds were closely related to each other.  
 
Seven compounds were purified by a single manual collection from 
analytical HPLC by repetitively injecting 500 µg of the crude extract (4.3 
mg) using the standard gradient. 1D and 2D Capillary NMR spectroscopy as 
well as mass spectrometry and AntiMarin database searching determined 
these to be members of known ployesters rather than lasiodiplodins. 
Capillary NMR spectroscopy determined the weights of the seven 
compounds isolated: F8095-1, 15 µg; F8095-2, 6 µg; F8095-3, 16 µg; 
F8095-4, 8 µg; F8095-5, 22 µg; F8095-6, 22 µg; F8095-7, 23 µg. 
 
8.2.2 Physical data for the polyesters 
 
15G256V (F8095-1, Figure 2.8): white solid; UV (MeOH) λmax 216, 264, 
301 nm; NMR data reported previously,77 ESIMS m/z 407 [M+Na]+. 
 
(+)-6-hydroxymellein (F8095-2, Figure 2.10): white solid; UV (MeOH) λmax 
216, 267, 301 nm; NMR data reported previously,77 ESIMS m/z 193 [M-H]-. 
 
15G256α-2 (F8095-3, Figure 2.12): white solid; UV (MeOH) λmax 216, 265, 
301 nm; NMR data reported previously,77 ESIMS m/z 681 [M+H]+, 703 
[M+Na]+. 
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15G256п (F8095-4, Figure 2.14): white solid; UV (MeOH) λmax 216, 265, 
301 nm; NMR data reported previously,77 ESIMS m/z 579 [M+H]+, 601 
[M+Na]+. 
 
15G256α (F8095-5, Figure 2.17): white solid; UV (MeOH) λmax 216, 265, 
301 nm; NMR data reported previously,77 ESIMS m/z 663 [M+H]+, 685 
[M+Na]+. 
 
15G256α-1 (F8095-6, Figure 2.18): white solid; UV (MeOH) λmax 216, 265, 
301 nm; NMR data reported previously,77 ESIMS m/z 663 [M+H]+, 685 
[M+Na]+. 
 
15G256β (F8095-7, Figure 2.20): white solid; UV (MeOH) λmax 216, 265, 
301 nm; NMR data reported previously,77 ESIMS m/z 647 [M+H]+, 669 
[M+Na]+. 
 
8.3 Experimental for Chapter 3 
 
8.3.1 Chromatography of F8268 (Original F6878 and F7474)  
 
8.3.1.1 Preliminary investigations 
 
The crude extract of F6878 (45.3 mg), which was the original extract 
examined, showed excellent P388 activity (<97.5 in IC50 test). MT plate 
analysis showed the bioactive region mainly came from the retention time 
18-22 minutes when applying the standard gradient. The two pure peaks 
(F6878-D3 and F6878-D11) were found to be new compounds after the MT 
plate had been analysed using CapNMR. 
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A further two samples were supplied and given the codes F7474 (62.1 mg) 
and F8268 (2.53 g). F7474 was used to study the two pure peaks initially 
characterised as F6878-D3 and D11. F8268 was used to study the 
compounds in the bioactive region.   
 
8.3.1.2 Purification of F7474-D3, D11 
 
Manual collection of the two new compounds from analytical HPLC was 
carried out using a linear gradient (10-75% ACN/H2O with 0.05% formic 
acid over 20 min). A reverse phase C18 column (5 µ, 250 x 4.6mm) was 
used with a standard flow rate of 1 mL/min. The purification led to 
F7474-D3 (2.5 mg) and F7474-D11 (3.1mg). 
 
8.3.1.3 Chromatography of F8268 
 
The crude extract was first partitioned between Pet. Ether and MeOH. The 
MeOH soluble material was concentrated and fractionated on a Sephadex 
LH-20 column, using MeOH as the solvent. Ten fractions were collected. 
Injection of a small amount of each of the ten fractions on the analytical C18 
HPLC column with a standard flow rate of 1 mL/min showed fraction 2 and 
3 contained peaks from the active region (20 mins to 24 mins). These two 
fractions were further purified by analytical HPLC.  
 
In fraction 2, five compounds were purified applying a linear gradient 
(55-65% ACN/H2O with 0.05 formic acid) over 20 min by analytical HPLC 
using a reverse phase C18 column with flow rate of 1 mL/min. 1D and 2D 
NMR spectroscopy, in conjunction with mass spectrometry, confirmed the 
compounds as a new series of peptides.  
 
Chapter 8                          Experimental 
 
189 
In fraction 3, four peaks were purified applying a linear gradient (20-85% 
ACN/H2O with 0.05% formic acid) on an analytical HPLC C18 colum. On 
the basis of 1D and 2D NMR spectroscopy, and mass spectrometry, these 
four peaks were found to be a series of related novel compounds. 
 
8.3.1.4 Purification of the peptides 
 
Manual collection of the five new peptides from analytical HPLC was 
carried out using a linear gradient (55-65% ACN/H2O with 0.05% formic 
acid over 20 min). A reverse phase C18 column (5 µ, 250 x 4.6mm) was 
used with a standard flow rate of 1 mL/min. The purification led to 
F8268-A-1 (0.2 mg), F8268-A-2 (0.9 mg), F8268-A-3 (4.7 mg), F8268-A-4 
(0.7 mg) and F8268-A-5 (0.6 mg). 
 
8.3.1.5 Purification of F8268-3 series of compounds 
 
Manual collection of the four novel compounds from analytical HPLC was 
carried out using a linear gradient (20-85% ACN/ H2O with 0.05% formic 
acid over 20 min). A reverse phase C18 column (5 µ, 250 x 4.6mm) was 
used with a standard flow rate of 1 mL/min. The purification led to 
F8268-3-3 (1.5 mg), F8268-3-4 (1.1 mg), F8268-3-6 (2.4 mg), and 
F8268-3-7 (1.1 mg). 
 
8.3.2 Preparation and analysis of Marfey derivatives 
 
F8268-A-2, F8268-A-3, F7474-D3 and F7474-D11 were each hydrolysed by 
heating the respective peptide (0.3 mg) in HCl (1 mL; 6 M) at 110 oC for 24 
h. After cooling, the solution was evaporated to dryness and redissolved in 
H2O (50 µL). To each of these acid hydrolysate solutions, or to a solution of 
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the reference amino acid (50 µL; 50 mM), was added a solution of FDAA 
(Marfey’s reagent, Nα-(2,4-dinitro-5-fluorophenyl)-L-alaninamide)100 in 
acetone (100 µL of 1% (w/v) solution). After addition of NaHCO3 solution 
(20 µL; 1 M), the mixture was incubated for 1 hr at 40 oC. The reaction was 
stopped by addition of HCl (10 µL; 2 M), the solvents were evaporated to 
dryness, and the residue was redissolved in MeOH-H2O (1 mL; 1:1). An 
aliquot of this solution (F7474-D3 and F7474-D11, each 10 µL) was 
analysed with a linear gradient (35-45% ACN/H2O with 0.05% TFA on an 
analytical HPLC C18 column. An aliquot of this solution (F8268-A-2 and 
F8268-A-3, each 10 µL) was analysed with a linear gradient (45-80% 
ACN/H2O with 0.05% TFA on an analytical HPLC C18 column. 
 
8.3.3 Synthesis of D, and L-Me-Kynurenines 
 
L and D kynurenine (21.3 mg; 0.1 mM) were individually dissolved in 
CH3OH (750 µL), BOC-ON (2-(tert-butoxycarbonyloxyimino)-2-phenyl- 
acetonitrile; 27 mg; 0.12 mmol) and TEA (triethylamine; 40 µL; 3.75 mM) 
were then added. The solution was stirred at room temperature overnight. 
The solvents were evaporated to dryness, and the residue redissolved in 
ACN (400 µL), and NaBH3CN (0.3 mM) and CH2O (72 µL, 13mM) added 
to the solution. Acetic acid was then used to adjust the pH to 6. The solution 
was stirred overnight at room temperature before the solvent was evaporated 
to dryness. The residue was purified by reverse phase chromatograph on a 
bench C18 column using a step gradient (100% H2O; 20% CH3OH with H2O; 
40% CH3OH with H2O; 60% CH3OH with H2O; 80% CH3OH with H2O; 
100% CH3OH). The BOC-N-Me-kynurenine was located in the 20% 
CH3OH fraction. Under HPLC condition the BOC-N-Me-kynurenines eluted 
at 10.6 min using the standard gradient. Finally, TFA (1 mL) was added to 
each of the BOC-N-Me-kynurenine samples. After 30 mins, the solution was 
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evaporated to dryness, to yield L-Me-kynurenine (700 µg; 3.15 µmol 3.1% 
overall yield), and D-Me-kynurenine (1.7 mg; 7.65 µmol 7.7% overall 
yield). 
 
8.3.4 Physical data for compounds from Chapter 3 
 
F7474-D11 (Figure 3.823): yellow solid; [α]20D -100
o (c 0.75 MeOH); UV 
(MeOH) λmax 226, 262, 391 nm; 
1H- and 13C-NMR data, see Table 3.13; 
HRESIMS m/z 382.1744 [M+H]+ (calcd for C21H23N3O4, 382.1767). 
 
F7474-D3 (Figure 3.68): white solid; [α]20D -32
o (c 0.65 MeOH); UV 
(MeOH) λmax 203, 249 286 nm; 
1H- and 13C-NMR data, see Table 3.12; 
HRESIMS m/z 427.2326 [M+H]+ (calcd for C23H30N4O4, 427.2345). 
 
F8268-A-1 (Figure 3.26): pale yellow solid; [α]20D -118
o (c 0.017 MeOH); 
UV (MeOH) λmax end absorption only; 
1H- and 13C-NMR data, see Appendix 
1 Table 1.1; HRESIMS m/z 778.5051 [M+H]+ (calcd for C39H67N7O9, 
778.5078). 
 
F8268-A-2 (Figure 3.28): pale yellow solid; [α]20D -120
o (c 0.1 MeOH); UV 
(MeOH) λmax end absorption only; 
1H- and 13C-NMR data, see Appendix 1 
Table 1.2; HRESIMS m/z 780.5214 [M+H]+ (calcd for C39H69N7O9, 
780.5235). 
 
F8268-A-3 (Figure 3.20): pale yellow solid; [α]20D -84
o (c 0.5 MeOH); UV 
(MeOH) λmax end absorption only; 
1H- and 13C-NMR data, see Table 3.1; 
HRESIMS m/z 792.5263 [M+H]+ (calcd for C40H69N7O9, 792.5235). 
 
F8268-A-4 (Figure 3.23): pale yellow solid; [α]20D -180
o (c 0.1 MeOH); UV 
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(MeOH) λmax end absorption only; 
1H- and 13C-NMR data, see Appendix 1 
Table 1.3; HRESIMS m/z 794.5357 [M+H]+ (calcd for C40H71N7O9, 
794.5391). 
 
F8268-A-5 (Figure 3.32): pale yellow solid; [α]20D -160
o (c 0.05 MeOH); 
UV (MeOH) λmax end absorption only; 
1H- and 13C-NMR data, see Appendix 
1 Table 1.4; HRESIMS m/z 806.5391 [M+H]+ (calcd for C41H71N7O9, 
806.5383). 
 
F8268-3-3 (Figure 3.46): white solid; [α]20D -60
o (c 0.5 MeOH); UV (MeOH) 
λmax 205, 295 nm; 
1H-NMR data, see Table 3.8; 13C-NMR data see Appendix 
1 Table 1.5; HRESIMS m/z 461.2959 [M+H]+ (calcd for C27H40O6, 
461.2903). 
 
F8268-3-4 (Figure 3.50): white solid; [α]20D -14.5
o (c 0.5 MeOH); UV 
(MeOH) λmax 204, 297 nm; 
1H-NMR data, see Table 3.9; 13C-NMR data see 
Appendix 1 Table 1.5;; HRESIMS m/z 445.2935 [M+H]+ (calcd for 
C27H40O5, 445.2954). 
 
F8268-3-6 (Figure 3.43): white solid; [α]20D -155
o (c 0.5 MeOH); UV 
(MeOH) λmax 205, 294 nm; 
1H-NMR data, see Table 3.7; 13C-NMR data see 
Appendix 1 Table 1.5;; HRESIMS m/z 503.3054 [M+H]+ (calcd for 
C29H42O7, 503.3009). 
 
F8268-3-7 (Figure 3.55): white solid; [α]20D -18
o (c 0.5 MeOH); UV (MeOH) 
λmax 204, 299 nm; 
1H-NMR data, see Table 3.10; 13C-NMR data see 
Appendix 1 Table 1.5;; HRESIMS m/z 487.3023 [M+H]+ (calcd for 
C29H42O6, 487.3059). 
 
N-Me-kynurenine (Figure 3.85): yellow solid; UV (MeOH) λmax 230, 261, 
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386 nm; 1H-NMR data: δH-2 4.37 (CH), δH-2 3.74 (CH2), δH-6 7.80 (CH), δH-7 
6.64 (CH), δH-8 7.45 (CH), δH-9 6.80 (CH), δH-11 2.92 (CH2); 
13C-NMR data: 
δC-1 197.5, δC-2 38.3, δC-3 28.2, δC-4 170.6, δC-5 111.5, δC-6 131.6, δC-7 116.0, 
δC-8 136.1, δC-9 114.2, δC-10 152.5, δC-11 49.0; HRESIMS m/z 223.1044 
[M+H]+ (calcd for C11H14N2O3, 223.1082).  
 
8.4 Experimental for Chapter 4 
 
8.4.1 Chromatography of F7855 
 
An aliquot of the crude extract of F7855 was chromatographed by reverse 
phase analytical HPLC and assayed for cytotoxicity against the P388 cell 
line. UV/visible detection on the HPLC showed that the seven compounds 
were closely related to each other. The UV library indicated they were 
similar to the lasiodiplodins.  
 
Seven compounds were finally purified by repetitive manual collection from 
analytical HPLC by using the standard gradient. 1D and 2D Capillary NMR 
as well as mass spectrometry proved these to be members of 
de-O-methyl-lasiodiplodins. Weight calculation from 1H assignment from 
Capillary NMR determined the weights of seven compounds are F7855-1 (2 
µg), F7855-2 (16 µg), F7855-3 (2 µg), F7855-4 (12 µg), F7855-5 (5 µg), 
F7855-6 (7 µg), and F7855-7 (328 µg). 
 
8.4.2 Physical data for the de-O-methyl-lasiodiplodins 
 
6-hydroxy-de-O-methyl-lasiodiplodin (F7855-2, Figure 4.11): white solid; 
UV (MeOH) λmax 218, 264, 301 nm; NMR data reported previously,
103 
ESIMS m/z 295 [M+H]+. 
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(3R,4R)-4-hydroxy-de-O-methyl-lasiodiplodin (F7855-4, Figure 4.19): white 
solid; UV (MeOH) λmax 218, 264, 301 nm; 
1H- and 13C-NMR data, see Table 
4.1; HRESIMS m/z 295.1543 [M+H]+ (calcd for C16H23O5, 295.1545). 
6-oxo-de-O-methyl-lasiodiplodin (F7855-5, Figure 4.15): white solid; UV 
(MeOH) λmax 218, 264, 301 nm; NMR data reported previously,
102 ESIMS 
m/z 293 [M+H]+, 315 [M+Na]+. 
 
(E)-9-etheno-de-O-methyl-lasiodiplodin (F7855-6, Figure 4.23): white solid; 
UV (MeOH) λmax 234, 274, 312; 
1H- and 13C-NMR data, see Table 4.2; 
HRESIMS m/z 277.1476 [M+H]+ (calcd for C16H20O4, 277.1440). 
 
de-O-methyl-lasiodiplodin (F7855-7, Figure 4.7): white solid; UV (MeOH) 
λmax 218, 264, 301 nm; NMR data reported previously,
107 ESIMS m/z 279 
[M+H]+, 301 [M+Na]+. 
 
8.5 Experimental for Chapter 5 
 
8.5.1 Chromatography of F7090 (Original F3772) 
 
The crude extract (1 mg) was obtained from a fungal collection (F3772) that 
had been stored for several years in the Chemistry Department. The simple 
nature of the extract allowed for minimal purification. Purification was 
carried out with analytical HPLC using the standard gradient to give two 
compounds. 1H Capillary NMR and mass spectrometry with AntiMarin 
database searching indicated these two compounds to be previously 
undescribed compounds. 
 
A regrow of the original fungus as F7090 by Gill Ellis gave an extract that 
was partitioned between Pet Ether and MeOH. The MeOH soluble material 
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(total 84.4 mg) was chromatographed by reverse phase HPLC (20 mg) using 
the standard gradient. Two compounds presented the same UV 
chromophores. Semi-preparative HPLC using the same gradient as used in 
analytical HPLC, was used to purify these compounds. The purification led 
to F7090-A (1.6 mg) and F7090-B (1.1 mg). 
 
8.5.2 Physical data for the dimers F7090-A & B 
 
F7090-A (Figure 5.15): yellow oil; [α]20D -30
o (c 0.5 MeOH); UV (MeOH) 
λmax  203, 258, 363 nm; 
1H- and 13C-NMR data, see Table 5.1; HRESIMS 
m/z 675.1943 [M+H]+ (calcd for C32H34O16, 675.1925). 
F7090-B (Figure 5.15): yellow oil; [α]20D 56
o (c 0.5 MeOH); UV (MeOH) 
λmax  203, 258, 363 nm; 
1H- and 13C-NMR data, see Table 5.2; HRESIMS 
m/z 675.1920 [M+H]+ (calcd for C32H34O16, 675.1925). 
 
8.6 Experimental for Chapter 6 
 
8.6.1 Time-course experiments 
 
Ten vials of sterile MYE broth (10 mL each) were inoculated with 4 plugs 
each from an actively growing agar culture of the tetrahydrofuran-producing 
fungus, F5048. All inoculated broths were incubated under static conditions, 
at 30oC by Gill Ellis. 
 
Monitoring the cultures for production of tetrahydrofurans began at 24 hours 
to 10 days after inoculation. Each day, one 10 mL culture was taken and 
extracted with EtOAc according to the protocol outlined in Section 7.1.2, 
The resulting extract was chromatographed using the standard gradient 
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(Section 8.1.4) on the analytical HPLC. 9 days after inoculation gave the 
best production of both new and known compounds. 
 
8.6.2 Biosynthetic 
13
C labeling 
 
Thirty vials of sterile MYE broth (15 mL each) containing 1 mg/mL labeled 
acetates ([2-13C]-CH3COONa, or [1,2-
13C2]-CH3COONa ) were inoculated 
with 4 plugs each from a actively growing agar culture of the 
tetrahydrofuran-producing fungus, F5048. The labelled cultures were put 
under static conditions for a further 9 days. Extraction of the cultures was 
carried out as before using the protocol given in Section 8.1.2. analytical 
HPLC using the standard gradient with TFA ascertained the known and new 
compounds were present and in good quantity. Purification of labelled 
tetrahydrofurans was carried out by manual collection with analytical HPLC 
using the standard gradient. [2-13C]-CH3COONa labelled tetrahydrofuran A 
(26 µg) and [1, 2-13C]-CH3COONa labelled tetrahydrofuran A (212 µg); 
[2-13C]-CH3COONa tetrahydrofuran B (12 µg) and [1, 2-
13C]-CH3COONa 
labelled tetrahydrofuran B (7 µg ) were purified respectively. 
 
8.6.3 Physical data for the tetrahydrofurans 
 
Tetrahydrofuran A (Figure 6.1): white solid; UV (MeOH) λmax 228, 264; 
1H- 
and 13C-NMR data, see Table 6.1; ESIMS m/z 207 [M+H]+, 229 [M+Na]+. 
 
Tetrahydrofuran B (Figure 6.1): white solid; UV (MeOH) λmax 235; 
1H- and 
13C-NMR data, see Table 6.1; ESIMS m/z 237 [M+H]+, 259 [M+Na]+. 
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Appendix 1 
 
 
 
NMR data for: 
 
F8268-A-1 (Figure 3.26) 
F8268-A-2 (Figure 3.29) 
F8268-A-4 (Figure 3.23) 
F8268-A-5 (Figure 3.32) 
F8268-3-3 (Figure 3.46) 
F8268-3-4 (Figure 3.50) 
F8268-3-6 (Figure 3.43) 
F8268-3-7 (Figure 3.55)
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Amino Acids position δ13C, ppm  δ1H, ppm 
A: Pipecolic acid 1-CO 168.7  
  2-CH 52.5 5.00 
  3-CH2 25.9 1.25 
  3'-CH2 25.9 2.37 
  4-CH2 21.5 1.10 
  4'-CH2 21.5 1.61 
  5-CH2 25.9 1.34 
  5'-CH2 25.9 1.63 
  6-CH2 43.9 2.88 
  6'-CH2 43.9 4.04 
B: 3-Hydroxyleucine 1-CO 173.4  
  2-CH 55.1 4.78 
  3-CH 75.7 3.46 
  4-CH 29.0 1.79 
  5-CH3 15.2 0.88 
  6-CH3 21.4 0.91 
  NH  7.39 
  OH  4.77 
C:leucine 1-CO 172.5   
  2-CH 57.6 4.38 
  3-CH 28.2 2.02 
  4-CH3 17.5 0.92 
  5-CH3 19.9 1.03 
  NH   8.65 
D: N-Methylalanine 1-CO 171.8  
  2-CH 50.3 5.58 
  3-CH3 15.6 1.02 
  N-CH3 30.3 2.86 
E: N-Methyl-3-hydroxyleucine 1-CO 168.0  
 2-CH 63.1 3.78 
 3-CH 70.4 3.63 
 4-CH 29.5 1.37 
 5-CH3 15.8 0.77 
 6-CH3 21.7 0.82 
 N-CH3 29.7 2.85 
 OH  5.05 
F: 2-Amino-4-methyl-5-hexenoic acid 1-CO 173.4  
  2-CH 49.0 4.71 
  3-CH2 36.5 1.51 
  3'-CH2 36.5 1.59 
  4-CH 36.2 2.01 
  5-CH 143.1 5.66 
  6-CH2 115.7 4.87 
  6'-CH2 115.7 5.00 
 7-CH3 21.4 0.95 
  NH   7.83 
G: N-Methylalanine 1-CO 174.3  
  2-CH 51.2 4.99 
  3-CH3 14.3 1.26 
  N-CH3 31.7 2.96 
Table 1.1: NMR data of F8268-A-1 in DMSO 
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Amino Acids position δ13C, ppm  δ1H, ppm 
A: Pipecolic acid 1-CO 168.7  
  2-CH 55.4 5.00 
  3-CH2 25.9 1.25 
  3'-CH2 25.9 2.37 
  4-CH2 21.5 1.1 
  4'-CH2 21.5 1.62 
  5-CH2 25.9 1.37 
  5'-CH2 25.9 1.63 
  6-CH2 43.8 2.91 
  6'-CH2 43.8 4.06 
B: 3-Hydroxyleucine 1-CO 173.4  
  2-CH 55.1 4.79 
  3-CH 75.7 3.46 
  4-CH 29.0 1.79 
  5-CH3 15.2 0.89 
  6-CH3 21.4 0.92 
  NH  7.39 
C: isoleucine 1-CO 172.3   
  2-CH 55.6 4.47 
  3-CH 33.8 1.77 
  4-CH2 26.2 1.39 
  4'-CH2 26.2 1.50 
  5-CH3 14.2 0.88 
  6-CH3 12.4 0.88 
  NH   8.55 
D: N-Methylalanine 1-CO 171.3  
  2-CH 50.0 5.60 
  3-CH3 15.5 1.01 
  N-CH3 30.0 2.83 
E: N-Methyl-3-hydroxyleucine 1-CO 168.0  
 2-CH 63.1 3.81 
 3-CH 70.5 3.63 
 4-CH 29.4 1.39 
 5-CH3 15.6 0.78 
 6-CH3 21.7 0.83 
 N-CH3 29.7 2.86 
 OH  5.02 
F: leucine 1-CO 173.2  
  2-CH 49.1 4.84 
  3-CH2 38.0 1.38 
  3'-CH2 38.0 1.56 
  4-CH 25.7 1.54 
  5-CH3 23.8 0.84 
 6-CH3 21.5 0.86 
  NH   7.82 
G: N-Methylalanine 1-CO 174.3  
  2-CH 51.2 5.00 
  3-CH3 14.3 1.27 
  N-CH3 31.8 3.04 
Table 1.2: NMR data of F8268-A-2 in DMSO 
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Amino Acids position δ13C, ppm  δ1H, ppm 
A:  Pipecolic acid 1-CO 168.9  
  2-CH 52.6 4.97 
  3-CH2 25.8 1.24 
  3'-CH2 25.8 2.34 
  4-CH2 21.4 1.09 
  4'-CH2 21.4 1.61 
  5-CH2 25.8 1.34 
  5'-CH2 25.8 1.63 
  6-CH2 43.8 2.98 
  6'-CH2 43.8 4.02 
B: 3-Hydroxyleucine 1-CO 173.4  
  2-CH 55.0 4.75 
  3-CH 75.7 3.44 
  4-CH 29.0 1.77 
  5-CH3 15.0 0.84 
  6-CH3 21.1 0.89 
  NH  7.43 
  OH  5.12 
C: isoleucine 1-CO 172.4   
  2-CH 55.5 4.45 
  3-CH 33.6 1.76 
  4-CH2 27.5 1.39 
  4'-CH2 27.5 1.50 
  5-CH3 12.1 0.84 
  6-CH3 14.1 0.83 
  NH   8.65 
D: N-Methylalanine 1-CO 171.4  
  2-CH 50.0 5.60 
  3-CH3 15.3 1.00 
  N-CH3 29.8 2.80 
E: N-Methyl-3-hydroxyleucine 1-CO 168.2  
 2-CH 63.2 3.80 
 3-CH 70.4 3.62 
 4-CH 29.4 1.35 
 5-CH3 15.5 0.74 
 6-CH3 21.4 0.80 
 N-CH3 29.8 2.81 
F:Norleucine 1-CO 173.4  
  2-CH 48.8 4.83 
  3-CH2 36.1 1.47 
  3'-CH2 36.1 1.47 
  4-CH 33.5 1.78 
  5-CH2 27.5 0.96 
  5'-CH2 27.5 1.14 
  6-CH3 11.8 0.75 
 7-CH3 19.8 0.76 
  NH   7.78 
G: N-Methylalanine 1-CO 174.6  
  2-CH 51.4 4.93 
  3-CH3 14.1 1.25 
  N-CH3 31.6 3.00 
Table 1.3: NMR data of F8268-A-4 in DMSO 
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Amino Acids position δ13C, ppm  δ1H, ppm 
A:  Pipecolic acid 1-CO 168.7  
  2-CH 52.5 4.99 
  3-CH2 25.9 1.25 
  3'-CH2 25.9 2.36 
  4-CH2 21.5 1.10 
  4'-CH2 21.5 1.60 
  5-CH2 25.9 1.37 
  5'-CH2 25.9 1.65 
  6-CH2 43.8 2.90 
  6'-CH2 43.8 4.06 
B: 3-Hydroxyleucine 1-CO 173.2  
  2-CH 55.0 4.78 
  3-CH 75.7 3.41 
  4-CH 29.0 1.78 
  5-CH3 15.2 0.88 
  6-CH3 21.5 0.92 
  NH  7.34 
  OH  4.93 
C:  isoleucine 1-CO 172.4   
  2-CH 55.7 4.47 
  3-CH 33.8 1.76 
  4-CH2 26.4 1.37 
  4'-CH2 26.4 1.49 
  5-CH3 14.2 0.88 
  6-CH3 12.4 0.86 
  NH   8.59 
D: N-Methylalanine 1-CO 171.4  
  2-CH 50.1 5.63 
  3-CH3 15.7 1.02 
  N-CH3 30.0 2.85 
E: N-methyl-2-amino-3-hydr- 
oxy-4-methylhexanoic acid 
1-CO 167.9  
 2-CH 63.1 3.86 
 3-CH 68.0 3.79 
 4-CH 35.9 1.10 
 5-CH2 27.9 1.11 
 5'-CH2 27.9 1.27 
 6-CH3 12.4 0.75 
 7-CH3 13.5 0.77 
 N-CH3 29.8 2.87 
 OH  4.96 
F:2-Amino-4-methyl-5-hexenoic acid 1-CO 173.2  
  2-CH 49.0 4.69 
  3-CH2 36.4 1.49 
  3'-CH2 36.4 1.61 
  4-CH 36.0 2.00 
  5-CH 143.1 5.66 
  6-CH2 115.8 4.86 
  6'-CH2 115.8 5.00 
 7-CH3 21.5 0.93 
  NH   7.76 
G: N-Methylalanine 1-CO 174.4  
  2-CH 51.2 4.99 
  3-CH3 14.3 1.26 
  N-CH3 31.8 2.96 
Table 1.4: NMR data of F8268-A-5 in DMSO 
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Position 
NF00659A3 
δ
13
C, ppm 
F8268-3-3 
δ
13
C, ppm 
F8268-3-4 
δ
13
C, ppm 
F8268-3-6 
δ
13
C, ppm 
F8268-3-7 
δ
13
C, ppm 
1 35.04 35.3 35.2 34.9 34.9 
2 27.80 30.4 30.5 27.2 27.2 
3 79.62 77.8 77.9 79.5 79.6 
4 75.99 78.0 77.5 76.2 76.1 
5 75.08 74.7 74.1 75.2 74.8 
6 27.80 27.2 27.1 27.2 27.1 
7 34.98 34.5 34.0 34.4 34.0 
8 37.55 37.0 37.0 37.7 37.0 
9 37.82 37.4 42.9 37.4 43.1 
10 39.96 39.5 40.0 39.2 39.9 
11 32.96 32.2 24.1 32.1 23.9 
12 72.49 72.5 27.5 72.4 27.5 
13 147.55 146.6 144.3 146.7 144.3 
14 56.20 55.8 55.6 55.8 55.7 
15 25.45 24.4 25.5 24.4 25.5 
16 116.73 116.3 108.8 116.3 108.7 
17 28.18 27.5 28.0 27.4 28.0 
18 23.16 21.0 21.0 21.9 21.9 
19 25.45 24.8 24.7 24.5 24.5 
20 20.66 19.5 19.5 19.5 19.6 
21 170.24   171.0 171.3 
22 21.18   20.0 20.2 
1'' 165.52 167.3 167.1 167.3 168.3 
2'' 101.16 100.6 103.0 100.5 102.8 
3'' 166.48 167.7 166.6 167.7 168.4 
4'' 107.72 108.5 107.7 108.4 108.5 
5'' 155.24 156.0 155.7 155.8 155.8 
6'' 10.31 9.0 9.2 8.96 9.3 
7'' 17.02 16.0 16.1 16.0 16.2 
Table 1.5: 
13
C NMR data of F8268-3 series compounds in CD3OD and 
NF00659A3 in pyridine-d5
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Evolving trends in the dereplication of natural product 
extracts: new methodology for rapid small-scale investigation 
of natural product extracts 
 
In addition to this paper work from this thesis has been 
presented at a total of seven Plenary or Invited oral 
presentations by Professors John Blunt and Murray Munro 
during 2007-2008 
Evolving trends in the dereplication of natural product 
extracts: new methodology for rapid small-scale investigation 
of natural product extracts 
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Publication Date (Web): August 19, 2008 (Article) 
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